<SEC-DOCUMENT>0001104659-25-045127.txt : 20250506
<SEC-HEADER>0001104659-25-045127.hdr.sgml : 20250506
<ACCEPTANCE-DATETIME>20250506172030
ACCESSION NUMBER:		0001104659-25-045127
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		25
CONFORMED PERIOD OF REPORT:	20250430
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
ITEM INFORMATION:		Change in Shell Company Status
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250506
DATE AS OF CHANGE:		20250506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Liminatus Pharma, Inc.
		CENTRAL INDEX KEY:			0001971387
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42626
		FILM NUMBER:		25918369

	BUSINESS ADDRESS:	
		STREET 1:		6 CENTERPOINTE DR.
		STREET 2:		#625
		CITY:			LA PALMA
		STATE:			CA
		ZIP:			90623
		BUSINESS PHONE:		213-273-5453

	MAIL ADDRESS:	
		STREET 1:		6 CENTERPOINTE DR.
		STREET 2:		#625
		CITY:			LA PALMA
		STATE:			CA
		ZIP:			90623

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Iris Parent Holding Corp.
		DATE OF NAME CHANGE:	20230328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2513673d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:LIMN="http://tribecapitalgrowthcorp.com/20250430">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_LIMN_tribecapitalgrowthcorp.com_20250430 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20250430_20250430 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001971387 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000005" name="dei:EntityCentralIndexKey">0001971387</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="limn-20250430.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001971387</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-30</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-302025-04-30_dei_FormerAddressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001971387</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-30</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-302025-04-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001971387</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-30</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-302025-04-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001971387</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-30</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_900_edei--DocumentType_c20250430__20250430_zzIyJzK8hLgd"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of
the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--DocumentPeriodEndDate_c20250430__20250430_zoehdMjUP5q5"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">April 30, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20250430__20250430_z7CAIdrFazca"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000012" name="dei:EntityRegistrantName">LIMINATUS PHARMA, INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 38%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250430__20250430_z1tRzlqw2xt8"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20250430__20250430_z6mJFwrcFm96"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000014" name="dei:EntityFileNumber">001-42626</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 38%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20250430__20250430_zg6Ind0Cwggg"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000015" name="dei:EntityTaxIdentificationNumber">93-2710748</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer </span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 76%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250430__20250430_ziQnMz8FF52c"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000016" name="dei:EntityAddressAddressLine1">6 Centerpointe Drive #625</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20250430__20250430_z2gRW2nfkqx6"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000017" name="dei:EntityAddressCityOrTown">La Palma</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20250430__20250430_zYSCxbbxFbS9"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000018" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 21%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20250430__20250430_z7HxsVbshAV6"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000019" name="dei:EntityAddressPostalZipCode">90623</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90B_edei--CityAreaCode_c20250430__20250430_zpuL9NEPELo1"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000020" name="dei:CityAreaCode">213</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20250430__20250430_zICw3yG8eXVc"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000021" name="dei:LocalPhoneNumber">273-5453</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90B_edei--EntityInformationFormerLegalOrRegisteredName_c20250430__20250430_zbVJ73rwVy3l"><ix:nonNumeric contextRef="AsOf2025-04-30" id="Fact000022" name="dei:EntityInformationFormerLegalOrRegisteredName">Iris Acquisition Corp</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_902_edei--EntityAddressAddressLine1_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_z8hZ2cVBtvVb"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" id="Fact000023" name="dei:EntityAddressAddressLine1">3rd Floor Zephyr House</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityAddressAddressLine2_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_zz0Hr6OejTNg"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" id="Fact000024" name="dei:EntityAddressAddressLine2">122 Mary Street, George Town</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine3_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_zPKQ14tuLrSg"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" id="Fact000025" name="dei:EntityAddressAddressLine3">PO Box 10085</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_906_edei--EntityAddressCityOrTown_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_zk19leeOsyo"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" id="Fact000026" name="dei:EntityAddressCityOrTown">Grand Cayman</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_zEUhLhr2mGH2"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" id="Fact000027" name="dei:EntityAddressPostalZipCode">KY1-1001</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCountry_c20250430__20250430__dei--EntityAddressesAddressTypeAxis__dei--FormerAddressMember_zCLoVc4SGCW9"><ix:nonNumeric contextRef="From2025-04-302025-04-30_dei_FormerAddressMember" format="ixt-sec:countrynameen" id="Fact000028" name="dei:EntityAddressCountry">Cayman Islands</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20250430__20250430_zeMg12DelmJl"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleanfalse" id="Fact000029" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_908_edei--SolicitingMaterial_c20250430__20250430_zHfQRvYDvwd9"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleanfalse" id="Fact000030" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20250430__20250430_zgQq2i6rvsO5"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleanfalse" id="Fact000031" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250430__20250430_z6MyGSzSGq"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleanfalse" id="Fact000032" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8PxMmXRhjv3"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember" id="Fact000033" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zISVJP2eXOkb"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember" id="Fact000034" name="dei:TradingSymbol">LIMN</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90D_edei--SecurityExchangeName_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjx8acFlR0b1"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember" format="ixt-sec:exchnameen" id="Fact000035" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zr02reTpRspi"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember" id="Fact000036" name="dei:Security12bTitle">Warrants</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_z4uSPrXLLS29"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember" id="Fact000037" name="dei:TradingSymbol">LIMNW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_908_edei--SecurityExchangeName_c20250430__20250430__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zhl9uk7ePye5"><ix:nonNumeric contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember" format="ixt-sec:exchnameen" id="Fact000038" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2 of the
Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Emerging growth
company </span><span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250430__20250430_zmFbbsz4yg7e"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleantrue" id="Fact000039" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityExTransitionPeriod_c20250430__20250430_zdIiWAvM7C45"><ix:nonNumeric contextRef="AsOf2025-04-30" format="ixt:booleanfalse" id="Fact000040" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTRODUCTORY NOTE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise stated or
unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Registrant,&#8221;
the &#8220;Combined Company,&#8221; the &#8220;Company&#8221; and &#8220;ParentCo&#8221; refer to Liminatus Pharma,&#160;Inc. (formerly
known as Iris Parent Holding Corp.), a Delaware corporation, after giving effect to the Business Combination (as defined below), and where
appropriate, our wholly-owned subsidiaries (including Liminatus Pharma, LLC) following the Closing Date (as defined below). Furthermore,
unless otherwise stated or unless the context otherwise requires, references to &#8220;Iris&#8221; refer to Iris Acquisition Corp (formerly
known as Tribe Capital Growth Corp I), a Delaware corporation, prior to the Closing Date, and references to &#8220;Liminatus&#8221; refer
to Liminatus Pharma, LLC, a Delaware limited liability company, prior to the Closing Date. All references herein to the &#8220;Board&#8221;
refer to the board of directors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Terms used in this Current
Report on Form&#160;8-K (this &#8220;Report&#8221;) but not defined herein, or for which definitions are not otherwise incorporated by
reference herein, shall have the meanings given to such terms in the <a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm" style="-sec-extract: exhibit">Proxy Statement/Prospectus filed by Iris with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on February&#160;7, 2025</a> (the &#8220;Proxy Statement/Prospectus&#8221;) and such definitions
are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Report incorporates by
reference certain information from reports and other documents that were previously filed with the SEC, including certain information
from the Proxy Statement/Prospectus. To the extent there is a conflict between the information contained in this Report and the information
contained in such prior reports and documents and incorporated by reference herein, the information in this Report controls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Closing of Business Combination</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;30, 2025 (the
 &#8220;Closing Date&#8221;), the Company completed the business combination contemplated by the Business Combination Agreement, dated
as of November&#160;30, 2022 (as it may be amended, supplemented or otherwise modified from time to time, the &#8220;Business Combination
Agreement&#8221;) by and among Iris, ParentCo, Liminatus Pharma Merger Sub,&#160;Inc., a Delaware corporation and wholly-owned subsidiary
of ParentCo (&#8220;Liminatus Merger Sub&#8221;), SPAC Merger Sub,&#160;Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo
(&#8220;SPAC Merger Sub&#8221; and together with Liminatus Merger Sub, the &#8220;Merger Subs&#8221;), and Liminatus. The Business Combination
Agreement was previously reported on the Current Report on Form&#160;8-K filed by Iris with the SEC on December&#160;1, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Completion of the Mergers</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As previously reported on
the Current Report on Form&#160;8-K filed by Iris with the SEC on March&#160;10, 2025,&#160;Iris held a special meeting of stockholders
on March&#160;4, 2025 (the &#8220;Special Meeting&#8221;). At the Special Meeting,&#160;Iris&#8217; stockholders approved the proposals
outlined in the Proxy Statement/Prospectus, including, among other things, adoption of the Business Combination Agreement and approval
of the transactions contemplated by the Business Combination Agreement, including: (a)&#160;the merger of Liminatus Merger Sub with and
into Liminatus (the &#8220;Liminatus Merger&#8221;), with Liminatus surviving the Liminatus Merger as a direct wholly-owned subsidiary
of ParentCo, and (b)&#160;simultaneously with the Liminatus Merger, the merger of SPAC Merger Sub with and into Iris (the &#8220;SPAC
Merger&#8221; and, together with the Liminatus Merger, the &#8220;Mergers&#8221;), with Iris surviving the SPAC Merger as a direct wholly-owned
subsidiary of ParentCo (the transactions contemplated by the foregoing clauses (a)&#160;and (b)&#160;the &#8220;Business Combination,&#8221;
and together with the other transactions contemplated by the Business Combination Agreement, the &#8220;Transactions&#8221;), and the
issuance of the Company&#8217;s securities as consideration thereunder, as described in the section titled &#8220;<i>The Business Combination
Proposal</i>&#8221; beginning on page&#160;103 of the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Closing Date, (i)&#160;Iris
effected the SPAC Merger by filing a certificate of merger with the Secretary of State of the State of Delaware in accordance with the
applicable provisions of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;), and (ii)&#160;the Company effected
the Liminatus Merger by filing a certificate of merger with the Secretary of State of the State of Delaware in accordance with the applicable
provisions of the Delaware Limited Liability Company Act (the &#8220;DLLC Act&#8221;), with each of the Mergers being consummated and
effective simultaneously as of April&#160;30, 2025. The certificates of merger are filed herewith as Exhibits 2.2 and 2.3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Business
Combination, the Company filed an amended and restated certificate of incorporation (the &#8220;ParentCo Certificate of Incorporation&#8221;),
which, among other things, changed the Company&#8217;s name to &#8220;Liminatus Pharma,&#160;Inc.&#8221; The ParentCo Certificate of Incorporation
is filed herewith as Exhibit&#160;3.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Closing Date, the Business
Combination, among other transactions contemplated by the Business Combination Agreement, was completed (the &#8220;Closing&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Effect of the Business Combination on Existing
Iris Equity</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Business Combination
Agreement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(i)</td><td style="text-align: justify">immediately prior to the effective time of the Mergers (the &#8220;Effective Time&#8221;), every issued
and outstanding Iris Unit automatically separated into its constituent parts and the holder thereof were deemed to hold one share of Iris
Class&#160;A Common Stock, par value $0.0001 per share (the &#8220;Iris Class&#160;A Shares&#8221;) and one-fourth of one whole redeemable
warrant that was included as part of each Iris Unit (the &#8220;Public Warrants&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(ii)</td><td style="text-align: justify">at the Effective Time, each issued and outstanding Iris Class&#160;A Share converted automatically into
one share of common stock, par value $0.0001 per share of ParentCo (&#8220;ParentCo Common Stock&#8221;), following which all Iris Class&#160;A
Shares were automatically cancelled and ceased to exist and be outstanding;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(iii)</td><td style="text-align: justify">at the Effective Time, each issued and outstanding Public Warrant, in accordance with the terms of the
Warrant Agreement, immediately and automatically converted into the right to purchase shares of ParentCo Common Stock on the same terms
and conditions as are set forth in the Warrant Agreement (each a &#8220;ParentCo Public Warrant&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(iv)</td><td style="text-align: justify">at the Effective Time, each issued and outstanding non-redeemable warrant of Iris that was issued by Iris
in a private placement at the time of the consummation of its initial public offering, entitling the holder thereof to purchase one Iris
Class&#160;A Share at $11.50 per share (the &#8220;Private Placement Warrants&#8221;), except those issued to Cantor Fitzgerald&#160;&amp;
Co. (&#8220;Cantor&#8221;), were forfeited; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(v)</td><td style="text-align: justify">at the Effective Time and in accordance with the Warrant Agreement, each Private Placement Warrant issued
to Cantor immediately and automatically converted into the right to purchase shares of ParentCo Common Stock on the same terms and conditions
as are set forth in the Warrant Agreement (each a &#8220;ParentCo Private Placement Warrant&#8221;).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Effective Time, each
share of common stock of SPAC Merger Sub outstanding immediately prior to the Effective Time converted into an equal number of shares
of common stock of Iris each of which is held by ParentCo, with the same rights, powers and privileges as the shares so converted, and
such shares constituted the only outstanding shares of capital stock of Iris.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Merger Consideration</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Closing, pursuant
to the terms of the Business Combination Agreement, the aggregate consideration paid in the Transactions to the direct or indirect
owners of Liminatus consisted of 17.5 million shares of ParentCo Common Stock (based on a deemed price of $10.00 per share of
ParentCo Common Stock).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Business Combination does not purport to be complete and is qualified in its entirety by reference to the full text of the Business
Combination Agreement and the amendments to the Business Combination Agreement, which are filed herewith as Exhibit&#160;2.1 and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sponsor Forfeiture</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Business
Combination, pursuant to the terms of the Sponsor Forfeiture Agreement,&#160;Iris Acquisition Holdings LLC, a Delaware limited liability
company (the &#8220;Sponsor&#8221;), forfeited 4,177,778 Private Placement Warrants effective immediately prior to the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PIPE Equity Investment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently with the Closing
of the Business Combination, pursuant to the terms of the PIPE Equity Subscription Agreement, the Company completed its PIPE Equity Investment,
issuing and selling 1,500,000 shares of ParentCo Common Stock in a private placement to an accredited investor (the &#8220;PIPE Investor&#8221;),
at a purchase price per share of $10.00, for an aggregate purchase price of $15,000,000, issued in reliance on the exemption provided
by Section&#160;4(a)(2)&#160;of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01. Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The disclosure set forth in
the &#8220;Introductory Note&#8221; above is incorporated into this Item 1.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Amended and Restated Registration Rights Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Closing Date, ParentCo
entered into an Amended and Restated Registration Rights Agreement (the &#8220;RRA&#8221;) with the Sponsor, Cantor, certain former members
of Liminatus and the PIPE Investor. Pursuant to the RRA, ParentCo agreed to file a resale shelf registration statement on behalf of the
ParentCo security holders party to the agreement within 30 days after the closing of the Business Combination. The RRA also provides certain
demand rights and piggyback rights to ParentCo stockholders, subject to certain specified underwriter cutbacks and issuer blackout periods.
ParentCo will bear all costs and expenses incurred in connection with the resale shelf registration statement, any demand registration
statement, any underwritten takedown, any block trade, any piggyback registration statement prior to its withdrawal and all expenses incurred
in performing or complying with its other obligations under the RRA, whether or not the registration statement becomes effective. The
RRA will terminate with respect to any holder party thereto, on the date that such holder party no longer holds any registrable securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the RRA does not purport to be complete and is qualified in its entirety by the terms and conditions of the RRA, which is filed herewith
as Exhibit&#160;10.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lock-Up Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently with the execution
of the Business Combination Agreement, ParentCo entered into a Lock-Up Agreement (the &#8220;Lock-Up Agreement&#8221;) with the Sponsor
and certain Liminatus Members with respect to the shares of ParentCo Common Stock issued as consideration under the Business Combination
Agreement. The Lock-Up Agreement includes, among other things, the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain Liminatus Members
will not be able to transfer any shares of ParentCo Common Stock beneficially owned or otherwise held by them for a period that is the
earlier of: (a)&#160;for one-third of the shares, six months after the Closing Date, for one-third of the shares, twelve months after
the Closing Date; and for one-third of the shares, twenty-four months after the Closing Date; (b)&#160;the date on which the closing price
of the ParentCo Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and similar transactions) for any 20 trading days within any 30-trading day period; or (c)&#160;the date on which ParentCo completes a
liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of ParentCo&#8217;s stockholders
having the right to exchange their shares of ParentCo common stock for cash, securities or other property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by the full text of the Lock-Up Agreement, which
is filed herewith as Exhibit&#160;10.2 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Indemnification Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Closing Date, the Company
entered into indemnification agreements with each of its directors and executive officers. These indemnification agreements require the
Company to indemnify its directors and executive officers for certain expenses, including attorneys&#8217; fees, judgments, fines and
settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of the
Company&#8217;s directors or executive officers or any other company or enterprise to which the person provides services at the Company&#8217;s
request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the indemnification agreements does not purport to be complete and is qualified in its entirety by the full text of the form of indemnification
agreement, which is filed herewith as Exhibit&#160;10.5 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 2.01. Completion of Acquisition or Disposition
of Assets.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The disclosure set forth in
the &#8220;Introductory Note&#8221; above is incorporated into this Item 2.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the vote
at the Special Meeting on March&#160;4, 2025, public stockholders holding 59,844 Iris Class&#160;A Shares exercised their right to redeem
such shares for a pro rata portion of the funds in the trust account established at the consummation of Iris&#8217; initial public offering
(the &#8220;Trust Account&#8221;). As a result, approximately $702,359 (approximately $11.74 per share) was removed from the Trust Account
to pay such holders. Immediately after giving effect to the redemption of 59,844 Iris Class&#160;A Shares in connection with the Business
Combination, there were 114,633 public shares and 6,900,000 public warrants outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of the
Business Combination,&#160;Iris&#8217;s Class&#160;A common stock, units and public warrants ceased trading on the OTC Pink Marketplace,
and ParentCo Common Stock and ParentCo Public Warrants began trading on The Nasdaq Stock Market (&#8220;Nasdaq&#8221;) on May&#160;1,
2025, under the symbols &#8220;LIMN&#8221; and &#8220;LIMNW,&#8221; respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;10 INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Item 2.01(f)&#160;of Form&#160;8-K
states that if the predecessor registrant was a shell company, as Iris was immediately before the Business Combination, then the registrant
must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form&#160;10.
Accordingly, the Company, as the successor issuer to Iris, is providing the information below that would be included in a Form&#160;10
if the Company were to file a Form&#160;10. Please note that the information provided below relates to the Company as the combined company
after the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Forward-Looking Statements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain statements contained
in this Report may constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act and
Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and for purposes of the &#8220;safe
harbor&#8221; provisions of the United States Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements
regarding the financial position, business strategy and the plans and objectives of management for future operations, including as they
relate to the Company. These statements constitute projections, forecasts, and forward-looking statements, and are not guarantees of performance.
Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this Report,
forward-looking statements may be identified by the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221;
 &#8220;estimate,&#8221; &#8220;future,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;strategy,&#8221; &#8220;opportunity,&#8221;
 &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221;
 &#8220;scales,&#8221; &#8220;representative of,&#8221; &#8220;valuation,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221;
 &#8220;will be,&#8221; &#8220;will continue,&#8221; &#8220;will likely result,&#8221; or other similar expressions that predict or indicate
future events or trends or that are not statements of historical facts. In addition, any statements that refer to projections, forecasts
or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company cautions readers
of this Report that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and
many of which are beyond the Company&#8217;s control, which could cause the actual results to differ materially from the expected results.
These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance
metrics, revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, other
performance metrics, projections of market opportunity, expected management and governance of the Company. These statements are based
on various assumptions, whether or not identified in this Report, and on the current expectations of the Company&#8217;s management and
are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended
to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or
probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. The risk factors
and cautionary language contained in this Report, and incorporated herein by reference, provide examples of risks, uncertainties and events
that may cause actual results to differ materially from the expectations described in such forward-looking statements, including among
other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td><td style="text-align: justify">changes in the competitive industries and markets in which the Company operates or plans to operate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">changes in applicable laws or regulations affecting the Company&#8217;s business;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company&#8217;s ability to implement business plans, forecasts, and other expectations after the completion
of the Business Combination, and identify and realize additional opportunities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">risks related to the Company&#8217;s potential inability to achieve or maintain profitability and generate
significant revenue;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">current and future conditions in the global economy, including as a result of economic uncertainty, and
its impact on the Company, its business and the markets in which it operates;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company&#8217;s potential inability to manage growth effectively;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company&#8217;s ability to recruit, train and retain qualified personnel;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">estimates for the prospects and financial performance of the Company&#8217;s business may prove to be
incorrect or materially different from actual results;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">costs related to the Business Combination and the failure to realize anticipated benefits of the Business
Combination;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">risks related to the Company&#8217;s marketing and growth strategies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the effects of competition on the Company&#8217;s business;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">expectations with respect to future operating and financial performance and growth, including when the
Company will generate positive cash flow from operations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company&#8217;s ability to raise funding on reasonable terms as necessary to develop its products
in the timeframe contemplated by its business plan;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the inability to maintain the listing of the Company&#8217;s common stock and warrants on Nasdaq following
the Business Combination;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">other risks and uncertainties indicated in this Report, including those under &#8220;Risk Factors&#8221;
beginning on page&#160;26 in the Proxy Statement/Prospectus and other filings that have been made or will be made with the SEC by the
Company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, there may be
events that the Company&#8217;s management is not able to predict accurately or over which the Company has no control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The business of the Company
is described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Business of Liminatus</i>&#8221; beginning on page&#160;184,
which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risk Factors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The risks associated with
the Company are described in the Proxy Statement/Prospectus, including those under &#8220;Risk Factors&#8221; beginning on page&#160;26
in the Proxy Statement/Prospectus and specifically including in the sections titled &#8220;Risk Factors &#8211; Risks Related to Liminatus&#8217;s
Business and Operations&#8221; beginning on page&#160;26 of the Proxy Statement/Prospectus, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Information</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited financial statements
of ParentCo for the fiscal years ended December&#160;31, 2024 and 2023 are filed herewith as Exhibit&#160;99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited financial statements
of Liminatus for the fiscal years ended December&#160;31, 2024 and 2023 are filed herewith as Exhibit&#160;99.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited financial statements
of Iris for the fiscal years ended December&#160;31, 2024 and 2023 are incorporated by reference to pages&#160;52-75 in the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1831874/000141057825000751/iraa-20241231x10k.htm" style="-sec-extract: exhibit">Annual Report on Form&#160;10-K for the year ended December&#160;31, 2024 filed by Iris with the SEC on April&#160;16, 2025</a> (the &#8220;Iris Form&#160;10-K&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Properties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The business address of Liminatus&#8217;s
principal executive office is 6 Centerpointe Dr.&#160;#625, La Palma, California 90623.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company believes that
all of its properties have been adequately maintained, are generally in good condition, are suitable and adequate for its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations of Liminatus for the fiscal years ended December&#160;31, 2024 and 2023
is set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Unless the context otherwise
requires, for purposes of this section, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;the Company&#8221; or
 &#8220;Liminatus&#8221; refer to Liminatus Pharma, LLC prior to the consummation of the Business Combination. You should read the following
discussion and analysis of our financial condition and results of operations together with our financial statements and related notes
included elsewhere in this report. Some of the information contained in this discussion and analysis or set forth elsewhere in this report,
including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements
that involve risks, uncertainties, and assumptions. As a result of many factors, including those set forth in the &#8220;Risk Factors&#8221;
section of <i>this filing</i>, our actual results could differ materially from the results described in or implied by the
forward-looking statements contained in the following discussion and analysis.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a pre-clinical
stage life sciences and pre-revenue company developing a next generation CD47 checkpoint inhibitor under a license agreement. In October&#160;2022,
the Company was assigned a license and development agreement, as amended, with InnoBation Bio Co. Ltd (&#8220;InnoBation&#8221;) (the
 &#8220;CD47 License&#8221;), whereby, effective March&#160;31, 2023, the Company received an exclusive license to develop and commercialize
products for the CD47 immune checkpoint inhibitor to treat solid cancers, and companion diagnostics used to monitor treatment with CD47
products (collectively, &#8220;CD47 Products&#8221;), from Curis Biotech Holdings LLC, the parent company of Valetudo Therapeutics LLC
(&#8220;Valetudo&#8221;), a related party of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We were formed
in Delaware on April&#160;12, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since
our inception, our operations have focused on raising capital and entering into license and development agreements for conducting
research and development activities for our products. We do not have any product candidates approved for sale and have not generated
any revenue from product sales. We have funded our operations through the sale of equity, raising an aggregate of $4.5 million of
gross proceeds from the sale of membership interests, and debt, issuing $10.0 million of bonds and $10.0 million of notes through
December&#160;31, 2024. Subsequent to December&#160;31, 2024, the Company raised additional gross proceeds of $0.7 million of notes
with Amantes, LLC (&#8220;Amantes&#8221;) and Prophase Sciences LLC (&#8220;Prophase&#8221;), both of which are related parties of
the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since our
inception, we have incurred significant operating losses. Our net loss was $3.5 million and $5.0 million for the years ended December&#160;31,
2024 and 2023, respectively. As of December&#160;31, 2024, we had an accumulated deficit of $28.7 million. We anticipate that our expenses
will increase significantly in connection with our ongoing activities, as we:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">conduct clinical trials for our CD47 product, as well as initiate and complete additional trials of future
potential product candidates;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">seek regulatory approval for any product candidates that successfully complete clinical trials;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">scale up our clinical and regulatory capabilities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">manufacture materials for clinical trials or potential commercial sales;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">establish a commercialization infrastructure and scale up manufacturing and distribution capabilities
to commercialize any product candidates for which we may obtain regulatory approval;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">adapt our regulatory compliance efforts to incorporate requirements applicable to marketed products;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">maintain, expand, and protect our intellectual property portfolio;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">hire additional clinical, manufacturing quality control, regulatory, manufacturing, and scientific and
administrative personnel;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">add operational, financial and management information systems and personnel, including personnel to support
our product development and planned future commercialization efforts; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">incur additional legal, accounting, and other expenses in operating as a public company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Combination</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;30,
2022, we entered into a business combination agreement (the &#8220;Business Combination Agreement&#8221;), with Iris Acquisition Corp,
a Delaware publicly traded special purpose acquisition company (&#8220;Iris&#8221;),&#160;Iris Parent Holding Corp., a Delaware corporation
(&#8220;ParentCo&#8221;), Liminatus Pharma Merger Sub,&#160;Inc., a wholly-owned subsidiary of ParentCo (&#8220;Liminatus Merger Sub&#8221;),
and SPAC Merger Sub,&#160;Inc., a wholly-owned subsidiary of ParentCo (&#8220;SPAC Merger Sub&#8221; and together with Liminatus Merger
Sub, the &#8220;Merger Subs&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;1,
2023, we entered into an amendment to the Business Combination Agreement to extend the Outside Date, as defined in the Business Combination
Agreement, to September&#160;11, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;14,
2023, we entered into a second amendment to the Business Combination Agreement to extend the Outside Date, as defined in the Business
Combination Agreement, to March&#160;9, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;9,
2024, we entered into a third amendment to the Business Combination Agreement to extend the Outside Date, as defined in the Business Combination
Agreement, to July&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;19,
2024, we entered into a fourth amendment to the Business Combination Agreement to extend the Outside Date, as defined in the Business
Combination Agreement, to September&#160;3, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;16,
2024, we entered into a fifth amendment to the Business Combination Agreement to extend the Outside Date, as defined in the Business Combination
Agreement, to December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&#160;23,
2024, we entered into a sixth amendment to the Business Combination Agreement to, among other things, reduce the enterprise value associated
with the Company to $175 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">On
</span>December&#160;26, 2024, we entered into a seventh amendment to the Business Combination Agreement to extend the Outside Date<span style="color: #231f20">,
as defined in the Business Combination Agreement,</span> to June&#160;30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration
of the Liminatus Merger, our securityholders will receive 17,500,000 newly issued shares of ParentCo&#8217;s common stock with an aggregate
equity value of $175.0 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">Pursuant
to the Business Combination Agreement, on </span>April&#160;30, 2025<span style="color: #231f20">, in sequential order: (a)&#160;Liminatus
Merger Sub merged with and into Liminatus, with Liminatus continuing as the surviving company and a wholly owned subsidiary of ParentCo
(the &#8220;Liminatus Merger&#8221;) and (b)&#160;simultaneously with the Liminatus Merger, SPAC Merger Sub merged with and into Iris
(the &#8220;SPAC Merger,&#8221; together with the Liminatus Merger (the &#8220;Mergers&#8221;)), with Iris surviving the SPAC Merger as
a direct wholly-owned subsidiary of ParentCo.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>License Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>TDT Licenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June&#160;2018,
we entered into a license and development agreement with TDT (the &#8220;CAR-T License&#8221;), whereby we received an exclusive license
to develop and commercialize CAR-T products and a non-exclusive license to develop and commercialize companion diagnostics used to monitor
treatment with a CAR-T product (the &#8220;CAR-T Diagnostics&#8221;). Under the CAR-T License, we made an upfront payment recorded as
research and development expenses in the year ended December&#160;31, 2018 and fund all of the development costs for the CAR-T products
and the CAR-T Diagnostics which began with an additional upfront payment made during the year ended December&#160;31, 2018 of $5.0 million,
recorded as advances for research and development in the balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;10, 2020, we
were assigned a license and development agreement with TDT (the &#8220;Vaccine License&#8221;), whereby we received an exclusive license
to develop and commercialize vaccine products and a non-exclusive license to develop and commercialize companion diagnostics used to monitor
treatment with a vaccine product, from Viral Gene,&#160;Inc. (&#8220;Viral Gene&#8221;), our related party due to the fact that Viral
Gene and Liminatus share a mutual Chief Executive Officer. Under the Vaccine License, we were responsible for all of the developmental
costs for the Vaccine products after the upfront payment of $4.0 million, which was paid by Viral Gene to TDT.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the assignment
of the Vaccine License on April&#160;10, 2020, we recorded advances for research and development of $1.8 million for the remaining amount
of the upfront payment to TDT to be used on research and development costs and short-term debt of $0.4 million and accrued interest of
$18,000 for the outstanding loan and related interest due to TDT for the annual fee that was not paid by Viral Gene, with an offset of
$1.0 million recorded to additional paid-in capital in the balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;11,
2024, the Company received notice from TDT, exercising its right to terminate the License and Development Agreement, dated June&#160;10,
2018, by and between TDT and Liminatus. As of August&#160;2024, the CAR-T License and Vaccine License have been terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31,
2024, the Company and TDT are engaged in negotiations associated with the amounts due to TDT of $2.2 million, which has been accrued on
the Company&#8217;s balance sheet. Due to the termination of the License and Development Agreement between the Company and TDT, the Company
is uncertain as to amounts it will be required to pay to TDT, if any. As of December&#160;31, 2024, no agreement has been reached between
the parties, and the amount remains fully accrued until a final agreement has been executed between the two parties in accordance with
ASC 450-30, <i>Contingencies - Gain Contingencies</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Metavagen License</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2022,
we entered into a Subscription Agreement In Kind (the &#8220;Metavagen License&#8221;) with Metavagen LLC (&#8220;Metavagen&#8221;), owned
by Chris Kim and thus an entity under common control with us, whereby we received the license rights initially granted from InnoBation
to Metavagen to develop, market and sell YN1203,&#160;InnoBation Bio CAR NK biomarkers, including devices, compounds and products used
to detect analyte in body or tissue in exchange for 40,000,000 shares of our Class&#160;A member units. The Metavagen License transaction
was consummated as we had the right to use the license, but the license was not transferred. The license is recorded at Metavagen&#8217;s
cost basis of zero, thus we recorded Class&#160;A membership interest of $0.4 million, for the par value of the units issued, with an
offsetting reduction to additional paid-in capital. In March&#160;2023, the Metavagen License was cancelled, and our membership interest
was returned. As our cost basis of the license is zero, we recorded the reversal of the membership interest of $0.4 million with an offsetting
increase to additional paid-in capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>CD47 License with InnoBation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&#160;1,
2022, we signed an agreement, as amended (the &#8220;CD47 Assignment Agreement&#8221;), to be assigned the License and Development Agreement
by and between InnoBation and Valetudo, our related party and an entity under common control with us, effective March&#160;31, 2023. Under
the CD47 Assignment Agreement, we received exclusive worldwide rights to develop and commercialize the CD47 immune checkpoint inhibitor
to treat solid cancers, and companion diagnostics used to monitor treatment with CD47 products. On March&#160;31, 2023, we issued 78,555,554
shares of our Class&#160;A member units to Curis Biotech Holdings LLC, the parent company of Valetudo, as consideration for the CD47 Assignment
Agreement. The license was recorded at Valetudo&#8217;s costs basis of zero, thus we recorded class A membership interest of $0.8 million,
for the par value of the units issued, with an offset to additional paid-in capital in our balance sheet. We will also pay license fees
and management fees to be mutually agreed with InnoBation from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not
paid and do not owe any license fees, management fees, developmental or regulatory milestone payments or royalty payments under the CD47
License to date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Components of Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, we
have not generated any revenue from any sources, including from product sales, and we do not expect to generate any revenue from the sale
of products in the foreseeable future. If our development efforts for our product candidates are successful and result in regulatory approval,
or license agreements with third parties, we may generate revenue in the future from product sales. However, there can be no assurance
as to when we will generate such revenue, if at all.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Operating Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and Development Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and
development costs primarily consist of costs incurred by TDT who was performing our preclinical and clinical trials for our products in
accordance with the license agreements with TDT and the annual fee paid to TDT. Research and development expenses are recognized as incurred
and payments made prior to costs being incurred are capitalized until the costs are incurred. Costs incurred in obtaining technology licenses
through asset acquisitions are charged to research and development expense if the licensed technology has not reached technological feasibility
and has no alternative future use. Research and development expenses could include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">external research and development expenses incurred under agreements with clinical research to conduct
our preclinical studies, including:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">labor costs for TDT employees involved in research and development efforts;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">costs related to manufacturing material for preclinical studies and clinical trials, including fees paid
to contract manufacturing organizations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">laboratory supplies and research materials;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">costs related to compliance with regulatory requirements; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">allocated expenses for facilities, depreciation, and other allocated cost.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and
development activities are central to our business model. Product candidates in later stages of clinical development generally have higher
development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage
clinical trials. We plan to substantially increase our research and development expenses for the foreseeable future as we develop our
product candidates and manufacturing processes and conduct discovery and research activities for our preclinical and clinical programs.
We cannot determine with certainty the timing of initiation, the duration or the completion costs of current or future preclinical studies
and clinical trials of our product candidate due to the inherently unpredictable nature of preclinical and clinical development. Clinical
and preclinical development timelines, the probability of success and development costs can differ materially from expectations. We anticipate
that we will make determinations as to how we pursue our product candidate and how much funding to direct to each program on an ongoing
basis in response to the results of future preclinical studies and clinical trials, regulatory developments, and our ongoing assessments
as to commercial potential. We will need to raise substantial additional capital in the future. Our clinical development costs are expected
to increase significantly as we commence, continue, and expand our clinical trials. Our future expenses may vary significantly each period
based on factors such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">per patient clinical trial costs, including based on the number of doses that patients receive;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the number of patients who enroll in each clinical trial;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the number of clinical trials required for approval;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the number of sites included in the clinical trials;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the countries in which the clinical trials are conducted;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the length of time required to enroll eligible patients;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the drop-out or discontinuation rates of patients;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">potential additional safety monitoring requested by regulatory agencies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the duration of patient participation in the clinical trials and follow-up;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the phase of development of the product candidate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">third party contractors failing to comply with regulatory requirements or meet their contractual obligations
to us in a timely manner, or at all;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the cost of insurance, including product liability insurance, in connection with clinical trials;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">regulators or institutional review boards requiring that we or our investigators suspend or terminate
clinical development for various reasons, including noncompliance with regulatory requirements or a finding that the participants are
being exposed to unacceptable health risks; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the efficacy and safety profile of our product candidates.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and Administrative
Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and
administrative expenses currently consist of consulting fees for the chief executive officer and professional fees for legal costs relating
to our corporate matters, accounting and tax services and travel expenses. Other general and administrative expenses may also include
professional fees for patents, insurance costs and board of directors&#8217; expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate
that our general and administrative expenses will increase in the future as we continue to support research and development activities
and incur increased costs of operating a public company. These costs include increased headcount to support expanded operations and infrastructure,
and the initiation, continuation and expansion of our preclinical studies and clinical trials for our product candidates. Additionally,
we anticipate increased costs associated with maintaining compliance with Nasdaq rules&#160;and SEC requirements such as accounting, audit,
legal and consulting services, as well as director and officer liability insurance, investor, and public relations activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations for the
Years Ended December&#160;31, 2024 and 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and Administrative
Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and
administrative expenses were $0.6 million for the year ended December&#160;31, 2024 as compared to $1.0 million for the year ended December&#160;31,
2023. The decrease of $0.4 million was primarily related to decreases in accounting and legal costs related to the Business Combination
and general corporate matters during the year ended December&#160;31, 2024 as compared to the year ended December&#160;31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and Development Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">Research
and development expenses were $2.7 million for the year ended December&#160;31, 2024 as compared to $3.8 million for the year ended December&#160;31,
2023.</span> The decrease of $1.1 million was primarily related to decreased spending for preclinical and clinical trials for both the
CAR-T products and the GCC vaccine products because of the termination of the CAR-T License and Vaccine License during the year ended
December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other Income and Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest
expense was $0.3 million for the year ended December&#160;31, 2024 as compared to $0.2 million for the year ended December&#160;31,
2023. The increase of $0.1 million was primarily related to additional borrowings from Valetudo, Prophase, Hana Immunotherapeutics,
LLC and Amantes during the year ended December&#160;31, 2024. Interest income was $0.1 million for the year ended December&#160;31,
2024 as compared to approximately $10,000 for the year ended  December&#160;31, 2023. The increase in interest income was
primarily related to the issuance of $2.9 million in loans receivable to Iris during the year ended December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern, Liquidity and
Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Overview</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since our
inception, we have not generated any revenue and expect to continue to incur significant operating losses for the foreseeable future and
may never become profitable. As of December&#160;31, 2024, we had cash of approximately $56,000. We have funded our operations through
the sale of equity, raising an aggregate of $4.5 million of gross proceeds from the sale of membership interests, and debt, issuing $10.0
million of bonds and $10.0 million of notes through December&#160;31, 2024. Subsequent to December&#160;31, 2024, the Company raised additional
gross proceeds of $0.7 million of notes with Amantes  and Prophase, both of which are related parties of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Going Concern</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company
evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to
continue as a going concern over the next twelve months after the financial statements are issued. The Company&#8217;s cash requirements
include, but are not limited to, research and development costs, license fees and working capital requirements. Due to these cash requirements,
the Company does not believe that it will have sufficient cash to fund operations for one year after the date that the accompanying financial
statements are issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company
has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the
accompanying financial statements are issued. The Company&#8217;s financial statements do not include any adjustments relating to the
recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue
as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company
intends to raise additional cash through equity financings, debt financings or other arrangements to fund operations; however, there can
be no assurance that the Company will be able to raise adequate capital under acceptable terms, if at all. The sale of additional equity
may dilute existing members and newly issued member units may contain senior rights and preferences compared to currently outstanding
ordinary shares. Issued debt securities may contain covenants and limit the Company&#8217;s ability to pay dividends or make other distributions
to members. If the Company is unable to obtain such additional financing, future operations would need to be reevaluated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital Requirements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, we
have not generated any revenues from any source, including the commercial sale of approved drug products, and we do not expect to generate
revenue for at least the next few years. If we fail to complete the development of our product candidate in a timely manner or fail to
obtain their regulatory approval, our ability to generate future revenue will be adversely affected. We do not know when, or if, we will
generate any revenue from our product candidate, and we do not expect to generate revenue unless and until we obtain regulatory approval
of, and commercialize, our product candidate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect
our expenses to increase significantly in connection with our ongoing activities, particularly as we continue the research and development
of, and seek marketing approval for, our product candidate. In addition, if we obtain approval for our product candidate, we expect to
incur significant commercialization expenses related to sales, marketing, manufacturing, and distribution. Furthermore, following the
completion of the Business Combination, we expect to incur additional costs associated with operating as a public company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will also
be required to pay all clinical trial costs and expenses in connection with the development of the CD47 Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also required to repay
our $10.0 million bonds (the &#8220;Feelux Bonds&#8221;) to Feelux Co.,&#160;Ltd. (&#8220;Feelux&#8221;), our shareholder through its
wholly owned subsidiary Car-Tcellkor,&#160;Inc. (&#8220;Car-Tcellkor&#8221;), issued in 2018 and the related interest of 1% per annum
compounded annually which is expected to be settled through the issuance of ParentCo common shares, our $0.8 million loan issued in 2019
and due in May&#160;2023, that does not bear interest, from Car-Tcellkor, our shareholder and a wholly owned subsidiary of Feelux, our
loans with Valetudo, our related party, of $0.7 million (the &#8220;Valetudo Loan&#8221;) issued in December&#160;2022 and due in June&#160;2023,
and which bears no interest, our loan with Ewon Comfortech Co.,&#160;Ltd. (&#8220;Ewon&#8221;), our shareholder and related party, of
$2.0 million (the &#8220;Ewon Loan&#8221;) issued in December&#160;2022 and due in December&#160;2023, and related interest of 2% per
annum, our loans with Valetudo of $0.5 million issued in June&#160;2023 and due in December&#160;2023 that does not bear interest (the
&#8220;Valetudo June&#160;2023 Loans&#8221;), our additional loan with Valetudo of $0.3 million issued in July&#160;2023 and due in January&#160;2024,
and related interest of 6% per annum (the &#8220;Valetudo July&#160;2023 Loan&#8221;), our loans with Valetudo issued in August&#160;2023
totaling $0.4 million, due in January&#160;and February&#160;2024, and related interest of 6% per annum (the &#8220;Valetudo August&#160;2023
Loans&#8221;), our additional loan with Ewon of $0.2 million issued in September&#160;2023 and due in September&#160;2024 and related
part interest of 2% per annum (the &#8220;Ewon September&#160;2023 Loan&#8221;), our additional loan with Valetudo of $0.2 million issued
in November&#160;2023, due in January&#160;2024 and related interest of 6% per annum (the &#8220;Valetudo November&#160;2023 Loan&#8221;),
our other loan with Ewon of $1.0 million issued in December&#160;2023, due in December&#160;2024 that bears no interest (the &#8220;Ewon
December&#160;2023 Loan&#8221;), our loans with Valetudo issued in January&#160;2024 totaling $0.8 million, due in February&#160;2024,
and related interest of 6% per annum (the &#8220;Valetudo January&#160;2024 Loans&#8221;), our loan with Prophase Sciences LLC (&#8220;Prophase&#8221;)
of $0.2 million issued February&#160;2024 that bears 6% interest per annum and due June&#160;1, 2024 (the &#8220;Prophase February&#160;2024
Loan&#8221;), our loan with Prophase issued in March&#160;2024 of $0.3 million that bears interest of 6% per annum and due June&#160;1,
2024 (the &#8220;Prophase March&#160;2024 Loan&#8221;), our loan with Prophase issued in April&#160;2024 of $0.3 million that bears interest
of 6% per annum and due June&#160;1, 2024 (the &#8220;Prophase April&#160;2024 Loan&#8221;), our loans with Prophase issued in May&#160;2024
totaling $0.8 million that bears interest of 6% per annum and due June&#160;1, 2024 and July&#160;1, 2024 (the &#8220;Prophase May&#160;2024
Loans&#8221;), our loans with Prophase issued in July&#160;2024 of $0.1 million that bears interest of 6% per annum and due September&#160;14,
2024, September&#160;24, 2024 and September&#160;29, 2024 (the &#8220;Prophase July&#160;2024 Loans&#8221;), our loans with Prophase issued
in August&#160;2024 of $0.1 million that bears interest of 6% per annum and due October&#160;12, 2024 and October&#160;13, 2024 (the &#8220;Prophase
August&#160;2024 Loans&#8221;), our loan with Hana Immunotherapeutics, LLC (&#8220;Hana&#8221;) issued in August&#160;2024 of $0.3 million
that bears interest of 6% per annum and due September&#160;30, 2024 (the &#8220;Hana Loan&#8221;), our loan with Hana issued in August&#160;2024
of $0.6 million that bears interest of 6% per annum and due October&#160;26, 2024 (the &#8220;Hana August&#160;2024 Loan&#8221;), our
loans with Amantes LLC (&#8220;Amantes&#8221;) issued November&#160;2024 totaling $0.7 million that bear interest of 6% per annum and
due January&#160;1, 2025 (the &#8220;Amantes November&#160;2024 Loans&#8221;), our loans with Amantes issued in January&#160;2025 totaling
$0.3 million that bear interest of 6% per annum and due March&#160;1, 2025 and March&#160;22, 2025 (the &#8220;Amantes January&#160;2025
Loans&#8221;), our loan with Prophase issued in February&#160;2025 of $0.2 million that bears interest of 6% per annum and due April&#160;11,
2025 (the &#8220;Prophase February&#160;2025 Loan&#8221;), our loan with Prophase issued in March&#160;2025 of $0.2 million that bears
interest of 6% per annum and due June&#160;6, 2025 (the &#8220;Prophase March&#160;2025 Loan&#8221;), and our loans with Prophase issued
April 2025, totalling $3.6 million that bear interest at 6% per annum and are due May 2, 2025, May 13, 2025, and May 14, 2025 (the &#8220;Prophase
April 2025 Loans&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the Company&#8217;s loans
are with related parties, the Company and its related parties have mutually agreed to defer repayment of the past due loans until the
completion of the Business Combination. As such, the Company deems that it is not in default of its loan agreements. <span style="color: #231F20">Such
amounts were still due and payable subsequent to the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We therefore anticipate that
we will need substantial additional funding in connection with our continuing operations. After the completion of the Business Combination,
on a pro forma basis, the Company had approximately $12.0 million in cash and cash equivalents. We intend to devote most of the net proceeds
from the Business Combination to clinical development of our product candidates, repaying our debt, our public company compliance costs
and certain of the milestone payments under the CAR-T License and the Vaccine License agreements, if any. Based on our current business
plans, we believe that the anticipated net proceeds from the Business Combination will enable us to fund our operating expenses and capital
requirements through at least the next twelve months. Our estimate as to how long we expect the net proceeds from the Business Combination
to be able to fund our operating expenses and capital requirements is based on assumptions that may prove to be wrong, and we could use
our available capital resources sooner than we currently expect. Changing circumstances, some of which may be beyond our control, could
result in fewer cash and cash equivalents available to us or cause us to consume capital significantly faster than we currently anticipate,
and we may need to seek additional funds sooner than planned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of
the numerous risks and uncertainties associated with research, development, and commercialization of pharmaceutical drug products, we
are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors,
including, but not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the extent to which we develop, in-license or acquire other product candidates and technologies in our
product candidate pipeline;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the costs and timing of process development and manufacturing scale-up activities associated with our
product candidates and other programs as we advance them through clinical development;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the number and development requirements of product candidates that we may pursue;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the costs, timing, and outcome of regulatory review of our product candidates;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the timing and amount of our milestone and royalty payments to InnoBation under the CD47 License;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the costs and timing of future commercialization activities, including product manufacturing, marketing,
sales, and distributions, for any of our product candidates for which we receive marketing approval;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing
our intellectual property rights and defending any intellectual property-related claims;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the revenue, if any, received from sales of our product candidates for which we receive marketing approval;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the costs of operating as a public company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Identifying
potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive, and uncertain process
that takes many years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve
product sales. In addition, our product candidate, if approved, may not achieve commercial success. Our commercial revenues, if any, will
be derived from sales of our product candidates that we do not expect to be commercially available in the near term, if at all. Accordingly,
we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be
available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible
debt securities, the terms of these equity securities or this debt may restrict our ability to operate. Any future debt financing and
equity financing, if available, may involve covenants limiting and restricting our ability to take specific actions, such as incurring
additional debt, making capital expenditures, entering into profit-sharing or other arrangements or declaring dividends. If we raise additional
funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required
to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses
on terms that may not be favorable to us. If we are unable to raise capital when needed or on acceptable terms, we could be forced to
delay, reduce or eliminate our research and development programs or future commercialization efforts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash Flows</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Operating Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our net cash
used in operating activities was $1.5 million for the year ended December&#160;31, 2024, as compared to $3.3 million for the year ended
December&#160;31, 2023. The decrease in cash used in operating activities can be primarily attributed to a decrease in the Company&#8217;s
net loss of $1.4 million, offset by an increase in the Company&#8217;s amounts which are due to its research and development partner of
$1.3 million which have yet to be paid, and an increase in cash caused by $0.8 million of changes in other operating assets and liabilities,
offset by less advances to the Company for research and development of $1.7 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used
in investing activities was $2.9 million for the year ended December&#160;31, 2024 as compared to $0.8 million for the year ended December&#160;31,
2023 due to an increase in loans made to Iris.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Financing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided
by financing activities for the year ended December&#160;31, 2024 of $3.9 million resulted from borrowings from Valetudo, Prophase, Hana
and Amantes of $0.8 million, $1.6 million, $0.8 million and $0.7 million, respectively. Net cash used in financing activities of $0.5
million for the year ended December&#160;31, 2023 was from $3.4 million from borrowings with Valetudo, Prophase, and Ewon, offset by $3.9
million of repayments of short-term loans from Valetudo, Prophase, and Ewon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contractual Obligations
and Other Commitments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> See&#160;<i>Capital Requirements</i>,&#160;above for discussion of our commitments and contractual obligations. Additionally, in the
future we may enter into agreements in the normal course of business with contract research organizations, contract manufacturing organizations
and other vendors for research and development services for operating purposes, which are generally cancelable upon written notice. In
addition, some third party CMOs have intellectual property, such as patents and/or know-how with an annual fee and royalty bearing license
to its customers that forms part of the manufacturing agreement. These payments are therefore not included in our contractual obligations
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See Note 8
to our audited financial statements included elsewhere in this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Policies
and Significant Judgments and Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations is based on our financial statements, which have been prepared
in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the
reported amounts of assets, liabilities and expenses, and the disclosure of contingent assets and liabilities, in our financial statements.
In accordance with U.S. GAAP, we evaluate our estimates and judgments on an ongoing basis. We base our estimates on historical experience,
known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define
our critical accounting policies as those accounting principles that require us to make subjective estimates and judgments about matters
that are uncertain and are likely to have a material impact on our financial condition and results of operations, as well as the specific
manner in which we apply those principles. While our significant accounting policies are more fully described in Note 2 to our audited
financial statements appearing elsewhere in this report, we believe the following are the critical accounting policies used in the preparation
of our financial statements that require significant estimates and judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and
development costs primarily consist of costs incurred for preclinical and clinical trials for our products. Research and development expenses
are recognized as incurred and payments made prior to costs being incurred are capitalized until the costs are incurred. Costs incurred
in obtaining technology licenses through asset acquisitions are charged to research and development expense if the licensed technology
has not reached technological feasibility and has no alternative future use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See Note 2
to our audited financial statements included elsewhere in this report for information about recent accounting pronouncements, the timing
of their adoption, and our assessment, if any, of their potential impact on our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company and
Smaller Reporting Company Status</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2012, the JOBS
Act was enacted. Section&#160;107 of the JOBS Act provides that an &#8220;emerging growth company&#8221; can take advantage of the extended
transition period provided in Section&#160;7(a)(2)(B)&#160;of the Securities Act for complying with new or revised accounting standards.
Upon the closing of the Business Combination, we became an emerging growth company and delayed the adoption of certain accounting standards
until those standards would otherwise apply to private companies. We elected the extended transition period for complying with new or
revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, as an emerging
growth company, we may have taken advantage of specified reduced disclosure and other requirements that are otherwise applicable generally
to public companies. These provisions include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">being permitted to present only two years of audited financial statements in addition to any required
financial statements, with correspondingly reduced disclosure in the section titled &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations&#8221;;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">an exception from compliance with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act of 2002, as amended;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements
and registration statements;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">exemptions from the requirements of holding non-binding advisory votes on executive compensation or golden
parachute arrangements; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding
the communication of critical audit matters in the auditor&#8217;s report on financial statements.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will cease to qualify as
an emerging growth company on the date that is the earliest of: (i)&#160;December&#160;31, 2026, (ii)&#160;the last day of the fiscal
year in which we have more than $1.235 billion in total annual gross revenues, (iii)&#160;the date on which we are deemed to be a &#8220;large
accelerated filer&#8221; under the rules&#160;of the SEC, which means the market value of our common shares that is held by non-affiliates
exceeds $700.0 million as of the prior June&#160;30th, or (iv)&#160;the date on which we have issued more than $1.0 billion of non-convertible
debt over the prior three-year period. We may choose to take advantage of some but not all of these reduced reporting burdens. We have
taken advantage of certain reduced reporting requirements in this report. Accordingly, the information contained herein may be different
than you might obtain from other public companies in which you hold equity interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the disclosure
contained in the Iris Form&#160;10-K in the section titled &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations</i>&#8221; beginning on page&#160;44, which information is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Security Ownership of Certain Beneficial Owners
and Management</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information regarding the beneficial ownership of shares of ParentCo Common Stock, as of April&#160;30, 2025, following the consummation
of the Business Combination, by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each person known by the Company to be the beneficial owner of more than 5% of a class of voting securities on April&#160;30, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each of the Company&#8217;s officers and directors; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>all executive officers and directors of the Company as a group.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is determined
according to the rules&#160;of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it
possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable
or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants are deemed to be outstanding for purposes
of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding
for purposes of computing the beneficial ownership percentage of any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the paragraph above,
percentage ownership of ParentCo Common Stock is based on 26,014,633 shares of ParentCo Common Stock outstanding upon consummation of
the Business Combination on April&#160;30, 2025, after giving effect to the redemptions by Iris public stockholders in connection with
the Business Combination. The table below does not include the shares of ParentCo Common Stock underlying the ParentCo Public Warrants
or the ParentCo Private Placement Warrants because these securities are not exercisable within 60 days of April&#160;30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated,
we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock owned
by them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap"><span style="font-size: 10pt"><b>Name and Address of Beneficial Owner<sup>(1)</sup></b></span></td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap"><b>Number of<br/> </b> <b>Shares of Common Stock<br/> </b> <b>Beneficially Owned</b></td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap"><b>% of<br/> Outstanding<br/> </b> <b>Common Stock</b></td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt"><b>Directors and Executive Officers</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 70%"><span style="font-size: 10pt">Chris Kim<sup>(2)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><span style="font-size: 10pt">6,169,406</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><span style="font-size: 10pt">23.7</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Scott Dam</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Byong C Yoo</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Sang-jin Daniel Lee</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Beom K. Choi</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Eun Sook Lee</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Nicholas Fernandez</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Ji Yeon Baek</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">All executive officers and directors as a group (8 individuals)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6,169,406</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">23.7</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt"><b>5% or More Stockholders:</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Iris Acquisition Holdings LLC<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">6,900,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">26.5</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Valetudo Therapeutics LLC<sup>(4)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">6,169,406</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">23.7</td>
    <td>%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Ewon Comfortech Co.,&#160;Ltd.<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,500,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.8</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Feelux Co., Ltd <sup>(6)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4,000,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">15.4</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Nongae Apple Association 1st<sup>(7)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,470,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.7</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Red Peony Association 1st<sup>(8)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,470,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.7</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* Less than 1%</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise noted, the
business address of each of the directors and executive officers is c/o </span>Liminatus Pharma,&#160;Inc., 6 Centerpointe Dr.&#160;#625,
La Palma, California 90623.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">Consists of shares of ParentCo Common Stock held of record by Valetudo Therapeutics LLC. Mr.&#160;Chris
Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner
of, the shares held by Valetudo. The business address of Valetudo is 6 Centerpointe Dr.&#160;#625, La Palma, CA 90623. Mr.&#160;Kim disclaims
any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">Consists of shares of ParentCo Common Stock held of record by Iris Acquisition Holdings LLC (the &#8220;Sponsor&#8221;).
Iris Equity Holdings LLC is the managing member of the Sponsor. Iris Equity Holdings LLC possesses sole voting and investment power over
the shares held by the Sponsor. The natural person who has voting and/or investment power over the shares held by the Sponsor is Joon
Seok Yoo.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&#160;Chris
Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner
of, the shares held by Valetudo. The business address of Valetudo is 6 Centerpointe Dr.&#160;#625, La Palma, CA 90623.</span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">The business address of Ewon Comfortech Co.,&#160;Ltd. is 8 Cheomdan 1-ro Jeongeup, Jeonbuk, 56212 Republic
of South Korea. Ewon Comfortech is a publicly traded company in Korea.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td style="text-align: justify">Consists of shares of ParentCo Common Stock held by Feelux Co.,&#160;Ltd., a company formed in the Republic
of Korea. The business address of Feelux is 624-8, Sukwoo-Ri, Gwangjuk-Myeon, Yangju-Gun, Yangju, Gyeonggi, South Korea. Feelux is a publicly
traded company in Korea.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td style="text-align: justify">Consists of shares of ParentCo Common Stock held of record by Nongae Apple Association 1st. The natural
person who has voting and/or investment power over the shares held by Nongae Apple Association 1st is Mary H. Song. The business address
of Nongae Apple Association 1st is 42 147-gil (#2707) Unju-ro, Kangnam-gu, Seoul, Republic of Korea.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td style="text-align: justify">Consists of shares of ParentCo Common Stock held of record by Red Peony Association 1st. The natural person
who has voting and/or investment power over the shares held by Red Peony Association 1st is Kyung Bok Hyun. The business address of Red
Peony Association 1st is 353, Hyoryeong-ro, Seocho-dong, Seocho-gu, Seoul, Republic of Korea.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s directors
and executive officers after the Closing are described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Management of
ParentCo Following the Business Combination</i>&#8221; beginning on page&#160;207 which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following persons constitute
the executive officers and directors of the Company:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr style="font-size: 1pt">
    <td style="font-size: 1pt; vertical-align: top; text-align: justify">&#160;</td>
    <td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Kim</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Dam</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Byong C. Yoo, PhD</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Science Officer</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sang-jin Daniel Lee, PhD</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head of Research&#160;&amp; Development</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beom K. Choi</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Technology Officer</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eun Sook Lee, MD, PhD</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas Fernandez</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ji Yeon Baek</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director and Executive Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information regarding the
compensation of the named executive officers and directors of the Company before and after the Business Combination is set forth in the
Proxy Statement/Prospectus in the section titled &#8220;<i>Executive Officer and Director Compensation</i>&#8221; beginning on page&#160;206
of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Committees of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Combined Company&#8217;s
Board has three standing committees: an audit committee, a compensation committee and a nominating and corporate governance committee,
each of which has the composition and responsibilities described below. Members serve on these committees until their resignation or until
otherwise determined by our Board. Each committee operates under a charter that was approved by the Board. The Board may from time to
time establish other committees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ParentCo&#8217;s audit committee
consists of Dr.&#160;Eun Sook Lee, Dr.&#160;Ji Yeon Baek and Nicholas Fernandez, each of whom is an independent director under applicable
Nasdaq listing standards. Nicholas Fernandez has been appointed chair of the audit committee. The Board has determined that Nicholas Fernandez
qualifies as an &#8220;audit committee financial expert,&#8221; as defined under rules&#160;and regulations of the SEC. The audit committee&#8217;s
duties, which are specified in the Audit Committee Charter, include, but are not limited to: the appointment, compensation, retention,
replacement, and oversight of the work of our independent registered public accounting firm, pre-approving all audit and permitted non-audit
services to be provided by our independent registered public accounting firm, reviewing and approving any related party transaction required
to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction and reviewing
with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory, or
compliance matters, including any correspondence with regulators or government agencies and any employee complaints.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Compensation Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ParentCo&#8217;s compensation
committee consists of Dr.&#160;Eun Sook Lee, Dr.&#160;Ji Yeon Baek and Nicholas Fernandez, each of whom is an independent director under
applicable Nasdaq listing standards. Dr.&#160;Eun Sook Lee has been appointed chair of the compensation committee. The compensation committee&#8217;s
duties, include, but are not limited to: determining or recommending to the Board for determination, the compensation of our executive
officers, including our chief executive officer, administering our equity compensation plans, overseeing our overall compensation policies
and practices, compensation plans, and benefits programs and preparing the compensation committee report that the SEC will require in
our annual proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nominating and Corporate Governance Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ParentCo&#8217;s nominating
and corporate governance committee consists of Dr.&#160;Eun Sook Lee, Dr.&#160;Ji Yeon Baek and Nicholas Fernandez, each of whom is an
independent director under applicable Nasdaq listing standards. Nicholas Fernandez has been appointed chair of the nominating and corporate
governance committee. The nominating and corporate governance committee, among other things, will determine the qualifications, qualities,
skills, and other expertise required to be a director and to develop, and recommend to the Board for its approval, criteria to be considered
in selecting nominees for director, identifying and screening individuals qualified to become members of the Board and making recommendations
to the Board regarding the selection and approval of the nominees for director to be submitted to a stockholder vote at the annual meeting
of stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Relationships and Related Transactions,
and Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain relationships and
related person transactions of Iris and Liminatus are described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Certain
Relationships and Related Transactions</i>&#8221; beginning on page&#160;222 of the Proxy Statement/Prospectus, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nasdaq listing rules&#160;require
that a majority of the board of directors of a company listed on Nasdaq be composed of &#8220;independent directors,&#8221; which is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship,
which, in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of independent judgment
in carrying out the responsibilities of a director. ParentCo&#8217;s board of directors has determined that each of Dr.&#160;Eun Sook
Lee, Dr.&#160;Ji Yeon Baek and Nicholas Fernandez is an independent director under the Nasdaq listing rules&#160;and Rule&#160;10A-3 of
the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the disclosure
regarding director independence in the section of the Proxy Statement/Prospectus titled &#8220;<i>Management of ParentCo Following the
Business Combination</i>&#8221; beginning on page&#160;207 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
under &#8220;Item 1.01 Entry into a Material Definitive Agreement&#8221; and &#8220;Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers&#8221; of this Report is incorporated
into this Item 2.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business
activities. The Company is not a party to any material legal proceedings and is not aware of any material pending or threatened claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Price of and Dividends on the Registrant&#8217;s
Common Equity and Related Stockholder Matters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;1, 2025, the ParentCo
Common Stock began trading on The Nasdaq Global Market under the symbol &#8220;LIMN&#8221; and the ParentCo Public Warrants began trading
on The Nasdaq Capital Market under the symbol &#8220;LIMNW.&#8221; The Company has not paid any cash dividends on its common stock to
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of May&#160;1, 2025, there
were 12 holders of record of ParentCo Common Stock and two holders of record of ParentCo Public Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board, in its sole discretion,
will make any determination from time to time with respect to the use of any excess cash accumulated, which may include, among other uses,
the payment of dividends on the ParentCo Common Stock. It is not contemplated that the Company will pay cash dividends for the foreseeable
future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Sales of Unregistered Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information about unregistered
sales of the Company&#8217;s equity securities is set forth under Item 3.02 of this Report, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Description of Registrant&#8217;s Securities
to be Registered</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The description of the Company&#8217;s
securities is contained in the Proxy Statement/Prospectus in the section titled &#8220;<i>Description of ParentCo Capital Stock</i>&#8221;
beginning on page&#160;214 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has 501,000,000
shares of authorized capital stock, which consist of: (i)&#160;500,000,000 shares of common stock, par value $0.0001 per share, and (ii)&#160;1,000,000
shares of preferred stock, par value $0.0001 per share. The outstanding shares of ParentCo Common Stock are fully paid and non-assessable.
As of the Closing Date, there were outstanding 26,014,633 shares of ParentCo Common Stock, after giving effect to the redemptions by Iris
public stockholders in connection with the Business Combination, no shares of the Company&#8217;s preferred stock, public warrants to
purchase 6,900,000 shares of ParentCo Common Stock, and private warrants to purchase 835,555 shares of ParentCo Common Stock. Company
stockholders who hold their shares in electronic format in U.S. brokerage accounts are not deemed to be separate stockholders, as such
shares are held of record by Cede&#160;&amp; Co., which is counted by the Company&#8217;s transfer agent as a single stockholder of record.
Such holder numbers do not include Depository Trust Company participants or beneficial owners holding shares through nominee names.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification of Directors and Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The description of the indemnification
arrangements with the Company&#8217;s directors and officers is contained in Item 1.01 of this Report and in the Proxy Statement in the
section titled &#8220;<i>Limitation on Liability and Indemnification of Directors and Officers</i>&#8221; beginning on page&#160;212 of
the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information about changes
in accountants on accounting and financial disclosure is set forth under Item 4.01 of this Report, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial Statements, Supplementary Data and
Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the disclosure
set forth under Item 9.01 of this Report concerning the Company&#8217;s financial statements and supplementary information, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Quantitative and Qualitative Disclosures about
Market Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is a smaller reporting
company as defined by Rule&#160;12b-2 of the Exchange Act and is not required to provide the information otherwise required under this
item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in the &#8220;Introductory Note&#8221; above is hereby incorporated by reference. The description of the Company&#8217;s securities is
contained in the Proxy Statement/Prospectus in the section titled &#8220;<i>Iris&#8217;s Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations</i>&#8221; beginning on page&#160;177, and &#8220;Certain Relationships and Related Transactions&#8221;
beginning on page&#160;222 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.03. Material Modification to Rights
of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Special Meeting,&#160;Iris
stockholders approved the Company&#8217;s amended and restated certificate of incorporation (the &#8220;Charter&#8221;) to, among other
things, change the corporate name from &#8220;Iris Acquisition Corp&#8221; to &#8220;Iris Parent Holding Corp.,&#8221; change the total
number of shares of the Company&#8217;s capital stock from (a)&#160;280,000,000 Iris Class&#160;A Shares, 20,000,000 shares of Class&#160;B
Common Stock and 1,000,000 shares of preferred stock, par value $0.0001 per share, of Iris to (b)&#160;500,000,000 shares of ParentCo
Common Stock and 1,000,000 shares of preferred stock, par value $0.0001 per share, of ParentCo, eliminate the Class&#160;B Common Stock
and any rights of holders thereof and authorize all other changes in connection with the replacement of Iris&#8217;s constitutional documents
with the Charter and the Company&#8217;s amended and restated bylaws (the &#8220;Bylaws&#8221;) in connection with the consummation of
the Business Combination. The terms of the Charter are described in greater detail in the section titled &#8220;<i>The ParentCo Charter
Proposal</i>&#8221; beginning on page&#160;131 of the Proxy Statement/Prospectus and is incorporated herein by reference. The Charter,
which became effective upon filing with the Secretary of State of the State of Delaware on the Closing Date, includes the amendments proposed
by the ParentCo Charter Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The description of the Charter
and the general effect of the Charter and the Bylaws upon the rights of holders of the Company&#8217;s capital stock are included in the
Proxy Statement/Prospectus under the sections titled (i)&#160;&#8220;The Advisory Charter Proposals&#8221; beginning on page&#160;133
of the Proxy Statement/Prospectus, (ii)&#160;&#8220;Comparison of Stockholders&#8217; Rights&#8221; beginning on page&#160;148 of the
Proxy Statement/Prospectus, and (iii)&#160;&#8220;Description of ParentCo Capital Stock&#8221; beginning on page&#160;214 of the Proxy
Statement/Prospectus, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;30, 2025, in
connection with the Business Combination, the Company filed the Charter with the Secretary of State of the State of Delaware, including
the changing of the Company&#8217;s name to &#8220;Liminatus Pharma,&#160;Inc.,&#8221; and adopted the Bylaws, in the form attached as
Annex I to the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Copies of the Charter
and the Bylaws are attached as Exhibit&#160;3.1 and Exhibit&#160;3.2, respectively, to this Report and are incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 4.01 Changes in Registrant&#8217;s Certifying
Accountant.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>(a)&#160;Dismissal of independent
registered public accounting firm.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of the
Business Combination and the filing of Form 15 by Iris, Marcum LLP (&#8220;Marcum&#8221;) ceased to be &#160;Iris&#8217;s independent
registered public accounting firm. Prior to the consummation of the Business Combination, Marcum audited Iris&#8217;s financial statements
for the fiscal year ended December&#160;31, 2024, which consist only of the accounts of Iris prior to the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The report of Marcum on the
financial statements of Iris as of December&#160;31, 2024 and 2023 did not contain an adverse opinion or a disclaimer of opinion, and
were not qualified or modified as to uncertainties, audit scope or accounting principles, except for an explanatory paragraph as to Iris&#8217;
ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal years ended
December&#160;31, 2024 and 2023 and through the Closing Date, there were no disagreements between Iris and Marcum on any matter of accounting
principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction
of Marcum, would have caused it to make reference to the subject matter of the disagreements in its report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal years ended
December&#160;31, 2024 and 2023 and through the Closing Date, there were no &#8220;reportable events&#8221; (as that term is defined in
Item 304(a)(1)(v)&#160;of Regulation S-K), other than the material weaknesses in internal controls identified by management related to
complex financial instruments, maintaining compliance with income tax regulations, the preparation of complete and accurate financial
statement disclosures, income tax accounting, and identifying related party transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has provided Marcum
with a copy of the foregoing disclosures and has requested that Marcum furnish the Company with a letter addressed to the SEC stating
whether it agrees with the statements made by the Company set forth above. A copy of Marcum&#8217;s letter, dated May 6, 2025, is filed
as Exhibit&#160;16.1 to this Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>(b)&#160;Disclosures regarding
the new independent auditor.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of the
Business Combination, the Company appointed WithumSmith+Brown, PC (&#8220;Withum&#8221;) as the Company&#8217;s independent registered
public accounting firm to audit the Company&#8217;s consolidated financial statements as of and for the year ending December&#160;31,
2025. Withum served as the independent registered public accounting firm of Liminatus and the Company prior to the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.01. Changes in Control of Registrant.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
above under &#8220;Introductory Note&#8221; and Item 2.01 of this Report is incorporated herein by reference. Reference is also made to
the disclosure in the Proxy Statement/Prospectus in the section titled &#8220;<i>The Business Combination Proposal</i>&#8221; beginning
on page&#160;103, which is incorporated herein by reference. Further reference is made to the information contained in Item 2.01 to this
Report, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the consummation of the
Business Combination, (i)&#160;the following Iris&#8217;s board members resigned in connection with the Business Combination: Rohit Nanani,
Richard Peretz, Manish Shah and Nicholas Fernandez; and (ii)&#160;Chris Kim, Eun Sook Lee, Nicholas Fernandez and Ji Yeon Baek were appointed
to the Company&#8217;s Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, upon the consummation
of the Business Combination, (i)&#160;Sumit Mehta resigned from his position as Chief Executive Officer, Lisha Parmar resigned from her
position as Chief Financial Officer and Omkar Halady resigned from his position as Vice President, and (ii)&#160;Chris Kim was appointed
as Chief Executive Officer, Scott Dam was appointed as Chief Financial Officer, Byong C. Yoo was appointed as Chief Science Officer, Sang-jin
Daniel Lee was appointed as Head of Research and Development, and Beom K. Choi was appointed as Chief Technology Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
above in the sections titled &#8220;Directors and Executive Officers,&#8221; &#8220;Director and Executive Compensation,&#8221; &#8220;Committees
of the Board,&#8221; &#8220;Certain Relationships and Related Transactions, and Director Independence&#8221; and &#8220;Indemnification
of Directors and Officers&#8221; in Item 2.01 of this Report are incorporated herein by reference. Reference is also made to the disclosure
in the Proxy Statement/Prospectus in the section titled &#8220;<i>Information about Iris &#8211; Committees of the Iris Board</i>&#8221;
beginning on page&#160;167, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liminatus Pharma,&#160;Inc. 2025 Omnibus Equity
Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Business
Combination, the Company adopted the Liminatus Pharma,&#160;Inc. 2025 Omnibus Equity Incentive Plan (the &#8220;2025 Plan&#8221;) described
in the Proxy Statement/Prospectus in the section entitled &#8220;<i>The Incentive Plan Proposal</i>&#8221; beginning on page&#160;126
and incorporated herein by reference. That summary of the 2025 Plan does not purport to be complete and is qualified in its entirety by
reference to the text of the 2025 Plan, which is filed as Annex B to the Proxy Statement/Prospectus and is incorporated herein by reference.
The plan allows the Company to make equity and equity-based incentive awards, as well as cash awards, to employees, directors and consultants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Decisions with respect to
the compensation of the Company&#8217;s directors and executive officers will be made by the compensation committee of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in Item 3.03 of this Report is incorporated by reference into this Item 5.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.05. Amendments to Registrant&#8217;s
Code of Ethics, or Waiver of a Provision of the Code of Ethics.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Business
Combination, on April&#160;30, 2025, the Board approved and adopted a new Code of Ethics applicable to all employees, officers and directors
of the Company, including the Company&#8217;s principal executive officer, principal financial officer and principal accounting officer
or controller (or persons performing similar functions to the aforementioned officers). A copy of the Code of Ethics and Business Conduct
is attached to this Report as Exhibit&#160;14.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.06. Change in Shell Company Status.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination,&#160;Iris ceased being a shell company. Reference is made to the disclosure in the Proxy Statement/Prospectus in the section
titled &#8220;<i>The Business Combination Proposal</i>&#8221; beginning on page&#160;103 of the Proxy Statement/Prospectus, and such disclosure
is incorporated herein by reference. Further, the information contained in Item 2.01 of this Report is incorporated by reference into
this Item 5.06.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 30, 2025,
ParentCo and Iris issued a press release announcing that the Business Combination had closed on April&#160;30, 2025. A copy of the
press release is filed herewith as Exhibit&#160;99.4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Item
7.01, including Exhibit&#160;99.4, is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange
Act, or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings
of the Company under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Report
will not be deemed an admission as to the materiality of any information of the information contained in this Item 7.01, including Exhibit&#160;99.4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the Business
Combination, ParentCo became the successor issuer to Iris. Pursuant to Rule&#160;12g-3(a)&#160;under the Exchange Act, ParentCo&#8217;s
common stock and warrants are deemed registered under Section&#160;12(b)&#160;of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(a)&#160;Financial Statements of Businesses
Acquired.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited financial statements
of ParentCo for the fiscal years ended December&#160;31, 2024 and 2023, the related notes and report of independent registered public
accounting firm are filed herewith as Exhibit&#160;99.1 and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited financial statements
of Liminatus for the fiscal years ended December&#160;31, 2024 and 2023, the related notes and report of independent registered public
accounting firm are filed herewith as Exhibit&#160;99.2 and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(b)&#160;Pro Forma Financial Information.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain unaudited pro forma
condensed combined financial information is filed herewith as Exhibit&#160;99.3 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(d)&#160;Exhibits.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following exhibits are
filed as part of, or incorporated by reference into, this Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;<br/>
No.</b></span></td>
    <td style="border-bottom: white 1pt solid; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 92%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNA" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNA" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination Agreement, dated November&#160;30, 2022, as amended, by and among Iris Acquisition Corp,&#160;Iris Parent Holding Corp., Liminatus Pharma, LLC, Liminatus Pharma Merger Sub,&#160;Inc. and SPAC Merger Sub,&#160;Inc. (incorporated by reference to Annex A to the proxy statement/prospectus filed with the SEC on February&#160;7, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex2-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex2-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Merger of Liminatus Pharma, LLC and Liminatus Pharma Merger Sub,&#160;Inc. filed on April&#160;30, 2025.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="tm2513673d1_ex2-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex2-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Merger of Iris Acquisition Corp and SPAC Merger Sub,&#160;Inc. filed on April&#160;30, 2025.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated
    Certificate of Incorporation of Iris Parent Holding Corp. (renamed Liminatus Pharma,&#160;Inc.) filed on April 30, 2025.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNEXI" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNEXI" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of Iris Parent Holding Corp. (renamed Liminatus Pharma,&#160;Inc.) (incorporated by reference to Annex I to the proxy statement/prospectus filed with the SEC on February&#160;7, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924082709/tm2314369d12_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924082709/tm2314369d12_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen Common Stock Certificate (incorporated by reference to Exhibit&#160;4.1 of the Registration Statement on Form&#160;S-4 (File No.&#160;333-275409), filed by the Registrant with the SEC on November&#160;8, 2023).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1831874/000110465921012972/tm215406d1_ex4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1831874/000110465921012972/tm215406d1_ex4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen Warrant Certificate (incorporated by reference to Exhibit&#160;4.3 of the Registration Statement on Form&#160;S-1 (File No.&#160;333-252413), filed by Iris Acquisition Corp with the SEC on January&#160;25, 2021).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1831874/000110465921034552/tm2192631d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1831874/000110465921034552/tm2192631d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement, dated as of March&#160;4, 2021, between Continental Stock Transfer&#160;&amp; Trust Company and Iris Acquisition Corp (incorporated by reference to Exhibit&#160;4.1 of Form&#160;8-K of Iris Acquisition Corp filed with the SEC on March&#160;10, 2021).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="tm2513673d1_ex4-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex4-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumption of Warrant Agreement, dated as of April&#160;30, 2025, by and among Iris Acquisition Corp,&#160;Iris Parent Holding Corp. and Continental Stock Transfer&#160;&amp; Trust Company.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Registration Rights Agreement, dated as of April&#160;30, 2025, by and among Iris Acquisition Corp,&#160;Iris Parent Holding Corp,&#160;Iris Acquisition Holdings LLC, Cantor Fitzgerald&#160;&amp; Co. and certain other parties thereto.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNG" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNG" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up Agreement, dated November&#160;30, 2022, by and among Iris Parent Holding Corp.,&#160;Iris Acquisition Holdings LLC and certain members of Liminatus Pharma, LLC (incorporated by reference to Annex G to the proxy statement/prospectus filed with the SEC on February&#160;7, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925003835/tm2432198d3_ex10-8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925003835/tm2432198d3_ex10-8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Waiver and Consent, dated January&#160;2, 2025, by and between Iris Parent Holding Corp. and Iris Acquisition Holdings
    LLC (incorporated by reference to Exhibit 10.8 of the Registration Statement on Form POS-AM (File No. 333-275409), filed by the Registrant with
the SEC on January 16, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924082709/tm2314369d12_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924082709/tm2314369d12_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Indemnity Agreement (incorporated by reference to Exhibit&#160;10.4 of the Registration Statement on Form&#160;S-4 (File No.&#160;333-275409), filed by the Registrant with the SEC on November&#160;8, 2023).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNB" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925010605/tm2432198-7_424b3.htm#tANNB" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Liminatus Pharma,&#160;Inc. 2025 Omnibus Equity Incentive Plan (incorporated by reference to Annex B to the proxy statement/prospectus filed with the SEC on February&#160;7, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924071657/tm2314369d7_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924071657/tm2314369d7_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License and Development Agreement entered into as of March&#160;30, 2022, by and between InnoBation Bio Co.,&#160;Ltd., as licensor, and Valetudo Therapeutics LLC, as licensee (incorporated by reference to Exhibit&#160;10.6 of the Registration Statement on Form&#160;S-4 (File No.&#160;333-275409), filed by the Registrant with the SEC on November&#160;8, 2023).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924071657/tm2314369d7_ex10-8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465924071657/tm2314369d7_ex10-8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignment of Contract entered into as of October&#160;1, 2022 by and between Valetudo Therapeutics and Liminatus Pharma, LLC (incorporated by reference to Exhibit&#160;10.7 of the Registration Statement on Form&#160;S-4 (File No.&#160;333-275409), filed by the Registrant with the SEC on November&#160;8, 2023).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925006325/tm2432198d5_ex10-9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925006325/tm2432198d5_ex10-9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement and Release, dated as of January&#160;24, 2025, by and between Viral Gene,&#160;Inc. and Liminatus Pharma, LLC (incorporated by reference to Exhibit&#160;10.9 of the Registration Statement on Form&#160;S-4 (File No.&#160;333-275409), filed by the Registrant with the SEC on November&#160;8, 2023).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex14-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex14-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="tm2513673d1_ex16-1.htm" style="-sec-extract: exhibit">16.1*</a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex16-1.htm" style="-sec-extract: exhibit">Letter from Marcum LLP, dated May 6, 2025.</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex21-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex21-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries of Liminatus Pharma,&#160;Inc.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="tm2513673d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audited financial statements of Iris Parent Holding Corp. for the years ended December&#160;31, 2024 and 2023.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="tm2513673d1_ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audited financial statements of Liminatus Pharma,&#160;Inc. for the years ended December&#160;31, 2024 and 2023.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="tm2513673d1_ex99-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3*</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm2513673d1_ex99-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaudited pro forma condensed combined financial information of Liminatus Pharma,&#160;Inc.</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925042489/tm2513514d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4**</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1971387/000110465925042489/tm2513514d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Press Release, dated
    April 30, 2025 (incorporated by reference to Exhibit 99.1 of the Form 8-K12B filed by the Registrant with the SEC on April 30, 2025).</span></a></td>
    </tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (formatted as Inline XBRL)</span></td>
    </tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">**</td><td style="text-align: justify">Furnished herewith.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: May 6, 2025</p></td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2" style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMINATUS PHARMA,&#160;INC.</span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top">/s/ Chris Kim&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160; </span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Kim</span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx9kMFOwzAMhp+g72DlPG1pBkjrDaoxITqYumlwzVoXRWviKsnG9ki8JWnKxGUQRYrs//9sx4yN2IIeVYsW3h/KAjaou1Z6hBIbtGgqDI786TmD8Jb4oZy30vgYXsCcAoOBuRvzXchH51E5rDPgNxMxm4hb4NNsOoPVkiW9npNpVI3GK9mCNDWsLHVWoZf2PFTYyBMZ0ufYaYvWKTIZpGM+yF8geCrghY7yk+zeQVHkLBnFk7CFpUMXXPOTR9OTMG9Rh3ZuoH9vnKY6OE86e5O2/5tbot6hDfmUC5Hy+5+WF/kKGTagyaw9Vfs/4MEB0XKlwNqHnfcD5q107rX5r9QF/wbsp3+G -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>tm2513673d1_ex2-2.htm
<DESCRIPTION>EXHIBIT 2.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 2.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CERTIFICATE OF MERGER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">LIMINATUS PHARMA MERGER SUB,&nbsp;INC.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">a Delaware corporation,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">WITH AND INTO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">LIMINATUS PHARMA, LLC,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">a Delaware limited liability company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">April&nbsp;30, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Title 8, Section&nbsp;264(c)&nbsp;of
the Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;) and Title 6, Section&nbsp;18-209(c)&nbsp;of the Delaware Limited Liability
Company Act (&ldquo;<U>DLLCA</U>&rdquo;), the undersigned hereby certifies relating to the merger (the &ldquo;<U>Merger</U>&rdquo;) of
Liminatus Pharma Merger Sub,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Disappearing Company</U>&rdquo;), with and into Liminatus
Pharma, LLC, a Delaware limited liability company (the &ldquo;<U>Surviving Company</U>,&rdquo; and together with the Disappearing Company,
collectively, the &ldquo;<U>Constituent Entities</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">FIRST: The names and states
of formation or incorporation, as applicable, of the Constituent Entities are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 43%"><FONT STYLE="font-size: 10pt"><U>Name</U></FONT></TD>
    <TD STYLE="text-align: center; width: 27%"><FONT STYLE="font-size: 10pt"><U>State of Incorporation</U></FONT></TD>
    <TD STYLE="text-align: center; width: 30%"><FONT STYLE="font-size: 10pt"><U>Type of Entity</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Liminatus Pharma Merger Sub,&nbsp;Inc.</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Liminatus Pharma, LLC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Limited Liability Company</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: That certain Business
Combination Agreement, dated as of November&nbsp;30, 2022 (as amended, the &ldquo;<U>Combination Agreement</U>&rdquo;), by and among
the Constituent Entities,&nbsp;Iris Parent Holding Corp., a Delaware corporation,&nbsp;Iris Acquisition Corp, a Delaware corporation,
and SPAC Merger Sub,&nbsp;Inc., a Delaware corporation, has been approved, adopted, certified, executed and acknowledged by each of the
Constituent Entities in accordance with Section&nbsp;264 of the DGCL and Section&nbsp;18-209 of the DLLCA, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">THIRD: The name of the surviving limited liability company
is: Liminatus Pharma, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOURTH: The Certificate of
Formation of the Surviving Company, as in effect immediately prior to the Effective Time (as defined below), shall be the Certificate
of Formation of the surviving limited liability company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIFTH: The Merger shall become
effective as of 4:05 p.m.&nbsp;Eastern Standard Time on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SIXTH: An executed copy of
the Combination Agreement is on file at the office of the Surviving Company at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Liminatus Pharma, LLC</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6 Centerpointe Dr.&nbsp;#625</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">La Palma, California 90623</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SEVENTH: A copy of the Combination
Agreement will be furnished by the Surviving Company, on request and without cost, to any member of the Surviving Company and any stockholder
of the Disappearing Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">*&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: 0.5in">IN WITNESS WHEREOF, the Surviving Company
has caused this Certificate of Merger to be signed by an authorized person as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LIMINATUS PHARMA, LLC,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">a Delaware limited liability company</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Chris Kim</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>Signature page&nbsp;to Certificate of Merger (Delaware)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.3
<SEQUENCE>3
<FILENAME>tm2513673d1_ex2-3.htm
<DESCRIPTION>EXHIBIT 2.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-style: normal; margin: 0; font-weight: normal">&nbsp;</P>

<P STYLE="text-align: right; margin: 0; font-style: normal; font-weight: normal"><B>Exhibit 2.3</B></P>

<P STYLE="margin: 0; font-style: normal; font-weight: normal">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">CERTIFICATE OF MERGER</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">OF</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SPAC MERGER SUB,&nbsp;INC.,</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">a Delaware corporation,</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">WITH AND INTO</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">IRIS ACQUISITION
CORP,</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">a Delaware corporation</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">April&nbsp;30, 2025</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Title
8, Section&nbsp;251(c)&nbsp;of the Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;), the undersigned hereby certifies relating
to the merger (the &ldquo;<U>Merger</U>&rdquo;) of SPAC Merger Sub,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Disappearing Corporation</U>&rdquo;),
with and into Iris Acquisition Corp, a Delaware corporation (the &ldquo;<U>Surviving Corporation</U>,&rdquo; and together with the Disappearing
Corporation, collectively, the &ldquo;<U>Constituent Entities</U>&rdquo;).</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">FIRST: The names and states of incorporation of the
Constituent Entities are:</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; width: 34%; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name</U></FONT></TD>
    <TD STYLE="font-style: normal; width: 32%; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>State
    of Incorporation</U></FONT></TD>
    <TD STYLE="font-style: normal; width: 34%; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Type
    of Entity</U></FONT></TD></TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC
    Merger Sub,&nbsp;Inc.</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporation</FONT></TD></TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iris
    Acquisition Corp</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="font-style: normal; text-align: center; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: That certain
Business Combination Agreement, dated as of November&nbsp;30, 2022 (as amended, the <U>Combination Agreement</U>), by and among the Constituent
Entities,&nbsp;Iris Parent Holding Corp., a Delaware corporation, Liminatus Pharma, LLC, a Delaware limited liability company, and Liminatus
Pharma Merger Sub,&nbsp;Inc., a Delaware corporation, has been approved, adopted, certified, executed and acknowledged by each of the
Constituent Entities in accordance with Section&nbsp;251(c)&nbsp;of the DGCL.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">THIRD: The name of the Surviving Corporation is:
Iris Acquisition Corp.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOURTH: Upon the effectiveness
of the Merger in accordance with Section&nbsp;251 of the DGCL and Section&nbsp;103 of the DGCL (the <U>Effective Time</U>), the certificate
of incorporation of the Surviving Corporation, as in effect immediately prior to the Effective Time, shall be amended in its entirety
to read as set forth on <U>Exhibit&nbsp;A</U> attached hereto and, as so amended shall be the Amended and Restated Certificate of Incorporation
of the Surviving Corporation at (and with effect from and after) the Effective Time until further amended pursuant to the DGCL.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">FIFTH: The Merger shall become effective as of 4:05
p.m.&nbsp;Eastern Time on the date&#8239;hereof.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SIXTH: An executed
copy of the Combination Agreement is on file at the office of the Surviving Corporation at:</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Iris Acquisition
Corp</P>

<P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6 Centerpointe Drive
#625</P>

<P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">La Palma, California 90623</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SEVENTH: A copy of
the Combination Agreement will be furnished by the Surviving Corporation, on request and without cost, to any stockholder of the Surviving
Corporation and any stockholder of the Disappearing Corporation.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">*</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">*&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;*</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Surviving Corporation
has caused this Certificate of Merger to be signed by an authorized officer as of the date first written above.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>IRIS ACQUISITION CORP,</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; width: 47%">/s/ Sumit Mehta</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Sumit Mehta</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>Exhibit&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>IRIS ACQUISITION CORP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;ONE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The name of the corporation is Iris Acquisition Corp (the
 &ldquo;<U>Corporation</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;TWO</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The address of the Corporation&rsquo;s
registered office in the State of Delaware is 251 Little Falls Drive, City of Wilmington, County of New Castle, Delaware 19808. The name
of its registered agent at such address is Corporation Service Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;THREE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The nature of the business
or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the
General Corporation Law of the State of Delaware (&ldquo;<U>DGCL</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;FOUR</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total number of shares
of stock which the Corporation has authority to issue is 100 shares of common stock, with a par value of $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;FIVE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Corporation is to have perpetual existence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;SIX</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In furtherance and not in
limitation of the powers conferred by statute, the board of directors of the Corporation is expressly authorized to make, alter or repeal
the bylaws of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;SEVEN</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Meetings of stockholders
may be held within or without the State of Delaware, as the bylaws of the Corporation may provide. The books of the Corporation may be
kept outside the State of Delaware at such place or places as may be designated from time to time by the board of directors or in the
bylaws of the Corporation. Election of directors need not be by written ballot unless the bylaws of the Corporation so provide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;EIGHT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A director of the Corporation
shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director,
except for liability&#8239;(a)&nbsp;for any breach of the director&rsquo;s duty of loyalty
to the Corporation or its stockholders, (b)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a
knowing violation of law, (c)&nbsp;under Section&nbsp;174 of the DGCL or (d)&nbsp;for any transaction from which the director derived
an improper personal benefit. If the DGCL is amended after the effective date of this certificate of incorporation to authorize corporate
action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall
be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any repeal or modification
of this ARTICLE&nbsp;EIGHT by either of (i)&nbsp;the stockholders of the Corporation or (ii)&nbsp;an amendment to the DGCL, shall not
adversely affect any right or protection existing at the time of such repeal or modification with respect to any acts or omissions occurring
before such repeal or modification of a person serving as a director at the time of such repeal or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;NINE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Corporation expressly elects not to be governed by Section&nbsp;203
of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>ARTICLE&nbsp;TEN</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation reserves
the right to amend, alter, change or repeal any provision contained in this certificate of incorporation in the manner now or hereafter
prescribed herein and by the laws of the State of Delaware, and all rights conferred upon stockholders herein are granted subject to
this reservation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">*</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>4
<FILENAME>tm2513673d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">Iris Parent Holding Corp. (the &ldquo;Corporation&rdquo;),
a corporation organized and existing under the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;), does hereby
certify as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
name of the Corporation is Iris Parent Holding Corp. The Corporation was incorporated under the name Iris Parent Holding Corp. by the
filing of its Certificate of Incorporation with the Secretary of State of the State of Delaware on November 23, 2022 (the &ldquo;Existing
Certificate&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Amended and Restated Certificate of Incorporation (the &ldquo;Amended and Restated Certificate&rdquo;), which amends and restates the
Existing Certificate in its entirety, has been approved by the Board of Directors of the Corporation (the &ldquo;Board of Directors&rdquo;)
in accordance with Sections 242 and 245 of the DGCL and has been adopted by the stockholders of the Corporation at a meeting of the stockholders
of the Corporation in accordance with the provisions of Section 211 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">3. &#8239;&#8239;&#8239;&#8239;&#8239;The text of the Existing Certificate
is hereby amended and restated by this Amended and Restated Certificate to read in its entirety as set forth in EXHIBIT A attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">4. &#8239;&#8239;&#8239;&#8239;&#8239;This Amended and Restated Certificate
shall become effective on the date of filing with the Secretary of State of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.25in; margin-bottom: 0pt; text-indent: 20pt">IN
WITNESS WHEREOF, Iris Parent Holding Corp. has caused this Amended and Restated Certificate to be signed by a duly authorized officer
of the Corporation, on <U>April 30, 2025</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">IRIS PARENT HOLDING CORP.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">/s/&#8239;Chris
    Kim</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:&#8239;Chris Kim</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: CEO, Secretary, and Treasurer</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Amended and Restated Certificate of
Incorporation]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;I</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>NAME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 219pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The name of the corporation is Liminatus Pharma,&nbsp;Inc.
(the &ldquo;Corporation&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;II</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>REGISTERED OFFICE AND AGENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The address of the Corporation&rsquo;s registered
office in the State of Delaware is c/o Corporation Service Company, 251 Little Falls Drive in the city of Wilmington, County of New Castle,
19808, and the name of its registered agent at such address is Corporation Service Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;III</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>PURPOSE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The purpose of the Corporation
is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware
(the &ldquo;DGCL&rdquo;) as it now exists or may hereafter be amended and supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;IV</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>CAPITALIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;4.1 Authorized Capital Stock. The
total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized
to issue is 501,000,000 shares, consisting of (a)&nbsp;500,000,000 shares of common stock (the &ldquo;<B><I>Common Stock</I></B>&rdquo;),
and (b)&nbsp;1,000,000 shares of preferred stock (the &ldquo;<B><I>Preferred Stock</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;4.2 Preferred Stock. Subject to <I>Article&nbsp;V</I>
of this Amended and Restated Certificate, the Board of Directors of the Corporation (the &ldquo;<B><I>Board</I></B>&rdquo;)is hereby expressly
authorized to provide out of the unissued shares of the Preferred Stock for one or more series of Preferred Stock and to establish from
time to time the number of shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences
and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions
thereof, as shall be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included
in a certificate of designation (a &ldquo;<B><I>Preferred Stock Designation</I></B>&rdquo;) filed pursuant to the DGCL, and the Board
is hereby expressly vested with the authority to the full extent provided by law, now or hereafter, to adopt any such resolution or resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Section&nbsp;4.3 Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">(a)&#8239;&#8239;&#8239;&#8239;<I>Voting.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;Except
as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation), the holders of the
Common Stock shall exclusively possess all voting power with respect to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ii)&#8239;&#8239;&#8239;&#8239;Except
as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation), the holders of shares
of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders of the Corporation
on which the holders of the Common Stock are entitled to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;<I>Dividends.</I> Subject to applicable law,
the rights, if any, of the holders of any outstanding series of the Preferred Stock and the provisions of <I>Article&nbsp;IV</I> hereof,
the holders of shares of Common Stock shall be&#8239;entitled to receive such dividends and other distributions (payable in cash, property
or capital stock of the Corporation) when, as and if declared thereon by the Board from time to time out of any assets or funds of the
Corporation legally available therefor and shall share equally on a per share basis in such dividends and distributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#8239;&#8239;&#8239;&#8239;<I>Liquidation, Dissolution or Winding
Up of the Corporation.</I> Subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock
and the provisions of <I>Article&nbsp;IV</I> hereof, in the event of any voluntary or involuntary liquidation, dissolution or winding
up of the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation, the holders of shares
of Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its stockholders,
ratably in proportion to the number of shares of Common Stock held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;4.4 Rights and Options. The Corporation
has the authority to create and issue rights, warrants and options entitling the holders thereof to acquire from the Corporation any shares
of its capital stock of any class or classes, with such rights, warrants and options to be evidenced by or in instrument(s)&nbsp;approved
by the Board. The Board is empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights,
warrants or options; provided, however, that the consideration to be received for any shares of capital stock issuable upon exercise thereof
may not be less than the par value thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;V</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 179pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;5.1 Board Powers. The business and
affairs of the Corporation shall be managed by, or under the direction of, the Board. In addition to the powers and authority expressly
conferred upon the Board by statute, this Amended and Restated Certificate or the By- Laws of the Corporation <B><I>(&ldquo;By-Laws&rdquo;),</I></B>
the Board is hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation,
subject, nevertheless, to the provisions of the DGCL, this Amended and Restated Certificate, and any By-Laws adopted by the stockholders
of the Corporation; provided, however, that no By-Laws hereafter adopted by the stockholders of the Corporation shall invalidate any prior
act of the Board that would have been valid if such By-Laws had not been adopted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Section&nbsp;5.2 Number, Election and Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the management of the business and for the
conduct of the affairs of the Corporation it is further provided that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#8239;&#8239;&#8239;&#8239;Subject
to the special rights of the holders of one or more outstanding series of Preferred Stock to elect directors, if any, the initial directors
of the Corporation shall be classified with respect to the time for which they severally hold office into three classes, designated as
Class&nbsp;I, Class&nbsp;II and Class&nbsp;III. The initial Class&nbsp;I directors shall serve for a term expiring at the first annual
meeting of the stockholders following the date of this Amended and Restated Certificate; the initial Class&nbsp;II directors shall serve
for a term expiring at the second annual meeting of the stockholders following the date of this Amended and Restated Certificate; and
the initial Class&nbsp;III directors shall serve for a term expiring at the third annual meeting following the date of this Amended and
Restated Certificate. At each annual meeting of the stockholders of the Corporation beginning with the first annual meeting of the stockholders
following the date of this Amended and Restated Certificate, subject to the special rights of the holders of one or more outstanding series
of Preferred Stock to elect directors, if any, the successors of the class of directors whose term expires at that meeting shall be elected
to hold office for a term expiring at the annual meeting of the stockholders held in the third year following the year of their election.
Each director shall hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation,
disqualification or removal. No decrease in the number of directors shall shorten the term of any incumbent director. The Board of Directors
is authorized to assign members of the Board of Directors already in office to Class&nbsp;I, Class&nbsp;II and Class&nbsp;III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;The
number of directors which shall constitute the whole Board of Directors shall be fixed exclusively by one or more resolutions adopted
from time to time by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">(c)&#8239;&#8239;&#8239;&#8239;The directors of the Corporation need not be elected
by written ballot unless the Bylaws so provide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Section&nbsp;5.3 Removal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the special rights of the holders of
one or more outstanding series of Preferred Stock to elect directors, the Board of Directors or any individual director may be removed
from office at any time, but only for cause and only by the affirmative vote of the holders of at least two-thirds (66 and &#8532;%)
of the voting power of all of the then outstanding shares of voting stock of the Corporation entitled to vote at an election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Section&nbsp;5.4 Newly Created Directorships and Vacancies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the special rights of the holders of
one or more outstanding series of Preferred Stock to elect directors, except as otherwise provided by law, any vacancies on the Board
of Directors resulting from death, resignation, disqualification, retirement, removal or other causes and any newly created directorships
resulting from any increase in the number of directors shall be filled exclusively by the affirmative vote of a majority of the directors
then in office, even though less than a quorum, or by a sole remaining director (other than any directors elected by the separate vote
of one or more outstanding series of Preferred Stock), and shall not be filled by the stockholders. Any director appointed in accordance
with the preceding sentence shall hold office until the expiration of the term to which such director shall have been appointed or until
his or her earlier death, resignation, retirement, disqualification, or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Section&nbsp;5.5 Preferred Stock &mdash; Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Whenever the holders of any one or more series
of Preferred Stock issued by the Corporation shall have the right, voting separately as a series or separately as a class with one or
more such other series, to elect directors at an annual or special meeting of stockholders, the election, term of office, removal and
other features of such directorships shall be governed by the terms of this Amended and Restated Certificate (including any Certificate
of Designation). Notwithstanding anything to the contrary in this Article&nbsp;V, the number of directors that may be elected by the holders
of any such series of Preferred Stock shall be in addition to the number fixed pursuant to paragraph B of this Article&nbsp;V, and the
total number of directors constituting the whole Board of Directors shall be automatically adjusted accordingly. Except as otherwise provided
in the Certificate of Designation(s)&nbsp;in respect of one or more series of Preferred Stock, whenever the holders of any series of Preferred
Stock having such right to elect additional directors are divested of such right pursuant to the provisions of such Certificate of Designation(s),
the terms of office of all such additional directors elected by the holders of such series of Preferred Stock, or elected to fill any
vacancies resulting from the death, resignation, disqualification or removal of such additional directors, shall forthwith terminate (in
which case each such director thereupon shall cease to be qualified as, and shall cease to be, a director) and the total authorized number
of directors of the Corporation shall automatically be reduced accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;VI</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>BYLAWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 213pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In furtherance and not in limitation of the powers
conferred by statute, the Board of Directors is expressly authorized to adopt, amend or repeal the Amended and Restated Bylaws of the
Corporation (as amended and/or restated from time to time). In addition to any vote of the holders of any class or series of stock of
the Corporation required by applicable law or by this Amended and Restated Certificate (including any Certificate of Designation in respect
of one or more series of Preferred Stock) or the Bylaws, the adoption, amendment or repeal of the Bylaws by the stockholders of the Corporation
shall require the affirmative vote of the holders of at least two- thirds (66 and &#8532;%) of the voting power of all of the then outstanding
shares of voting stock of the Corporation entitled to vote generally in an election of directors. No By-Laws hereafter adopted by the
stockholders shall invalidate any prior act of the Board that would have been valid if such By-Laws had not been adopted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;VII</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 193pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#8239;&#8239;&#8239;&#8239;Any
action required or permitted to be taken by the stockholders of the Corporation must be effected at an annual or special meeting of the
stockholders of the Corporation, and shall not be taken by written consent in lieu of a meeting. Notwithstanding the foregoing, any action
required or permitted to be taken by the holders of any series of Preferred Stock, voting separately as a series or separately as a class
with one or more other such series, may be taken without a meeting, without prior notice and without a vote, to the extent expressly so
provided by the applicable Certificate of Designation relating to such series of Preferred Stock, if a consent or consents in writing,
setting forth the action so taken, shall be signed by the holders of outstanding shares of the relevant series of Preferred Stock having
not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled
to vote thereon were present and voted and shall be delivered to the Corporation in accordance with the applicable provisions of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;Subject
to the special rights of the holders of one or more series of Preferred Stock, special meetings of the stockholders of the Corporation
may be called, for any purpose or purposes, at any time only by or at the direction of the Board of Directors, the Chairperson of the
Board of Directors, the Chief Executive Officer or the President, and shall not be called by any other person or persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#8239;&#8239;&#8239;&#8239;Advance
notice of stockholder nominations for the election of directors and of other business proposed to be brought by stockholders before any
meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;VIII</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>LIMITED LIABILITY; INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;8.1 Limitation of Director Liability.
A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of
fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL
as the same exists or may hereafter be amended unless they violated their duty of loyalty to the Corporation or its stockholders, acted
in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful
redemptions, or derived improper personal benefit from their actions as directors. Any amendment, modification or repeal of the foregoing
sentence shall not adversely affect any right or protection of a director of the Corporation hereunder in respect of any act or omission
occurring prior to the time of such amendment, modification or repeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section&nbsp;8.2 Indemnification and Advancement of Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#8239;&#8239;&#8239;&#8239;To the fullest
extent permitted by applicable law, as the same exists or may hereafter be amended, the Corporation shall indemnify and hold harmless
each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or
completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a &ldquo;<B><I>proceeding</I></B>&rdquo;)
by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation,
is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership,
joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (an &ldquo;<B><I>indemnitee</I></B>&rdquo;),
whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other
capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without
limitation, attorneys&rsquo; fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred
by such indemnitee in connection with such proceeding. The Corporation shall to the fullest extent not prohibited by applicable law pay
the expenses (including attorneys&rsquo; fees) incurred by an indemnitee in defending or otherwise participating in any proceeding in
advance of its final disposition; provided, however, that, to the extent required by applicable law, such payment of expenses in advance
of the final disposition of&#8239;the proceeding shall be made only upon receipt of an undertaking, by or on behalf of the indemnitee, to repay
all amounts so advanced if it shall ultimately be determined that the indemnitee is not entitled to be indemnified under this Section&nbsp;8.2
or otherwise. The rights to indemnification and advancement of expenses conferred by this Section&nbsp;8.2 shall be contract rights and
such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit
of his or her heirs, executors and administrators. Notwithstanding the foregoing provisions of this Section&nbsp;8.2(a), except for proceedings
to enforce rights to indemnification and advancement of expenses, the Corporation shall indemnify and advance expenses to an indemnitee
in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized
by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;The
rights to indemnification and advancement of expenses conferred on any indemnitee by this Section&nbsp;8.2 shall not be exclusive of any
other rights that any indemnitee may have or hereafter acquire under law, this Amended and Restated Certificate, the By-Laws, an agreement,
vote of stockholders or disinterested directors, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#8239;&#8239;&#8239;&#8239;Any
repeal or amendment of this Section&nbsp;8.2 by the stockholders of the Corporation or by changes in law, or the adoption of any other
provision of this Amended and Restated Certificate inconsistent with this Section&nbsp;8.2, shall, unless otherwise required by law, be
prospective only (except to the extent such amendment or change in law permits the Corporation to provide broader indemnification rights
on a retroactive basis than permitted prior thereto), and shall not in any way diminish or adversely affect any right or protection existing
at the time of such repeal or amendment or adoption of such inconsistent provision in respect of any proceeding (regardless of when such
proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to such repeal
or amendment or adoption of such inconsistent provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&#8239;&#8239;&#8239;&#8239;This
Section&nbsp;8.2 shall not limit the right of the Corporation, to the extent and in the manner authorized or permitted by law, to indemnify
and to advance expenses to persons other than indemnitees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;IX</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>CORPORATE OPPORTUNITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 166pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#8239;&#8239;&#8239;&#8239;To
the fullest extent permitted by Section&nbsp;122(17) of the DGCL, the doctrine of corporate opportunity, or any other analogous doctrine,
shall not apply with respect to the Corporation or any of its officers or directors, or any of their respective affiliates, in circumstances
where the application of any such doctrine to a corporate opportunity would conflict with any fiduciary duties or contractual obligations
they may have as of the date of this Amended and Restated Certificate or in the future. In addition to the foregoing, the doctrine of
corporate opportunity shall not apply to any other corporate opportunity with respect to any of the directors or officers of the Corporation
unless such corporate opportunity is expressly offered to such person in writing solely in his or her capacity as a director or officer
of the Corporation and such opportunity is one the Corporation is legally and contractually permitted to undertake and would otherwise
be reasonable for the Corporation to pursue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;Neither
the alteration, amendment, addition to or repeal of this Article&nbsp;IX, nor the adoption of any provision of this Amended and Restated
Certificate (including any Certificate of Designation) inconsistent with this Article&nbsp;IX, shall eliminate or reduce the effect of
this Article&nbsp;IX in respect of any business opportunity first identified or any other matter occurring, or any cause of action, suit
or claim that, but for this Article&nbsp;IX, would accrue or arise, prior to such alteration, amendment, addition, repeal or adoption.
This Article&nbsp;IX shall not limit any protections or defenses available to, or indemnification or advancement rights of, any director
or officer of the Corporation under this Amended and Restated Certificate, the Bylaws or applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;X</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything contained in this Amended and Restated Certificate to the contrary, in addition to any vote required by applicable law, the
following provisions in this Amended and Restated Certificate may be amended, altered, repealed or rescinded, in whole or in part, or
any provision inconsistent therewith or herewith may be adopted, only by the affirmative vote of the holders of at least two-thirds&#8239;(66
and &#8532;%) of the total voting power of all the then outstanding shares of stock of the Corporation entitled to vote thereon, voting
together as a single class: Part&nbsp;(b)&nbsp;of Article&nbsp;IV, Article&nbsp;V, Article&nbsp;VI, Article&nbsp;VII, Article&nbsp;VIII,
Article&nbsp;IX and this Article&nbsp;X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;&#8239;If
any provision or provisions of this Amended and Restated Certificate shall be held to be invalid, illegal or unenforceable as applied
to any circumstance for any reason whatsoever: (i)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance
and of the remaining provisions of this Amended and Restated Certificate (including, without limitation, each portion of any paragraph
of this Amended and Restated Certificate containing any such provision held to be invalid, illegal or unenforceable that is not itself
held to be invalid, illegal or unenforceable) shall not, to the fullest extent permitted by applicable law, in any way be affected or
impaired thereby and (ii)&nbsp;to the fullest extent permitted by applicable law, the provisions of this Amended and Restated Certificate
(including, without limitation, each such portion of any paragraph of this Amended and Restated Certificate containing any such provision
held to be invalid, illegal or unenforceable) shall be construed so as to permit the Corporation to protect its directors, officers, employees
and agents from personal liability in respect of their good faith service to or for the benefit of the Corporation to the fullest extent
permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;XI</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>DGCL SECTION&nbsp;203</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 189pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The Corporation hereby expressly elects not be governed
by Section&nbsp;203 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLE&nbsp;XII</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>EXCLUSIVE FORUM FOR CERTAIN LAWSUITS; CONSENT TO JURISDICTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;12.1 Forum. Subject to the last sentence
in this Section&nbsp;12.1, and unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent
permitted by the applicable law, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any stockholder
(including a beneficial owner) to bring (i)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any
action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation
or the Corporation&rsquo;s stockholders, (iii)&nbsp;any action asserting a claim against the Corporation, its directors, officers or employees
arising pursuant to any provision of the DGCL or this Amended and Restated Certificate or the By-Laws, or (iv)&nbsp;any action asserting
a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine and, if brought outside
of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&rsquo;s counsel
except any action (A)&nbsp;as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party
not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of
the Court of Chancery within ten days following such determination), (B)&nbsp;which is vested in the exclusive jurisdiction of a court
or forum other than the Court of Chancery, or (C)&nbsp;for which the Court of Chancery does not have subject matter jurisdiction. Notwithstanding
the foregoing, (i)&nbsp;the provisions of this Section&nbsp;12.1 will not apply to suits brought to enforce any liability or duty created
by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction and (ii)&nbsp;unless the Corporation consents
in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest
extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act of 1933, as amended, or the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;12.2 Consent
to Jurisdiction. If any action the subject matter of which is within the scope of Section&nbsp;12.1 immediately above is filed in a court
other than a court located within the State of Delaware (a &ldquo;<B><I>Foreign Action</I></B>&rdquo;) in the name of any stockholder,
such stockholder shall be deemed to have consented to&#8239;(i)&nbsp;the personal jurisdiction of the state and federal courts located within
the State of Delaware in connection with any action brought in any such court to enforce Section&nbsp;12.1 immediately above (an &ldquo;<B><I>FSC
Enforcement Action</I></B>&rdquo;) and (ii)&nbsp;having service of process made upon such stockholder in any such FSC Enforcement Action
by service upon such stockholder&rsquo;s counsel in the Foreign Action as agent for such stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;12.3 Severability. If any provision
or provisions of this <I>Article&nbsp;XII</I> shall be held to be invalid, illegal or unenforceable as applied to any person or entity
or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of
such provisions in any other circumstance and of the remaining provisions of this <I>Article&nbsp;XII</I> (including, without limitation,
each portion of any sentence of this <I>Article&nbsp;XII</I> containing any such provision held to be invalid, illegal or unenforceable
that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and
circumstances shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise acquiring any interest
in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this <I>Article&nbsp;XII.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section&nbsp;12.4 Deemed Notice. Any person or
entity purchasing or otherwise acquiring or holding any interest in any security of the Corporation shall be deemed to have notice of
and consented to this <I>Article&nbsp;XII</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>tm2513673d1_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSUMPTION OF WARRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS ASSUMPTION OF WARRANT
AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;), is made and entered effective as of April&nbsp;30, 2025, by and among Iris Acquisition
Corp., a Delaware corporation (formerly known as Tribe Capital Growth Corp I) (the &ldquo;<U>Company</U>&rdquo;),&nbsp;<FONT STYLE="color: #2D2D2D">Iris
Parent Holding Corp., </FONT>a Delaware corporation (&ldquo;<U>ParentCo</U>&rdquo;), and Continental Stock Transfer&nbsp;&amp; Trust Company,
a New York corporation, as warrant agent (the &ldquo;<U>Warrant Agent</U>&rdquo;). Capitalized terms used herein but not otherwise defined
shall have the meanings given to them in the Warrant Agreement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Warrant Agent previously entered into that certain Warrant Agreement, dated March&nbsp;4, 2021 (the &ldquo;<U>Warrant Agreement</U>&rdquo;),
pursuant to which the Warrant Agent agreed to act on behalf of the Company in connection with the issuance, registration, transfer, exchange,
redemption and exercise of up to 6,900,000 warrants (the &ldquo;<U>Public Warrants</U>&rdquo;) underlying units issued in the Company&rsquo;s
initial public offering (the &ldquo;<U>IPO</U>&rdquo;), up to 5,013,333 warrants (the &ldquo;<U>Private Placement Warrants</U>&rdquo;)
issued in a private placement consummated simultaneously with the IPO (the &ldquo;<U>Private Placement</U>&rdquo;), up to 1,000,000 Working
Capital Warrants and any additional Post IPO Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the IPO and the Private Placement were
consummated on March&nbsp;9, 2021;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company has entered
into a Business Combination Agreement (as amended, supplemented or otherwise modified from time to time, the &ldquo;<U>Combination Agreement</U>&rdquo;),
which provides for a Business Combination between the Company and Liminatus Pharma, LLC, a Delaware limited liability company (&ldquo;<U>Liminatus</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the Combination
Agreement, (i)&nbsp;Liminatus Pharma Merger Sub,&nbsp;Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo, will merge
with and into Liminatus (the &ldquo;<U>Liminatus Merger</U>&rdquo;), with Liminatus surviving the Liminatus Merger as a direct wholly-owned
subsidiary of ParentCo, and (ii)&nbsp;simultaneously with the Liminatus Merger, SPAC Merger Sub,&nbsp;Inc., a Delaware corporation and
wholly-owned subsidiary of ParentCo, will merge with and into the Company (the &ldquo;<U>SPAC Merger</U>&rdquo; and, together with the
Liminatus Merger, the &ldquo;<U>Mergers</U>&rdquo;), with the Company surviving the SPAC Merger as a direct wholly-owned subsidiary of
ParentCo; and as a result of the Business Combination, holders of shares of Class&nbsp;A common stock of the Company and units of Liminatus
will become holders of shares of common stock, par value $0.0001 per share, of ParentCo (&ldquo;<U>ParentCo Common Stock</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, upon consummation
of the Business Combination, as provided in <U>Section&nbsp;4.4</U> of the Warrant Agreement, the Warrants will no longer be exercisable
for Common Stock of the Company but instead will be exercisable for ParentCo Common Stock; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the Business Combination, ParentCo wishes to confirm the assumption of the Company&rsquo;s rights, duties, covenants and other obligations
(the &ldquo;<U>Obligations</U>&rdquo;) under the Warrant Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, for good and
valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>Assumption of the Obligations</U>. As of and with effect on and from the Closing (as defined in the
Combination Agreement), the Company hereby assigns to ParentCo all of the Company&rsquo;s rights, titles, interests and obligations in
and under the Warrant Agreement; and ParentCo hereby assumes, and agrees to pay, perform, satisfy and discharge in full, as the same become
due, all of the Company&rsquo;s liabilities and obligations under the Warrant Agreement arising on, from and after the Closing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>Consent</U>. The Warrant Agent hereby consents to (i)&nbsp;the assignment of the Warrant Agreement
by the Company to ParentCo and the assumption of the Warrant Agreement by ParentCo from the Company, in each case effective as of the
Closing, and (ii)&nbsp;the continuation of the Warrant Agreement, in full force and effect from and after the Closing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Amendments</U>. Except for
the assumption of the Obligations by ParentCo hereunder, the Warrant Agreement shall remain unchanged and in full force and effect.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company and ParentCo agree
to execute such reasonable further instruments or perform such reasonable acts which are or may become reasonably necessary to carry
out the intent of this Agreement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Agreement shall be governed
by and construed under the laws of the State of New York without regard to its conflict of laws principles.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Agreement may be executed
in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the
same instrument.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The balance of this page&nbsp;is intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">IRIS ACQUISITION CORP.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="width: 50%">&nbsp;</TD>
<TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Sumit Mehta&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Sumit Mehta</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">Title: Chief Executive Officer &nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">IRIS PARENT HOLDING CORP.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Chris Kim</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Chris Kim</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">Title: CEO, Secretary, and Treasurer &nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Warrant Agent</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Erika Young</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Erika Young</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Vice President</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>tm2513673d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">THIS AMENDED AND RESTATED REGISTRATION RIGHTS
AGREEMENT (this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of April&nbsp;30, 2025, is made and entered into by and among Iris Acquisition
Corp., a Delaware corporation formerly known as Tribe Capital Growth Corp I (the &ldquo;<B><I>SPAC</I></B>&rdquo;),&nbsp;Iris Parent Holding
Corp., a Delaware corporation (the &ldquo;<B><I>ParentCo</I></B>&rdquo; or the &ldquo;<B><I>Company</I></B>&rdquo;)),&nbsp;Iris Acquisition
Holdings LLC, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), Cantor Fitzgerald&nbsp;&amp; Co., a New
York general partnership (&ldquo;<B><I>Cantor</I></B>&rdquo;), the former members of Liminatus Pharma LLC set forth on the signature page&nbsp;hereto
(&ldquo;<B><I>Liminatus Members</I></B>&rdquo;), Ewon Comfortech Co.,&nbsp;Ltd. (the &ldquo;<B><I>Equity PIPE Subscribers</I></B>&rdquo;),
Ewon Comfortech Co.,&nbsp;Ltd. (the &ldquo;<B><I>Convertible Note PIPE Subscribers</I></B>&rdquo; and together with the Equity PIPE Subscribers,
the &ldquo;<B><I>PIPE Subscribers</I></B>&rdquo; and together with the Sponsor, Cantor, the Liminatus Members and any person or entity
who hereafter becomes a party to this Agreement pursuant to&nbsp;Section&nbsp;6.2&nbsp;of this Agreement, a &ldquo;<B><I>Holder</I></B>&rdquo;
and collectively the &ldquo;<B><I>Holders</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
the SPAC and certain former holders of the SPAC entered into that certain Registration Rights Agreement dated March&nbsp;4, 2021 (the
 &ldquo;<B><I>Original Agreement</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
Sponsor succeeded to the rights of the former holders under the Original Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
ParentCo, Sponsor, Liminatus Pharma LLC, a Delaware corporation (&ldquo;<B><I>Liminatus</I></B>&rdquo;), Liminatus Pharma Merger Sub,&nbsp;Inc.,
a Delaware corporation and wholly-owned subsidiary of ParentCo (&ldquo;<B><I>Liminatus Merger Sub</I></B>&rdquo;), and SPAC Merger Sub,&nbsp;Inc.,
a Delaware corporation and wholly-owned subsidiary of ParentCo (&ldquo;<B><I>SPAC Merger Sub</I></B>&rdquo;) entered into a Business Combination
Agreement as of November&nbsp;30, 2022 (as amended, modified, supplemented or waived from time to time, the &ldquo;<B><I>Transaction Agreement</I></B>&rdquo;
and the transactions contemplated by the Transaction Agreement to be completed on and prior to the closing date thereof, collectively,
the &ldquo;<B><I>Business Combination</I></B>&rdquo;), pursuant to which, among other things, in the manner, and on the terms and subject
to the conditions and exclusions set forth therein, effective as of the closing of the Business Combination, (a)&nbsp;Liminatus Merger
Sub will merge with and into Liminatus, with Liminatus surviving as a direct wholly-owned subsidiary of ParentCo (the &ldquo;<B><I>Company
Merger</I></B>&rdquo;), and (b)&nbsp;simultaneously with the Company Merger, SPAC Merger Sub will merge with and into IRIS, with IRIS
surving as a direct wholly-owned subsidiary of ParentCo (the &ldquo;<B><I>SPAC Merger</I></B>&rdquo; and, together with the Company Merger,
the &ldquo;<B><I>Mergers</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
pursuant to the Mergers, the Sponsor and Liminatus Members were issued common stock, par value $0.0001 of ParentCo (&ldquo;<B><I>Common
Stock</I></B>&rdquo;) and may be issued shares of Common Stock in the future pursuant to the terms of the Transaction Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
pursuant to the Mergers, Sponsor and Cantor were issued certain warrants to purchase Common Stock (the &ldquo;<B><I>Warrants</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
ParentCo, SPAC and the Equity PIPE Subscribers have entered into that certain Subscription Agreement, dated as of November&nbsp;28, 2022
(the &ldquo;<B><I>Equity Subscription Agreement</I></B>&rdquo;), pursuant to which the Equity PIPE Subscribers purchased shares of the
Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
ParentCo, SPAC and the Convertible Note PIPE Subscribers have entered into that certain Convertible Note Subscription Agreement, dated
as of November&nbsp;28, 2022 (the &ldquo;<B><I>Convertible Note Subscription Agreement</I></B>&rdquo;), pursuant to which the Convertible
Note PIPE Subscribers purchased convertible notes of ParentCo (the &ldquo;<B><I>Convertible Notes</I></B>&rdquo;) that are convertible
into shares of the Common Stock pursuant to the terms of such Convertible Notes;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
the Company and the Holders desire to amend the Original Agreement in the form of this Agreement, pursuant to which the Company shall
grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW</B></FONT>,<B>&nbsp;THEREFORE</B>,
in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound,
hereby agree to amend and restated the Original Agreement in its entirety as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">1.1&nbsp;&nbsp;&nbsp;Definitions.&nbsp;&nbsp;&nbsp;The
terms defined in this&nbsp;<I>Article&nbsp;I</I>&nbsp;shall, for all purposes of this Agreement, have the respective meanings set forth
below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Adverse Disclosure</I></B>&rdquo;
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the principal executive
officer or principal financial officer of the Company, after consultation with counsel to the Company, (i)&nbsp;would be required to be
made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus
and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii)&nbsp;would not be required
to be made at such time if the Registration Statement were not being filed, and (iii)&nbsp;the Company has a bona fide business purpose
for not making such information public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Agreement</I></B>&rdquo; shall have the meaning given
in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Block Trade</I></B>&rdquo; means
an offering or sale of Registrable Securities by any Holder on a block trade or underwritten basis (whether firm commitment or otherwise)
effected pursuant to a Registration Statement without substantial marketing efforts prior to pricing, including, without limitation, a
same day trade, overnight trade or similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Board</I></B>&rdquo; shall mean the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Business Combination</I></B>&rdquo; shall have the meaning
given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Business Day</I></B>&rdquo; means
any day except a Saturday, a Sunday or any other day on which commercial banks are required or authorized to close in New York, New York,
excluding as a result of &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-Liminatus employee&rdquo; or any other
similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental entity so long as
the electronic funds transfer systems, including for wire transfers, of commercially banking institutions in New York, New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Cantor Private Placement Warrants
Purchase Agreement</I></B>&rdquo; shall mean that certain Private Placement Warrants Purchase Agreement between SPAC and Cantor dated
as of March&nbsp;4, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Commission</I></B>&rdquo; shall mean the Securities and
Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Common Stock</I></B>&rdquo; shall have the meaning given
in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Company</I></B>&rdquo; shall have the meaning given in
the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Company Merger</I></B>&rdquo; shall have the meaning given
in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Convertible Note PIPE Subscribers</I></B>&rdquo; shall
have the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Convertible Note Subscription Agreement</I></B>&rdquo;
shall have the meaning given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Convertible Notes</I></B>&rdquo; shall have the meaning
given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Demand Registration</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Demanding Holder</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Effectiveness Deadline</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Equity PIPE Subscribers</I></B>&rdquo; shall have the
meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Equity Subscription Agreement</I></B>&rdquo; shall have
the meaning given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Exchange Act</I></B>&rdquo; shall
mean the Securities Exchange Act of 1934, as it may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Filing
Deadline</B>&rdquo;</I></FONT>&nbsp;shall have the meaning set forth in&nbsp;subsection 2.1.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Form&nbsp;S-1 Shelf</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Form&nbsp;S-3 Shelf</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Holder</I></B>&rdquo; and &ldquo;<B><I>Holders</I></B>&rdquo;
shall have the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Insider Letter</I></B>&rdquo; shall
mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and each of the Company&rsquo;s
officers, directors, director nominees and advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Liminatus</I></B>&rdquo; shall have the meaning given
in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Liminatus Members</I></B>&rdquo; shall have the meaning
given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Liminatus Merger Sub</I></B>&rdquo; shall have the meaning
given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Lock-up Period</I></B>&rdquo; shall
mean, with respect to 1/3 of the Lock-up Shares the period ending on the date that is 6&nbsp;months following the Closing (as defined
in the Transaction Agreement), with respect to an additional 1/3 of the Lock-up Shares, the period ending on the date that is 12&nbsp;months
following the Closing, and with respect to the remainder of the Lock-up Shares, the period ending on the date that is 24&nbsp;months following
the Closing; provided that the Lock-up Period shall immediately end on (x)&nbsp;the date on which the VWAP of the Common Stock equals
or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20
Trading Days within any 30-Trading Day period or (y)&nbsp;the date on which the Company completes a liquidation, merger, capital stock
exchange, reorganization or other similar transaction that results in all of the Company&rsquo;s stockholders having the right to exchange
their shares of Common Stock for cash, securities or other property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Lock-up Shares</I></B>&rdquo; shall
mean shares of Common Stock of ParentCo received by each Holder pursuant to the Business Combination Agreement (including any securities
convertible into, or exchangeable for, or representing the rights to receive shares of Common Stock of ParentCo, if any, acquired during
the Lock-up Period), but excluding the Equity PIPE Subscribers and the Convertible Note PIPE Subscribers who shall not be subject to the
Lock-up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Maximum Number of Securities</I></B>&rdquo; shall have
the meaning given in&nbsp;subsection 2.1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Merger</I></B>&rdquo; shall have the meaning given in
the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Minimum Takedown Threshold</I></B>&rdquo; shall have the
meaning given in&nbsp;subsection 2.1.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Misstatement</I></B>&rdquo; shall
mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under
which they were made) not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>ParentCo</I></B>&rdquo; shall have the meaning given in
the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Permitted Transferees</I></B>&rdquo;
shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior
to the expiration of the Lock-up Period, as the case may be, under the Insider Letter, the Cantor Private Placement Warrants Purchase
Agreement, this Agreement and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Piggyback Registration</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>PIPE Subscribers</I></B>&rdquo; shall have the meaning
given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Pro Rata</I></B>&rdquo; shall have the meaning given in&nbsp;subsection
2.1.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Prospectus</I></B>&rdquo; shall mean
the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and
all post-effective amendments and including all material incorporated by reference in such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Registrable Security</I></B>&rdquo;
shall mean (a)&nbsp;the shares of Common Stock issued or issuable upon the conversion of any Convertible Notes, (b)&nbsp;the Warrants
and the Common Stock issued or issuable upon the exercise of the Warrants, (c)&nbsp;any outstanding share of the Common Stock or any other
equity security (including the shares of Common Stock issued or issuable upon the exercise of any other equity security) of the Company
held by a Holder as of the date of this Agreement, (d)&nbsp;any shares of Common Stock issued or issuable after the date hereof pursuant
to the Transaction Agreement, (e)&nbsp;the shares of Common Stock issued or issuable pursuant to the Equity PIPE Subscription Agreement,
and (f)&nbsp;any other equity security of the Company issued or issuable with respect to any such share of the Common Stock by way of
a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization;&nbsp;provided,&nbsp;however,
that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A)&nbsp;a Registration
Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have
been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B)&nbsp;such securities shall have been
otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered
by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C)&nbsp;such
securities shall have ceased to be outstanding; (D)&nbsp;such securities may be sold without registration pursuant to Rule&nbsp;144 promulgated
under the Securities Act (or any successor rule&nbsp;promulgated thereafter by the Commission) (but with no volume or other restrictions
or limitations); or (E)&nbsp;such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or
other public securities transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Registration</I></B>&rdquo; shall
mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules&nbsp;and regulations promulgated thereunder, and such registration statement becoming
effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Registration Expenses</I></B>&rdquo;
shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(A)&nbsp;&nbsp;&nbsp;all registration and filing
fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority,&nbsp;Inc.) and any
securities exchange on which the Common Stock is then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(B)&nbsp;&nbsp;&nbsp;fees and expenses of compliance
with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue
sky qualifications of Registrable Securities);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(C)&nbsp;&nbsp;&nbsp;printing, messenger, telephone and delivery expenses;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(D)&nbsp;&nbsp;&nbsp;reasonable fees and disbursements of counsel for
the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(E)&nbsp;&nbsp;&nbsp;reasonable fees and disbursements
of all independent registered public accountants of the Company incurred specifically in connection with such Registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(F)&nbsp;&nbsp;&nbsp;reasonable fees and expenses
of one (1)&nbsp;legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration to be registered
for offer and sale in the applicable Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Registration Statement</I></B>&rdquo;
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the
Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Requesting Holders</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Securities Act</I></B>&rdquo; shall mean the Securities
Act of 1933, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Shelf Registration</I></B>&rdquo; shall have the meaning
given in&nbsp;Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>SPAC</I></B>&rdquo; shall have the meaning given in the
Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>SPAC Merger</I></B>&rdquo; shall have the meaning given
in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>SPAC Merger Sub</I></B>&rdquo; shall have the meaning
given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Sponsor</I></B>&rdquo; shall have the meaning given in
the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Subsequent Shelf Registration</I></B>&rdquo; shall have
the meaning given in&nbsp;subsection 2.1.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Trading Day</I></B>&rdquo; means a day during which trading
in the Common Stock generally occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Trading Market</I></B>&rdquo; means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE
American, the NYSE, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Transaction Agreement</I></B>&rdquo; shall have the meaning
given in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Transfer</I></B>&rdquo; shall mean
the (i)&nbsp;sale or assignment of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position within the meaning of Section&nbsp;16 of the Exchange Act with
respect to, any security, (ii)&nbsp;entry into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash
or otherwise, or (iii)&nbsp;public announcement of any intention to effect any transaction specified in clause (i)&nbsp;or (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Underwriter</I></B>&rdquo; shall
mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer&rsquo;s
market-making activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Underwritten Lock-up Period</I></B>&rdquo; shall have
the meaning given in&nbsp;subsection 2.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>Underwritten Registration</I></B>&rdquo;
or &ldquo;<B><I>Underwritten Offering</I></B>&rdquo; shall mean a Registration in which securities of the Company are sold to an Underwriter
in a firm commitment underwriting for distribution to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Underwritten Shelf Takedown</I></B>&rdquo; shall have
the meaning given in&nbsp;subsection 2.1.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><I>VWAP</I></B>&rdquo; means, for any
date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed or quoted on
a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30&nbsp;a.m.&nbsp;(New
York City time) to 4:02&nbsp;p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink
Sheets&rdquo; published by OTC Markets Group,&nbsp;Inc. (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of
a share of Common Stock as determined by an independent appraiser selected in good faith by the Board, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Withdrawal Notice</I></B>&rdquo; shall have the meaning
given in&nbsp;subsection 2.1.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B><I>Yearly Limit</I></B>&rdquo; shall have the meaning given
in&nbsp;subsection 2.1.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.1&nbsp;&nbsp;&nbsp;Shelf Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.1&nbsp;&nbsp;&nbsp;Filing.&nbsp;&nbsp;&nbsp;The
Company shall, subject to&nbsp;Section&nbsp;3.4&nbsp;hereof, submit or file within 30&nbsp;days of the closing date of the Business Combination
(the &ldquo;<B><I>Filing Deadline</I></B>&rdquo;), and use commercially reasonable efforts to cause to be declared effective as soon as
practicable thereafter, a Registration Statement for a Shelf Registration (&ldquo;<B><I>Shelf Registration</I></B>&rdquo;) on Form&nbsp;S-1
(the &ldquo;<B><I>Form&nbsp;S-1 Shelf</I></B>&rdquo;), or, if the Company is eligible to use a Registration Statement on Form&nbsp;S-3,
a Shelf Registration on Form&nbsp;S-3 (the &ldquo;<B><I>Form&nbsp;S-3 Shelf</I></B>&rdquo;), in each case, covering the resale of all
the Registrable Securities (determined as of two Business Days prior to such submission or filing) on a delayed or continuous basis and
shall use its commercially reasonable efforts to have the Shelf Registration declared effective after the filing thereof, but no later
than the earlier of (i)&nbsp;the 60th calendar day (or 90th calendar day if the Commission notifies the Company that it will &ldquo;review&rdquo;
the Registration Statement) following the earlier of (A)&nbsp;the filing of the Registration Statement and (B)&nbsp;the Filing Deadline,
and (ii)&nbsp;the 10th Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission
that the Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review (such deadline the &ldquo;<B><I>Effectiveness
Deadline</I></B>&rdquo;),&nbsp;<I>provided,</I>&nbsp;that if the Filing Deadline or Effectiveness Deadline falls on Saturday, Sunday or
other day that the Commission is closed for business, the Filing Deadline or Effectiveness Deadline, as the case may be, shall be extended
to the next Business Day on which the Commission is open for business. Such Shelf Registration shall provide for the resale of the Registrable
Securities included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder named
therein. Subject to&nbsp;Sections&nbsp;2.1.2&nbsp;and&nbsp;3.4&nbsp;hereof, the Company shall maintain a Shelf Registration in accordance
with the terms hereof, and shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements
as may be necessary to keep a Shelf Registration continuously effective, available for use by the Holders named therein to sell their
Registrable Securities included therein, and in compliance with the provisions of the Securities Act until such time as there are no longer
any Registrable Securities. In the event the Company files a Form&nbsp;S-1 Shelf, the Company shall use its commercially reasonable efforts
to convert the Form&nbsp;S-1 Shelf (and any Subsequent Shelf Registration) to a Form&nbsp;S-3 Shelf as soon as reasonably practicable
after the Company is eligible to use Form&nbsp;S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.2&nbsp;&nbsp;&nbsp;Subsequent Shelf Registration.&nbsp;&nbsp;&nbsp;If
any Shelf Registration ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still
outstanding, the Company shall, subject to Section&nbsp;3.4 hereof, use its commercially reasonable efforts to, as promptly as is reasonably
practicable, cause such Shelf Registration to again become effective under the Securities Act (including using its commercially reasonable
efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf Registration), and shall use its commercially
reasonable efforts to, as promptly as is reasonably practicable, amend such Shelf Registration in a manner reasonably expected to result
in the withdrawal of any order suspending the effectiveness of such Shelf Registration or file an additional registration statement as
a Shelf Registration (a &ldquo;<B><I>Subsequent Shelf Registration</I></B>&rdquo;) registering the resale of all Registrable Securities
under such Subsequent Shelf Registration (determined as of two Business Days prior to such filing), and pursuant to any method or combination
of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is filed, the Company
shall use its commercially reasonable efforts to (i)&nbsp;cause such Subsequent Shelf Registration to become effective under the Securities
Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be
an automatic shelf registration statement (as defined in Rule&nbsp;405 promulgated under the Securities Act) if the Company is a well-known
seasoned issuer (as defined in Rule&nbsp;405 promulgated under the Securities Act) at the most recent applicable eligibility determination
date) and (ii)&nbsp;keep such Subsequent Shelf Registration continuously effective, available for use by the Holders named therein to
sell their Registrable Securities included therein, and in compliance with the provisions of the Securities Act until such time as there
are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on Form&nbsp;S-3, to the extent that the Company
is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.3&nbsp;&nbsp;&nbsp;Additional Registrable
Securities.&nbsp;&nbsp;&nbsp;Subject to&nbsp;Section&nbsp;3.4&nbsp;hereof, in the event that any Holder or Holders, collectively, hold
Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon request of any such Holder
or Holders, shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by
either, at the Company&rsquo;s option, any then-available Shelf Registration (including by means of a post-effective amendment) or a Subsequent
Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf Registration or Subsequent
Shelf Registration shall be subject to the terms hereof;&nbsp;<I>provided, however</I>, that (i)&nbsp;the Company shall only be required
to cause such Registrable Securities to be covered if the total offering price thereof is reasonably expected to exceed, in the aggregate,
$10&nbsp;million and (ii)&nbsp;the Company shall only be required to register Registrable Securities pursuant to this&nbsp;Section&nbsp;2.1.3&nbsp;twice
per calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.4&nbsp;&nbsp;&nbsp;Requests for Underwritten
Shelf Takedown.&nbsp;&nbsp;&nbsp;Following the expiration of the Lock-up Period, if applicable, at any time and from time to time when
an effective Shelf Registration is on file with the Commission, any Liminatus Member, PIPE Subscribers, Cantor, or the Sponsor, or any
combination thereof (any of the Liminatus Members, PIPE Subscribers, Cantor, or the Sponsor making such demand, a &ldquo;<B><I>Demanding
Holder</I></B>&rdquo;) may request to sell all or any portion of its Registrable Securities in an Underwritten Offering or other coordinated
offering that is registered pursuant to a Shelf Registration (each, an &ldquo;<B><I>Underwritten Shelf Takedown</I></B>&rdquo;);&nbsp;<I>provided</I>&nbsp;that
the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include (a)&nbsp;Registrable Securities
proposed to be sold by the Demanding Holder, either individually or together with other Demanding Holders, with a total offering price
reasonably expected to exceed, in the aggregate, $10&nbsp;million (the &ldquo;<B><I>Minimum Takedown Threshold</I></B>&rdquo;) or (b)&nbsp;if
the Demanding Holders hold Registrable Securities with a total offering price reasonably expected to be less than the Minimum Takedown
Threshold, all of the Registrable Securities held by a Demanding Holder. All requests for Underwritten Shelf Takedowns shall be made by
giving written notice to the Company, which shall specify the approximate number of Registrable Securities proposed to be sold in the
Underwritten Shelf Takedown. The Company shall have the right to select the Underwriters for such offering (which shall consist of one
or more reputable nationally recognized investment banks), subject to the prior approval by the Demanding Holder(s)&nbsp;(which shall
not be unreasonably withheld, conditioned or delayed). The Liminatus Members, PIPE Subscribers, Cantor and the Sponsor, may each demand
Underwritten Shelf Takedowns pursuant to this&nbsp;Section&nbsp;2.1.4&nbsp;not more than two times in any twelve (12) month period (the
 &ldquo;<B><I>Yearly Limit</I></B>&rdquo;). Notwithstanding anything to the contrary in this Agreement, the Company may effect any Underwritten
Offering pursuant to any then-effective Registration Statement, including a Form&nbsp;S-3, which is then available for such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.5&nbsp;&nbsp;&nbsp;Reduction of Underwritten
Offering.&nbsp;&nbsp;&nbsp;If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advise(s)&nbsp;the
Company, the Demanding Holder(s)&nbsp;and the Holders requesting piggy back rights pursuant to this Agreement with respect to such Underwritten
Shelf Takedown (the &ldquo;<B><I>Requesting Holders</I></B>&rdquo;) (if any) in writing that the dollar amount or number of Registrable
Securities that the Demanding Holder(s)&nbsp;and the Requesting Holders (if any) desire to sell, taken together with all other shares
of Common Stock or other equity securities that the Company desires to sell and all other shares of Common Stock or other equity securities,
if any, that have been requested to be sold in such Underwritten Offering pursuant to separate written contractual piggy-back registration
rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that
can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method
or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the &ldquo;<B><I>Maximum
Number of Securities</I></B>&rdquo;), then the Company shall include in such Underwritten Offering, before including any shares of Common
Stock or other equity securities proposed to be sold by the Company or by other holders of shares of Common Stock or other equity securities,
the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro&nbsp;rata based on the respective number
of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Shelf
Takedown without exceeding the Maximum number of Securities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.1.6&nbsp;&nbsp;&nbsp;Underwritten Shelf Takedown
Withdrawal.&nbsp;&nbsp;&nbsp;Prior to the filing of the applicable &ldquo;red herring&rdquo; prospectus or prospectus supplement used
for marketing such Underwritten Shelf Takedown, a majority-in-interest of the Demanding Holders initiating an Underwritten Shelf Takedown
shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a &ldquo;<B><I>Withdrawal
Notice</I></B>&rdquo;) to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Underwritten
Shelf Takedown;&nbsp;<I>provided</I>&nbsp;that any other Demanding Holder(s)&nbsp;may elect to have the Company continue an Underwritten
Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten
Shelf Takedown by the Demanding Holder(s). If withdrawn, a demand for an Underwritten Shelf Takedown shall constitute a demand for an
Underwritten Shelf Takedown by the withdrawing Demanding Holder for purposes of&nbsp;Section&nbsp;2.1.4&nbsp;hereof and shall count toward
the Yearly Limit, unless either (i)&nbsp;the Demanding Holder(s)&nbsp;making the withdrawal has not previously withdrawn any Underwritten
Shelf Takedown or (ii)&nbsp;the Demanding Holder(s)&nbsp;making the withdrawal reimburses the Company for all Registration Expenses with
respect to such Underwritten Shelf Takedown (or, if there is more than one Demanding Holder, a&nbsp;<I>pro&nbsp;rata</I>&nbsp;portion
of such Registration Expenses based on the respective number of Registrable Securities that each Demanding Holder has requested be included
in such Underwritten Shelf Takedown); provided that, if any other Demanding Holder(s)&nbsp;elects to continue an Underwritten Shelf Takedown
pursuant to the proviso in the immediately preceding sentence, such Underwritten Shelf Takedown shall instead count as an Underwritten
Shelf Takedown demanded by the Demanding Holders for purposes of&nbsp;Section&nbsp;2.1.4&nbsp;hereof and shall count toward the Yearly
Limit. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Demanding
Holders and Requesting Holders. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration
Expenses incurred in connection with an Underwritten Shelf Takedown prior to its withdrawal under this&nbsp;Section&nbsp;2.1.6, other
than if a Demanding Holder elects to pay such Registration Expenses pursuant to clause (ii)&nbsp;of the second sentence of this&nbsp;Section&nbsp;2.1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.2&nbsp;&nbsp;&nbsp;Piggyback Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.2.1&nbsp;&nbsp;&nbsp;Piggyback Rights.&nbsp;&nbsp;&nbsp;If
the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities
or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of
stockholders of the Company (or by the Company and by the stockholders of the Company including, without limitation, pursuant to&nbsp;Section&nbsp;2.1&nbsp;hereof),
other than a Registration Statement (i)&nbsp;filed in connection with any employee stock option or other benefit plan, (ii)&nbsp;for an
exchange offer or offering of securities solely to the Company&rsquo;s existing stockholders, (iii)&nbsp;for an offering of debt that
is convertible into equity securities of the Company or (iv)&nbsp;for a dividend reinvestment plan, then the Company shall give written
notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10)&nbsp;days
before the anticipated filing date of such Registration Statement, which notice shall (A)&nbsp;describe the amount and type of securities
to be included in such offering, the intended method(s)&nbsp;of distribution, and the name of the proposed managing Underwriter or Underwriters,
if any, in such offering, and (B)&nbsp;offer to all of the Holders of Registrable Securities the opportunity to register the sale of such
number of Registrable Securities as such Holders may request in writing within five (5)&nbsp;days after receipt of such written notice
(such Registration a &ldquo;<B><I>Piggyback Registration</I></B>&rdquo;). The Company shall, in good faith, cause such Registrable Securities
to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed
Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this&nbsp;subsection 2.2.1&nbsp;to be
included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Registration
and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s)&nbsp;of distribution
thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this&nbsp;subsection
2.2.1&nbsp;shall enter into an underwriting agreement in customary form with the Underwriter(s)&nbsp;selected for such Underwritten Offering
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.2.2&nbsp;&nbsp;&nbsp;Reduction of Piggyback
Registration.&nbsp;&nbsp;&nbsp;If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration,
in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that
the dollar amount or number of the Common Stock that the Company desires to sell, taken together with (i)&nbsp;the Common Stock, if any,
as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the
Holders of Registrable Securities hereunder (ii)&nbsp;the Registrable Securities as to which registration has been requested pursuant
to&nbsp;Section&nbsp;2.2&nbsp;hereof, and (iii)&nbsp;the Common Stock, if any, as to which Registration has been requested pursuant to
separate written contractual piggy-back registration rights of other stockholders of the Company, exceeds the Maximum Number of Securities,
then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;If the Registration is undertaken
for the Company&rsquo;s account, the Company shall include in any such Registration (A)&nbsp;first, the Common Stock or other equity securities
that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B)&nbsp;second, to the extent
that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising
their rights to register their Registrable Securities pursuant to&nbsp;subsection 2.2.1&nbsp;hereof, Pro Rata, which can be sold without
exceeding the Maximum Number of Securities; and (C)&nbsp;third, to the extent that the Maximum Number of Securities has not been reached
under the foregoing clauses (A)&nbsp;and (B), the Common Stock, if any, as to which Registration has been requested pursuant to written
contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number
of Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;If the Registration is pursuant
to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration
(A)&nbsp;first, the Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders of
Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B)&nbsp;second, to the extent that the
Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their
rights to register their Registrable Securities pursuant to&nbsp;subsection 2.2.1, pro&nbsp;rata based on the number of Registrable Securities
that each Holder has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the
Holders have requested to be included in such Underwritten Registration, which can be sold without exceeding the Maximum Number of Securities;
(C)&nbsp;third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A)&nbsp;and (B),
the Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of
Securities; and (D)&nbsp;fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses
(A), (B)&nbsp;and (C), the Common Stock or other equity securities for the account of other persons or entities that the Company is obligated
to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the
Maximum Number of Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.2.3&nbsp;&nbsp;&nbsp;Piggyback Registration
Withdrawal.&nbsp;&nbsp;&nbsp;Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any
or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention
to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect
to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal
by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection
with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary
in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration
prior to its withdrawal under this&nbsp;subsection 2.2.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.2.4&nbsp;&nbsp;&nbsp;Unlimited Piggyback Registration
Rights.&nbsp;&nbsp;&nbsp;For purposes of clarity, any Registration effected pursuant to&nbsp;Section&nbsp;2.2&nbsp;hereof shall not be
counted as a Registration pursuant to a Demand Registration effected under&nbsp;Section&nbsp;2.1&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.3&nbsp;&nbsp;&nbsp;Market Stand-off.&nbsp;&nbsp;&nbsp;In
connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade) or any Company-initiated Registration
for the account of the Company (subject to the Company&rsquo;s compliance with&nbsp;Section&nbsp;2.2&nbsp;hereof), each Holder that is
an executive officer, director or Holder in excess of 5% of the then-outstanding shares of Common Stock agrees that it shall not Transfer
any shares of Common Stock or other equity securities of the Company (other than those included in such offering pursuant to this Agreement),
without the prior written consent of the Company, during the 90-day period (or such shorter time agreed to by the managing Underwriters)
beginning on the date of pricing of such offering (the &ldquo;<B><I>Underwritten Lock-up Period</I></B>&rdquo;), except as expressly permitted
by such lock-up agreement or in the event the Underwriters managing the offering otherwise consent in writing. Each Holder agrees to execute
a customary lock-up agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions
as the Company&rsquo;s directors and executive officers or the other shareholders of the Company). The Company will not be obligated to
undertake an Underwritten Shelf Takedown during any Underwritten Lock-up Period binding on the Holders, nor will the Company be obligated
to include in any Piggyback Registration any Registrable Securities that are then subject to a &ldquo;lock-up&rdquo; agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.4&nbsp;&nbsp;&nbsp;Block Trades.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.4.1&nbsp;&nbsp;&nbsp;Notwithstanding any other
provisions of this Agreement, but subject to&nbsp;Section&nbsp;3.4, if a Demanding Holder desires to effect a Block Trade, with a total
offering price reasonably expected to exceed, in the aggregate, either (x)&nbsp;the Minimum Takedown Threshold or (y)&nbsp;all remaining
Registrable Securities held by such Demanding Holder, then notwithstanding the time periods provided for in&nbsp;Section&nbsp;2.2.1, such
Demanding Holder only needs to notify the Company of the Block Trade at least three (3)&nbsp;business days prior to the day such offering
is to commence and the Company shall as promptly as is reasonably practicable, use its commercially reasonable efforts to facilitate such
Block Trade; provided that the Demanding Holder wishing to engage in the Block Trade shall use its commercially reasonable efforts to
work with the Company and any Underwriters or placement agents or sales agents prior to making such request in order to facilitate preparation
of the registration statement, prospectus and other offering documentation related to such Block Trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.4.2&nbsp;&nbsp;&nbsp;Prior to the filing of
the applicable &ldquo;red herring&rdquo; prospectus or prospectus supplement used in connection with a Block Trade, the Demanding Holder
that initiated such Block Trade shall have the right to submit a Withdrawal Notice to the Company and the Underwriter or Underwriters
or placement agents or sales agents (if any) of their intention to withdraw from such Block Trade. Notwithstanding anything to the contrary
in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade prior to its
withdrawal under this&nbsp;Section&nbsp;2.4.2&nbsp;in the first instance of any such withdrawal; provided, that the Holder shall be responsible
for the Registration Expenses incurred in connection with a Block Trade prior to any subsequent withdrawal under this&nbsp;Section&nbsp;2.4.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.4.3&nbsp;&nbsp;&nbsp;Notwithstanding anything
to the contrary in this Agreement,&nbsp;Section&nbsp;2.2&nbsp;hereof shall not apply to a Block Trade initiated by a Demanding Holder
pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.4.4&nbsp;&nbsp;&nbsp;The Demanding Holder wishing
to engage in a Block Trade shall have the right to select the Underwriters, placement agents or sales agents (if any) for such Block Trade
(which shall consist of one or more reputable nationally recognized investment banks),&nbsp;<I>provided</I>, that such selection shall
be subject to the consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.4.5&nbsp;&nbsp;&nbsp;A Holder in the aggregate
may demand no more than two Block Trades pursuant to this&nbsp;Section&nbsp;2.4&nbsp;in any 12-month period. For the avoidance of doubt,
any Block Trade effected pursuant to this&nbsp;Section&nbsp;2.4&nbsp;shall not be counted as a demand for an Underwritten Shelf Takedown
pursuant to&nbsp;Section&nbsp;2.1.4&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2.5&nbsp;&nbsp;&nbsp;Restrictions on
Registration Rights.&nbsp;&nbsp;&nbsp;If (A)&nbsp;during the period starting with the date sixty (60) days prior to the
Company&rsquo;s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the
effective date of, a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior
to receipt of a request for an Underwritten Shelf Takedown pursuant to&nbsp;Section&nbsp;2.1.4&nbsp;hereof and it continues to
actively employ, in good faith, all reasonable best efforts to cause the applicable Registration Statement to become effective;
(B)&nbsp;the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the commitment
of underwriters to firmly underwrite the offer; or (C)&nbsp;in the good faith judgment of the Board such Underwritten Offering would
be seriously detrimental to the Company and the Board concludes as a result that it is Liminatus to defer the undertaking of such
Underwritten Offering at such time, then in each case, as applicable, the Company shall furnish to such Holders a certificate signed
by the Chairman of the Board stating the applicable reason(s)&nbsp;set forth in Clauses (A)&nbsp;through (C)&nbsp;above underlying
the Company&rsquo;s decision to defer the undertaking of such Underwritten Offering. In such event, the Company shall have the right
to defer such offering for a period of not more than sixty (60) days; provided, however, that the Company shall not defer its
obligations in this manner more than once in any twelve (12) month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1&nbsp;&nbsp;&nbsp;General Procedures.&nbsp;&nbsp;&nbsp;If
at any time the Company is required to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect
such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and
pursuant thereto the Company shall, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.1&nbsp;&nbsp;&nbsp;prepare and file with the
Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts
to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration
Statement have been sold;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.2&nbsp;&nbsp;&nbsp;prepare and file with the
Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may
be requested by any Holder or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions
applicable to the registration form used by the Company or by the Securities Act or rules&nbsp;and regulations thereunder to keep the
Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the
intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.3&nbsp;&nbsp;&nbsp;prior to filing a Registration
Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and each Holder of
Registrable Securities included in such Registration, and each such Holder&rsquo;s legal counsel, copies of such Registration Statement
as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and
documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus),
and such other documents as the Underwriters and each Holder of Registrable Securities included in such Registration or the legal counsel
for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.4&nbsp;&nbsp;&nbsp;prior to any public offering
of Registrable Securities, use its best efforts to (i)&nbsp;register or qualify the Registrable Securities covered by the Registration
Statement under such securities or &ldquo;blue sky&rdquo; laws of such jurisdictions in the United States as any Holder of Registrable
Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii)&nbsp;take such
action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such
other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts
and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement
to consummate the disposition of such Registrable Securities in such jurisdictions;&nbsp;provided,&nbsp;however, that the Company shall
not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any
action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise
so subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.5&nbsp;&nbsp;&nbsp;cause all such Registrable
Securities to be listed on each securities exchange or automated quotation system on which similar securities issued by the Company are
then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.6&nbsp;&nbsp;&nbsp;provide a transfer agent
or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration
Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.7&nbsp;&nbsp;&nbsp;advise each seller of such
Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission
suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly
use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.8&nbsp;&nbsp;&nbsp;at least five (5)&nbsp;days
prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus
or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each
seller of such Registrable Securities and its counsel, including, without limitation, providing copies promptly upon receipt of any comment
letters received with respect to any such Registration Statement or Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.9&nbsp;&nbsp;&nbsp;notify the Holders at any
time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening
of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement,
and then to correct such Misstatement as set forth in&nbsp;Section&nbsp;3.4&nbsp;hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.10&nbsp;&nbsp;&nbsp;permit a representative
of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters, if any, and any attorney
or accountant retained by such Holders, or Underwriter to participate, at each such person&rsquo;s own expense, in the preparation of
the Registration Statement, and cause the Company&rsquo;s officers, directors and employees to supply all information reasonably requested
by any such representative, Underwriter, attorney or accountant in connection with the Registration;&nbsp;provided,&nbsp;however, that
such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company,
prior to the release or disclosure of any such information; and&nbsp;provided further, the Company may not include the name of any Holder
or Underwriter or any information regarding any Holder or Underwriter in any Registration Statement or Prospectus, any amendment or supplement
to such Registration Statement or Prospectus, any document that is to be incorporated by reference into such Registration Statement or
Prospectus, or any response to any comment letter, without the prior written consent of such Holder or Underwriter and providing each
such Holder or Underwriter a reasonable amount of time to review and comment on such applicable document, which comments the Company shall
include unless contrary to applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.11&nbsp;&nbsp;&nbsp;obtain a &ldquo;cold comfort&rdquo;
letter from the Company&rsquo;s independent registered public accountants in the event of an Underwritten Registration which the participating
Holders may rely on, in customary form and covering such matters of the type customarily covered by &ldquo;cold comfort&rdquo; letters
as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.12&nbsp;&nbsp;&nbsp;on the date the Registrable
Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company
for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if
any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders, placement
agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters,
and reasonably satisfactory to a majority in interest of the participating Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.13&nbsp;&nbsp;&nbsp;in the event of any Underwritten
Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter
of such offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.14&nbsp;&nbsp;&nbsp;make available to its
security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning
with the first day of the Company&rsquo;s first full calendar quarter after the effective date of the Registration Statement which satisfies
the provisions of&nbsp;Section&nbsp;11(a)&nbsp;of the Securities Act and Rule&nbsp;158 thereunder (or any successor rule&nbsp;promulgated
thereafter by the Commission);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.15&nbsp;&nbsp;&nbsp;if the Registration involves
the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable efforts to make available
senior executives of the Company to participate in customary &ldquo;road show&rdquo; presentations that may be reasonably requested by
the Underwriter in any Underwritten Offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.1.16&nbsp;&nbsp;&nbsp;otherwise, in good faith,
cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.2&nbsp;&nbsp;&nbsp;Registration Expenses.&nbsp;&nbsp;&nbsp;The
Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear
all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters&rsquo; commissions and discounts,
brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of &ldquo;Registration Expenses,&rdquo; all
reasonable fees and expenses of any legal counsel representing the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.3&nbsp;&nbsp;&nbsp;Requirements for Participation
in Underwritten Offerings.&nbsp;&nbsp;&nbsp;No person may participate in any Underwritten Offering for equity securities of the Company
pursuant to a Registration initiated by the Company hereunder unless such person (i)&nbsp;agrees to sell such person&rsquo;s securities
on the basis provided in any underwriting arrangements approved by the Company and (ii)&nbsp;completes and executes all customary questionnaires,
powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required
under the terms of such underwriting arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.4&nbsp;&nbsp;&nbsp;Suspension of Sales; Adverse
Disclosure.&nbsp;&nbsp;&nbsp;Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement,
each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or
amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement
or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the
Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration
at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial
statements that are unavailable to the Company for reasons beyond the Company&rsquo;s control, the Company may, upon giving prompt written
notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for
the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such
purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their
receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer
to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised
its rights under this&nbsp;Section&nbsp;3.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">3.5&nbsp;&nbsp;&nbsp;Reporting Obligations.&nbsp;&nbsp;&nbsp;As
long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange
Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company after the date hereof pursuant to&nbsp;Sections&nbsp;13(a)&nbsp;or&nbsp;15(d)&nbsp;of the Exchange Act and
to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants that it shall take such
further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares
of the Common Stock held by such Holder without registration under the Securities Act within the limitation of the exemptions provided
by Rule&nbsp;144 promulgated under the Securities Act (or any successor rule&nbsp;promulgated thereafter by the Commission), including
providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly
authorized officer as to whether it has complied with such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AND CONTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.1&nbsp;&nbsp;&nbsp;Indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">4.1.1&nbsp;&nbsp;&nbsp;The Company agrees to indemnify,
to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each person who controls such Holder
(within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys&rsquo; fees)
caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus
or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished
in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors
and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing
with respect to the indemnification of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">4.1.2&nbsp;&nbsp;&nbsp;In connection with any
Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing
such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus
and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the
Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation
reasonable attorneys&rsquo; fees) resulting from any untrue statement of material fact contained in the Registration Statement, Prospectus
or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein
or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained
in any information or affidavit so furnished in writing by such Holder expressly for use therein;&nbsp;provided,&nbsp;however, that the
obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each
such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale
of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters,
their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent
as provided in the foregoing with respect to indemnification of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">4.1.3&nbsp;&nbsp;&nbsp;Any person entitled to
indemnification herein shall (i)&nbsp;give prompt written notice to the indemnifying party of any claim with respect to which it seeks
indemnification (provided that the failure to give prompt notice shall not impair any person&rsquo;s right to indemnification hereunder
to the extent such failure has not materially prejudiced the indemnifying party) and (ii)&nbsp;unless in such indemnified party&rsquo;s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume
the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for all parties
indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict
of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying
party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot
be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such
settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">4.1.4&nbsp;&nbsp;&nbsp;The indemnification provided
for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified
party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. The Company
and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested
by any indemnified party for contribution to such party in the event the Company&rsquo;s or such Holder&rsquo;s indemnification is unavailable
for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">4.1.5&nbsp;&nbsp;&nbsp;If the indemnification
provided under&nbsp;Section&nbsp;4.1&nbsp;hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified
party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of
indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses,
claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party
and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified
party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied
by, such indemnifying party or indemnified party, and the indemnifying party&rsquo;s and indemnified party&rsquo;s relative intent, knowledge,
access to information and opportunity to correct or prevent such action;&nbsp;provided,&nbsp;however, that the liability of any Holder
under this&nbsp;subsection 4.1.5&nbsp;shall be limited to the amount of the net proceeds received by such Holder in such offering giving
rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be
deemed to include, subject to the limitations set forth in&nbsp;subsections 4.1.1,&nbsp;4.1.2&nbsp;and&nbsp;4.1.3&nbsp;above, any legal
or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto
agree that it would not be just and equitable if contribution pursuant to this&nbsp;subsection 4.1.5&nbsp;were determined by pro&nbsp;rata
allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this&nbsp;subsection
4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of&nbsp;Section&nbsp;11(f)&nbsp;of the Securities Act) shall
be entitled to contribution pursuant to this&nbsp;subsection 4.1.5&nbsp;from any person who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LOCK-UP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">5.1&nbsp;&nbsp;&nbsp;Lock-up.&nbsp;&nbsp;&nbsp;Pursuant
to the Lock-Up Agreement, the Sponsor, Cantor, and the Liminatus Members agree that they shall not Transfer any Lock-up Shares until the
end of the Lock-up Period, except as permitted by and in accordance with the Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.1&nbsp;&nbsp;&nbsp;Notices.&nbsp;&nbsp;&nbsp;Any
notice or communication under this Agreement must be in writing and given by (i)&nbsp;deposit in the United States mail, addressed to
the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii)&nbsp;delivery in person or by
courier service providing evidence of delivery, or (iii)&nbsp;transmission by hand delivery, or facsimile. Each notice or communication
that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received,
in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered
by courier service, hand delivery, or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit
of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement
must be addressed, if to the Company, to: 6 Centerpointe Dr., #625, La Palma, CA 90623, and, if to any Holder, at such Holder&rsquo;s
address or contact information as set forth in the Company&rsquo;s books and records. Any party may change its address for notice at any
time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30)
days after delivery of such notice as provided in this&nbsp;Section&nbsp;6.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6.2&nbsp;&nbsp;&nbsp;Assignment; No Third Party Beneficiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.2.1&nbsp;&nbsp;&nbsp;This Agreement and the
rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.2.2&nbsp;&nbsp;&nbsp;Prior to the expiration
of the Lock-up Period, if applicable, no Holder may assign or delegate such Holder&rsquo;s rights, duties or obligations under this Agreement,
in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only
if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.2.3&nbsp;&nbsp;&nbsp;This Agreement and the
provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns
of the Holders, which shall include Permitted Transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.2.4&nbsp;&nbsp;&nbsp;This Agreement shall not
confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and&nbsp;Section&nbsp;6.2&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.2.5&nbsp;&nbsp;&nbsp;No assignment by any party
hereto of such party&rsquo;s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the
Company shall have received (i)&nbsp;written notice of such assignment as provided in&nbsp;Section&nbsp;6.1&nbsp;hereof and (ii)&nbsp;the
written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement
(which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as
provided in this&nbsp;Section&nbsp;6.2&nbsp;shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.3&nbsp;&nbsp;&nbsp;Counterparts.&nbsp;&nbsp;&nbsp;This
Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original,
and all of which together shall constitute the same instrument, but only one of which need be produced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.4&nbsp;&nbsp;&nbsp;Governing Law; Venue.&nbsp;&nbsp;&nbsp;NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY&nbsp;BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I)&nbsp;THIS AGREEMENT
SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO
AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II)&nbsp;THE
VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.5&nbsp;&nbsp;&nbsp;Amendments and Modifications.&nbsp;&nbsp;&nbsp;Upon
the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question,
compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions,
covenants or conditions may be amended or modified;&nbsp;provided,&nbsp;however, that notwithstanding the foregoing, any amendment hereto
or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of capital stock of the Company,
in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected.
No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the
Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or
the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude
the exercise of any other rights or remedies hereunder or thereunder by such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.6&nbsp;&nbsp;&nbsp;Other Registration Rights.&nbsp;&nbsp;&nbsp;The
Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to
register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company
for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that
this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a
conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">6.7&nbsp;&nbsp;&nbsp;Term.&nbsp;&nbsp;&nbsp;This
Agreement shall terminate upon the earlier of (i)&nbsp;the tenth anniversary of the date of this Agreement or (ii)&nbsp;the date as of
which (A)&nbsp;all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable
period referred to in Section&nbsp;4(a)(3)&nbsp;of the Securities Act and Rule&nbsp;174 thereunder (or any successor rule&nbsp;promulgated
thereafter by the Commission)) or (B)&nbsp;the Holders of all Registrable Securities are permitted to sell the Registrable Securities
under Rule&nbsp;144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner
of sale. The provisions of&nbsp;Section&nbsp;3.5&nbsp;and&nbsp;<I>Article&nbsp;IV</I>&nbsp;shall survive any termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[</B></FONT><I>Signature
Page&nbsp;Follows</I><B>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B></FONT>, the undersigned have caused this Agreement to be executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; text-align: justify"><B>SPAC:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; text-align: justify"><B>IRIS ACQUISITION CORP.</B>, a Delaware corporation</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><B>By:</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt; text-align: justify"> /s/ Sumit Metha</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">Name:</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt; text-align: justify">Sumit Metha</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">Title:</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt; text-align: justify">Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IRIS PARENT HOLDING CORP., </B></FONT>a Delaware corporation</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 43%; padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOLDERS:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IRIS ACQUISITION HOLDINGS LLC, </B></FONT>a Delaware limited liability company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sumit Mehta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Sumit Mehta</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VALETUDO THERAPEUTICS LLC, </B></FONT>a Delaware limited liability company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FEELUX CO., LTD, </B></FONT>a [&nbsp;&nbsp;] company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Bae Bo Sung</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bae Bo Sung</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CANTOR FITZGERALD&nbsp;&amp; CO., </B></FONT>a [&nbsp;&nbsp;] company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EQUITY PIPE SUBSCRIBERS:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EWON
    COMFORTECH CO.,&nbsp;LTD.</B></FONT>, a South Korean company</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Joo Sung Park</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; width: 3%">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joo Sung Park</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>7
<FILENAME>tm2513673d1_ex14-1.htm
<DESCRIPTION>EXHIBIT 14.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 14.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CODE OF BUSINESS CONDUCT AND ETHICS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF<BR>
LIMINATUS PHARMA,&nbsp;INC.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Adopted: April&nbsp;30, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors (the
 &ldquo;Board&rdquo;) of Liminatus Pharma,&nbsp;Inc. (the &ldquo;Company&rdquo;) has adopted this Code of Business Conduct and Ethics (this
 &ldquo;Code&rdquo;) to provide value for our stockholders; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To encourage honest and ethical conduct, including fair dealing and the ethical handling of conflicts
of interest;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To promote accurate, fair and timely reporting of the Company&rsquo;s financial results and condition
and other information the Company releases to the public market in reports it files with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To comply with applicable laws and governmental rules&nbsp;and regulations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To prompt internal reporting of violations of this Code;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To protect the Company&rsquo;s legitimate business interests, including corporate opportunities, assets
and confidential information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To deter wrongdoing.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All directors, officers, employees
and independent contractors of the Company are expected to be familiar with this Code and to adhere to the principles and procedures set
forth in this Code. For purposes of this Code, all directors, officers, employees and independent contractors are referred to collectively
as &ldquo;employees&rdquo; or &ldquo;you&rdquo; throughout this Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A. Honest and Ethical Conduct</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All directors, officers, employees
and independent contractors owe duties to the Company to act with integrity. Integrity requires, among other things, being honest and
ethical. This includes the ethical handling of actual or apparent conflicts of interest between personal and professional relationships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All directors, officers, employees
and independent contractors have the following duties:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To conduct business with professional courtesy and integrity, and act honestly and fairly without prejudice
in all commercial dealings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To work in a safe, healthy and efficient manner, using skills, time and experience to the maximum of abilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To comply with applicable Company policies and job requirements, and adhere to a high standard of business
ethics;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To observe laws, governmental rules, regulations and accounting standards;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To deal fairly with the Company&rsquo;s customers, suppliers, competitors and employees, and not take
unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or
any other unfair dealings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To achieve responsible use of and control over all assets and resources employed or entrusted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To maintain the confidentiality of information where required or consistent with Company policies; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Not to disclose information or documents relating to the Company or its business, other than as required
by law, not to make any unauthorized public comment on Company affairs and not to misuse any information about the Company or its associates,
and not to accept improper or undisclosed material personal benefits from third parties as a result of any transaction or transactions
of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>B. Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A &ldquo;conflict of interest&rdquo;
arises when an individual&rsquo;s personal interest interferes or appears to interfere with the interests of the Company. A conflict of
interest can arise when a director, officer or employee takes actions or has personal interests that may make it difficult to perform
his or her Company work objectively and effectively. Conflicts of interest should be avoided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are a variety of situations
in which a conflict of interest may arise. While it would be impractical to attempt to list all possible situations, some common types
of conflicts may be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To serve as a director, employee or contractor for a company that has a business relationship with, or is a competitor of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To enter into any financial transaction, arrangement, or relationship that is beyond the ordinary course of business, involving the
Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To have a financial interest in a competitor, supplier or customer of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To receive improper personal benefits from a competitor, supplier or customer, as a result of any transaction or transactions of the
Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To accept financial interest beyond entertainment or nominal gifts in the ordinary course of business, such as a meal or a coffee
mug; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To use for personal gain, rather than for the benefit of the Company, an opportunity that is offered to you solely in your capacity
as an employee, officer or director of the Company and that is one that the Company is legally and contractually permitted to undertake
and that is otherwise reasonable for the Company to pursue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In most cases, anything that
would constitute a conflict for a director, officer or employee also would present a conflict if it is related to a member of his or her
family.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interests in other companies,
including potential competitors and suppliers, that are purely for management of the other entity, or where an otherwise questionable
relationship is disclosed to the Board and any necessary action is taken to ensure there will be no effect on the Company, are not considered
conflicts unless otherwise determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Evaluating whether a conflict
of interest exists can be difficult and may involve a number of considerations. We also encourage you to seek guidance from our Chief
Financial Officer when you have any questions or doubts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>C. Related-Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall strive to
avoid, wherever possible, all Related-Party Transactions (as defined below) that could result in actual or potential conflicts of interests,
except if in accordance with the approval process and guidelines included below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Related-Party Transactions&rdquo;
are defined as transactions in which (1)&nbsp;the aggregate amount involved will or may be expected to exceed $120,000 in any fiscal year,
(2)&nbsp;the Company or any of the Company&rsquo;s subsidiaries is a participant, and (3)&nbsp;any (a)&nbsp;executive officer, director
or nominee for election as a director, (b)&nbsp;greater than 5% beneficial owner of the Company&rsquo;s common stock, or (c)&nbsp;immediate
family member, of the persons referred to in clauses (a)&nbsp;and (b)&nbsp;(each, a &ldquo;Related Party&rdquo;), has or will have a direct
or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Approval
Process and Guidelines</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Each director and executive officer shall identify, any Related-Party Transaction involving a Related
Party and inform the Audit Committee of the Board (the &ldquo;Audit Committee&rdquo;) before the Company may engage in the transaction
with a Related Party. Each of the Company&rsquo;s directors and officers shall complete a directors&rsquo; and officers&rsquo; questionnaire
that elicits information about Related-Party Transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">In the event that the Company proposes to enter into, or materially amend, a Related-Party Transaction,
the Chief Financial Officer shall present such Related-Party Transaction to the Audit Committee for review and consideration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Any Related-Party Transaction, if not a Related-Party Transaction when originally consummated, or if not
initially identified as a Related-Party Transaction prior to consummation, shall be submitted to the Audit Committee for review as soon
as reasonably practicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>D. Disclosure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each director, officer or
employee, to the extent involved in the Company&rsquo;s disclosure process, including the Chief Executive Officer or Chief Financial Officer
is required to be familiar with the Company&rsquo;s disclosure controls and procedures applicable to him or her so that the Company&rsquo;s
public reports and documents comply in all material respects with the applicable securities laws and rules. In addition, each such person
having direct or supervisory authority regarding these securities filings or the Company&rsquo;s other public communications concerning
its general business, results, financial condition and prospects should, to the extent appropriate within his or her area of responsibility,
consult with other Company officers and employees and take other appropriate steps regarding these disclosures with the goal of making
full, fair, accurate, timely and understandable disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each director, officer or
employee, to the extent involved in the Company&rsquo;s disclosure process must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Familiarize himself or herself with the disclosure requirements applicable to the Company as well as the business and financial operations
of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Not knowingly misrepresent, or cause others to misrepresent, facts about the Company to others, whether within or outside the Company,
including to the Company&rsquo;s independent auditors, governmental regulators and self-regulatory organizations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>E. Compliance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the Company&rsquo;s
policy to comply with all applicable laws, rules&nbsp;and regulations. It is the responsibility of each employee, officer and director
to adhere to the standards and restrictions imposed by those laws, rules&nbsp;and regulations in the performance of their duties for the
Company, including those relating to accounting and auditing matters and insider trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board endeavors to ensure
that the directors, officers and employees of the Company act with integrity and observe the highest standards of behavior and business
ethics in relation to their corporate activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specifically, directors, officers
and employees must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Comply with the law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Act in the best interests of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Be responsible and accountable for their actions; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Observe the ethical principles of fairness, honesty and truthfulness, including disclosure of potential
conflicts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, it is against Company
policies for any individual to profit from undisclosed information relating to the Company or any other company in violation of insider
trading or other laws. Anyone who is aware of material nonpublic information relating to the Company, our customers, or other companies
may not use the information to purchase or sell securities in violation of securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are uncertain about
the legal rules&nbsp;involving your purchase or sale of any Company securities or any securities in companies that you are familiar with
by virtue of your work for the Company, you should consult with the Chief Financial Officer before making any such purchase or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>F. Reporting and Accountability</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has the authority
to interpret this Code in any particular situation. Any director, officer or employee who becomes aware of any known or suspected violation
of this Code is required to notify the Chief Financial Officer promptly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any questions relating to
how these policies should be interpreted or applied should be addressed to the Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each director, officer or
employee must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Notify the Chief Financial Officer promptly of any existing or potential violation of this Code; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Not retaliate against any other director, officer or employee for reports of potential violations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will follow the
following procedures in investigating and enforcing this Code and in reporting on the Code:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The Chief Financial Officer, as appropriate, will take all appropriate action to investigate any violations
reported. After the conclusion of an investigation of a director or executive officer, the conclusions shall be reported to the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The Board will conduct such additional investigation as it deems necessary. The Board will determine whether
a director or executive officer has violated this Code. Upon being notified that a violation has occurred, the Company will take such
disciplinary or preventive action as deemed appropriate, up to and including dismissal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>G. Corporate Opportunities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Employees, officers and directors
are prohibited from taking (or directing to a third party) a business opportunity that is offered to them solely in their capacity as
an employee, officer or director of the Company and that is one that the Company is legally and contractually permitted to undertake and
that is otherwise reasonable for the Company to pursue, unless the Company has already been offered the opportunity and turned it down.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sometimes, the line between
personal and Company benefits is difficult to draw, and sometimes there are both personal and Company benefits in certain activities.
Employees, officers and directors who intend to make use of Company property or services in a manner not solely for the benefit of the
Company should consult beforehand with the Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>H. Confidentiality</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In carrying out the Company&rsquo;s
business, employees, independent contractors, officers and directors often learn confidential or proprietary information about the Company,
its customers, suppliers, or joint venture parties. Employees, independent contractors, officers and directors must maintain the confidentiality
of all information so entrusted to them, except when disclosure is authorized or legally mandated. Confidential or proprietary information
of our Company, and of other companies, includes any non-public information that would be harmful to the relevant company or useful or
helpful to competitors if disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I. Fair Dealing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our core value of operating
is based on responsiveness, openness, honesty and trust with our members, business partners, employees and stockholders. We do not seek
competitive advantages through illegal or unethical business practices. Each employee, officer and director should endeavor to deal fairly
with the Company&rsquo;s customers, service providers, suppliers, competitors and employees. No employee, officer or director should take
unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or
any unfair dealing practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>J. Protection and Proper Use of Company Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All employees, officers and
directors should protect the Company&rsquo;s assets and ensure their efficient use. All Company assets should be used only for legitimate
business purposes. Theft, carelessness and waste have a direct impact on our profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>K. Waivers and Amendments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may waive provisions of this Code. Any employee or director who believes that a waiver may be called for should discuss the matter with
the Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any waiver of the Code for
executive officers or directors of the Company must be approved by the Board. The Company will disclose any such waivers within four business
days by filing a current report on Form&nbsp;8-K with the Commission or, in cases where a Form&nbsp;8-K is not required, by distributing
a press release, in each case as required by Section&nbsp;5610 of the Nasdaq Stock Market LLC Rules&nbsp;or any other applicable law or
rule&nbsp;of any other applicable stock exchange. Alternatively, the Company may disclose any such waivers on the Company&rsquo;s website
in a manner that satisfies the requirements of Item 5.05(c)&nbsp;of Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is committed to
continuously reviewing and updating its policies, and therefore reserves the right to amend this Code at any time, for any reason, subject
to applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>8
<FILENAME>tm2513673d1_ex16-1.htm
<DESCRIPTION>EXHIBIT 16.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 16.1</B></P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 6, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commissioners:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have read the statements made by Liminatus
Pharma, Inc. (formerly known as Iris Parent Holding Corp.) under Item 4.01 of its Form 8-K dated April 30, 2025. We agree with the statements
concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Liminatus Pharma, Inc. (formerly
known as Iris Parent Holding Corp.) contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marcum <FONT STYLE="font-variant: small-caps">llp&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>9
<FILENAME>tm2513673d1_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 21.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>List of Subsidiaries</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 60%">Subsidiary</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 39%">Place of Incorporation</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Liminatus Pharma, LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Delaware</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Iris Acquisition Corp</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Delaware</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>tm2513673d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Board of Directors and Stockholder of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Iris Parent Holding Corp.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Opinion on the Consolidated Financial Statements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Iris Parent Holding Corp. (the &ldquo;Company&rdquo;) as of December 31, 2024 and 2023, and the related consolidated
statements of operations, changes in stockholder&rsquo;s equity, and cash flows for each of the two years in the period ended December
31, 2024, and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;). In our opinion, the consolidated
financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and
its results of operations and cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting
principles generally accepted in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s Ability to Continue as a Going
Concern</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1, the Company has no substantive
operations, and insufficient cash as of December 31, 2024, to fund operations for twelve months from the date of this report. All of these
matters raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. Management&rsquo;s plans in regard to
these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from
the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basis for Opinion</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the
responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial
reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial
reporting. Accordingly, we express no such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide
a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ WithumSmith+Brown, PC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&rsquo;s auditor
since 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whippany, New Jersey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">May 6, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Liabilities and stockholder's equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; width: 74%; text-align: left; padding-bottom: 1pt">Accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">805</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">805</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Commitments and Contingencies (Note 4)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stockholder's equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Common stock, $0.0001 par value; 1,000 shares authorized; 100 shares issued and outstanding as of December&nbsp;31, 2024 and 2023, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Additional paid in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Stock subscription receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(805</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total stockholder's equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(805</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholder's equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>The accompanying notes
are an integral part of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended December&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Franchise tax expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Weighted average shares outstanding - basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted net loss per share</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(4.05</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3.78</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral part
of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF CHANGES
IN STOCKHOLDER&rsquo;S EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Common
    Stock</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Additional
    Paid in<BR>
    Capital</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Stock
    Subscription<BR>
    Receivable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Accumulated
    Deficit</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Stockholder's
    Equity</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 22%"><FONT STYLE="font-size: 8pt">December&nbsp;31, 2022</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">(10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">(22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">(22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Net loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(378</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(378</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">December&nbsp;31, 2023</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Net loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(405</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(405</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">December&nbsp;31, 2024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(805</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(805</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral part
of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF CASH
FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended December&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Operating Activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Changes in current assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash - beginning of the year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash - end of the year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral part
of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IRIS PARENT HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Note 1. Description
of Organization and Business Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Iris
Parent Holding Corp. (the &ldquo;Company&rdquo;) was incorporated in the State of Delaware on November&nbsp;23, 2022. The purpose of the
Company is to facilitate a business combination, as further described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><I>Wholly-owned subsidiaries</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
Company has two wholly-owned subsidiaries, Liminatus Pharma Merger Sub,&nbsp;Inc., a Delaware corporation (&ldquo;Liminatus Merger Sub&rdquo;),
and SPAC Merger Sub,&nbsp;Inc., a Delaware corporation and wholly-owned subsidiary of the Company (&ldquo;SPAC Merger Sub&rdquo;). The
purpose of these two wholly-owned subsidiaries is to facilitate a business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><I>Business Combination</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">On
November&nbsp;30, 2022,&nbsp;Iris Acquisition Corporation, a Delaware corporation (&ldquo;Iris&rdquo;), the Company, Liminatus Pharma,
LLC, a Delaware limited liability company (&ldquo;Liminatus&rdquo;), Liminatus Merger Sub and SPAC Merger Sub entered into a business
combination agreement (as it may be amended, supplemented or otherwise modified from time to time, the &ldquo;Business Combination Agreement&rdquo;)
whereby (a)&nbsp;Liminatus Merger Sub will merge with and into Liminatus (the &ldquo;Liminatus Merger&rdquo;), with Liminatus surviving
the Liminatus Merger as a direct wholly-owned subsidiary of the Company, and (b)&nbsp;simultaneously with the Liminatus Merger, SPAC Merger
Sub will merge with and into Iris (the &ldquo;SPAC Merger&rdquo; and, together with the Liminatus Merger, the &ldquo;Mergers&rdquo;),
with Iris surviving the SPAC Merger as a direct wholly-owned subsidiary of the Company (the transactions contemplated by the foregoing
clauses (a)&nbsp;and (b)&nbsp;the &ldquo;Business Combination&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the Business
Combination Agreement: (i)&nbsp;immediately prior to the effective time of the Mergers (the &ldquo;Effective Time&rdquo;), every issued
and outstanding security issued by Iris during its initial public offering (each, an &ldquo;Iris Unit&rdquo;) was automatically separated
and broken out into its constituent parts and the holder thereof was deemed to hold one share of Iris Class&nbsp;A Common Stock, par value
$0.0001 per share (the &ldquo;Iris Class&nbsp;A Shares&rdquo;) and one-fourth of one whole redeemable warrant that was included as part
of each Iris Unit (the &ldquo;Public Warrants&rdquo;), and such underlying constituent securities of Iris were converted in accordance
with the applicable terms of the Business Combination Agreement, (ii)&nbsp;at the Effective Time, each issued and outstanding Iris Class&nbsp;A
Share was converted automatically into and thereafter represent the right to receive one share of common stock, par value $0.0001 per
share (&ldquo;Common Stock&rdquo;), of the Company, following which all Iris Class&nbsp;A Shares ceased to be outstanding and were automatically
canceled and ceased to exist, (iii)&nbsp;at the Effective Time, each issued and outstanding Public Warrant immediately and automatically
represented the right to purchase shares of Common Stock on the same terms and conditions as are set forth in the warrant agreement, (iv)&nbsp;at
the Effective Time, each issued and outstanding non-redeemable warrant of Iris that was issued by Iris in a private placement at the time
of the consummation of its initial public offering, entitling the holder thereof to purchase one Iris Class&nbsp;A Share at $11.50 per
share, except those issued to Cantor Fitzgerald&nbsp;&amp; Co. (&ldquo;Cantor&rdquo;), were forfeited, and (v)&nbsp; the private placement
warrants issued to Cantor immediately and automatically represented the right to purchase shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Pursuant to the Business Combination Agreement, on April
30, 2025, in sequential order: (a) Liminatus Merger Sub merged with and into Liminatus, with Liminatus continuing as the surviving company
and a wholly owned subsidiary of the Company and (b) simultaneously with the Liminatus Merger, SPAC Merger Sub merged with and into Iris,
with Iris surviving the SPAC Merger as a direct wholly-owned subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Liquidity,
Capital Resources and Going Concern</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">As
discussed above, the Company currently has no substantive operations, and the purpose of the Company is to facilitate the Business Combination.
Management has determined that if the Company is unable to complete the Business Combination, then the Company will cease all operations
except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution of Iris of June&nbsp;30, 2025 raises
substantial doubt about the Company&rsquo;s ability to continue as a going concern. No adjustments have been made to the carrying amounts
of assets or liabilities as reported within these consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Note
2. Significant Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
Company&rsquo;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&ldquo;U.S. GAAP&rdquo;) as determined by the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting
Standards Codification (&ldquo;ASC&rdquo;) and pursuant to the rules&nbsp;and regulations of the Securities and Exchange Commission (&ldquo;SEC&rdquo;).
The consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances
and transactions have been eliminated in consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Emerging Growth
Company Status</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
Company is an &ldquo;emerging growth company,&rdquo; as defined in Section&nbsp;2(a)&nbsp;of the Securities Act of 1933, as amended (the
 &ldquo;Securities Act&rdquo;), as modified by the Jumpstart our Business Startups Act of 2012 (the &ldquo;JOBS Act&rdquo;), and it may
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&nbsp;404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden
parachute payments not previously approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Further,
Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the
new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at
the time private companies adopt the new or revised standard. This may make comparison of the Company&rsquo;s consolidated financial statements
with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the
extended transition period difficult or impossible because of the potential differences in accounting standards used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Use of Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&rsquo;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Actual results may differ
materially and adversely from these estimates. The Company is not aware of any significant estimates that required management to exercise
significant judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Concentration
of Credit Risk</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. Any loss incurred or a lack of access to such funds
could have a significant adverse impact on the Company&rsquo;s financial condition, results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><I>Segments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
Company&rsquo;s chief operating decision maker (&ldquo;CODM&rdquo;), the Chief Executive Officer, manages the Company&rsquo;s business
activities as a single operating and reportable segment. Accordingly, the Company&rsquo;s CODM uses net income/loss to measure the Company&rsquo;s
single segment&rsquo;s performance and allocate resources. Further, the CODM reviews and utilizes functional expenses to manage the Company&rsquo;s
operations. The Company&rsquo;s functional expenses related to franchise tax expenses and did not include any compensation-related expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Franchise</I></B></FONT><B><I>
Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The Company is
incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis. Franchise tax
liabilities and related interest and penalties incurred are recorded in accrued expenses on the consolidated balance sheet. For the years
ended December&nbsp;31, 2024 and 2023, the Company recorded $405 and $378, respectively, of franchise tax expense and related penalties
and interest. As of December&nbsp;31, 2024 and 2023, the Company had a franchise tax liability of $805 and $400, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The Company accounts
for income taxes in accordance with ASC Topic 740,&nbsp;<I>Income Taxes</I>&nbsp;(&ldquo;ASC 740&rdquo;). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">ASC 740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise&rsquo;s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
There were no tax accruals relating to uncertain tax positions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The Company recognizes
accrued interest and penalties related to unrecognized tax positions as income tax expense. There were no unrecognized tax positions and
no amounts accrued for interest and penalties as of December&nbsp;31, 2024 and 2023. The Company is currently not aware of any issues
under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the
United States as its only &ldquo;major&rdquo; tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. No unrecognized tax benefits were identified as of December&nbsp;31, 2024
or 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Recently Adopted
Accounting Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">In
November&nbsp;2023, the FASB issued Accounting Standards Update 2023-07, <I>Segment Reporting (Topic 280): Improvements to Reportable
Segment Disclosures</I>, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced
disclosures about significant segment expenses. The Company adopted this standard effective January&nbsp;1, 2024 using a retrospective
method. For further information, refer to the Segments section in Note 2 Significant Accounting Policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Recently Issued
Accounting Pronouncements &ndash; Not Yet Adopted</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">In
December&nbsp;2023, the FASB issued ASU 2023-09,&nbsp;<I>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</I>. The standard
requires entities to disclose additional categories about federal, state and foreign income taxes in the effective tax rate reconciliation
as well as provide annual income taxes paid disaggregated by federal, state and foreign taxes. The standard is effective for annual periods
beginning after December&nbsp;15, 2024. Early adoption is permitted. The Company does not believe that the adoption of this accounting
pronouncement would have a material effect on the Company&rsquo;s consolidated financial statements and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Management
does not believe that any additional recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Note 3. Related
Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">In
November&nbsp;2022, the Company issued 100 shares of the Company&rsquo;s common stock for an aggregate purchase price of $10 to Chris
Kim, the Company&rsquo;s Chief Executive Officer. Such shares on the date of issuance were duly and validly authorized and issued. Each
outstanding share of stock has voting power equal to one vote on each matter submitted at any stockholder&rsquo;s meeting. As of the date
of these consolidated financial statements, no consideration has been received from Mr.&nbsp;Kim for the issuance of these shares. Accordingly,
the Company has recorded a &ldquo;Stock subscription receivable&rdquo; within the stockholder&rsquo;s equity section on its consolidated
balance sheet as of December&nbsp;31, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Note 4. Commitments
and Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">The
Company is not a party to any material legal proceedings and is not aware of any material pending or threatened claims. </FONT>The
Company does not have any commitments as of December&nbsp;31, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Note 5. Subsequent
Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
Company has completed an evaluation of all subsequent events through the date of this filing to ensure that these consolidated financial
statements include appropriate disclosure of events both recognized in the consolidated financial statements and events which occurred
but were not recognized in the consolidated financial statements. No subsequent events were identified other than the closing of the Business Combination, as discussed Note 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>11
<FILENAME>tm2513673d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Board of Directors, Stockholders, and Members
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liminatus Pharma, LLC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Opinion on the Financial Statements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying balance sheets
of Liminatus Pharma, LLC (the &ldquo;Company&rdquo;) as of December 31, 2024 and 2023, the related statements of operations, changes in
members&rsquo; deficit, and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively
referred to as the &ldquo;financial statements&rdquo;). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of
the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States
of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Going Concern</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As discussed in Note 1, the Company has had recurring losses and
negative operating cash flows since inception, an accumulated deficit as of December 31, 2024, and insufficient cash and cash equivalents
as of December 31, 2024, to fund operations for twelve months from the date of this report. All of these matters raise substantial doubt
about the Company&rsquo;s ability to continue as a going concern. Management&rsquo;s plans in regard to these matters are also described
in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basis for Opinion</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement,
whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but
not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly,
we express no such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ WithumSmith+Brown, PC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&rsquo;s auditor
since 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whippany, New Jersey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">May 6, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMINATUS PHARMA, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><B>December 31,</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><B>2024</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><B>2023</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; width: 74%">Cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">56</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">434</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Loan receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,669</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due from related party, current</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">126</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Deferred transaction costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,401</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">840</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Prepaid and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">156</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">22</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,282</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,241</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due from related party, non-current</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">126</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total non-current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">127</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,409</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,242</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">LIABILITIES AND MEMBERS' DEFICIT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accounts payable and accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,484</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">933</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accrued interest, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">955</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">616</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due to research and development partner</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,782</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">242</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due to related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">195</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">195</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accrued maintenance fee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">360</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Short-term debt, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,973</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">16,050</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">24,749</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">18,036</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">COMMITMENTS AND CONTINGENCIES (Note 8)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Members' deficit:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Class A Member Units</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,547</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,547</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Class B Member Units</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">167</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">167</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Additional paid-in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,611</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,611</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(28,665</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(25,119</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total members' deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(19,340</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(15,794</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND MEMBERS' DEFICIT</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,409</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,242</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>The
accompanying notes are an integral part of these financial statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMINATUS PHARMA, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands, except member
unit and per member unit data)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended December 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; width: 74%; text-align: left">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">645</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,062</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,685</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Interest expense, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(339</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(175</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Interest income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">123</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total other income (expense), net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(216</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(165</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(3,546</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(4,984</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per Class A member unit, basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per Class B member unit, basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.15</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average Class A member units outstanding, basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">95,555,554</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">85,825,570</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average Class B member units outstanding, basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>The
accompanying notes are an integral part of these financial statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMINATUS PHARMA, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATEMENTS OF CHANGES IN MEMBERS&rsquo;
DEFICIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEARS ENDED DECEMBER
31, 2024 AND 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands, except member
unit data)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="26" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">For the years ended December 31, 2024 and 2023</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Class A Member Units</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Class B Members Units</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Additional Paid-in</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Accumulated</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Total Members'</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Units</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Amount</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Units</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Amount</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Capital</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Deficit</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Deficit</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 23%">Balance at December 31, 2022</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">57,000,000</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">4,000</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">16,666,666</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">167</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">5,158</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">(20,135</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 8%; text-align: right">(10,810</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">Cancellation of member units related to Metavagen license termination</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">(40,000,000</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">(239</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">239</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">Issuance of Class A member units in exchange for CD-47 License Agreement</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">78,555,554</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">786</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">(786</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(4,984</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(4,984</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif">Balance at December 31, 2023</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">95,555,554</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">4,547</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">167</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">4,611</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">(25,119</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: right">(15,794</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(3,546</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(3,546</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance at December 31, 2024</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">95,555,554</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">4,547</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">167</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">4,611</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">(28,665</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right">(19,340</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>The
accompanying notes are an integral part of these financial statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMINATUS PHARMA, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended December 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Operating Activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(3,546</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(4,984</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Changes in operating assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Advances for research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,684</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due from related party, current</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(26</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Deferred transaction costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(840</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Prepaid and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(12</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accounts payable and accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">425</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accrued maintenance fee</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">360</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Accrued interest, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">339</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">175</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Due to research and development partner</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,540</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">242</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Due to related parties, current</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(9</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,451</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,345</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Investing Activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loans to IRIS Acquisition Corp</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,850</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,850</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Financing Activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from issuance of short-term debt, related party</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,923</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,406</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Repayment of short-term debt, related party</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,856</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,923</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(450</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(4,614</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash, beginning of the year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">434</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,048</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash, end of the year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">56</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">434</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of cash flow information:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash paid for interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash paid for income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of non-cash financing and investing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Deferred transaction costs in accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">561</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cancellation of member units related to Metavagen license termination</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">239</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Issuance of Class A member units in exchange for CD-47 License Agreement</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">786</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>The
accompanying notes are an integral part of these financial statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMINATUS PHARMA, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DECEMBER 31, 2024 AND 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 1. Organization and Description
of Business Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Liminatus
Pharma, LLC (&ldquo;Liminatus&rdquo; or the &ldquo;Company&rdquo;) was formed by issuing member units to Consonatus,&nbsp;Inc. (the &ldquo;Initial
Member&rdquo;), which is controlled by Chris Kim, the Chief Executive Officer (&ldquo;CEO&rdquo;) of the Company, on April&nbsp;12, 2018
under the laws of Delaware. Liminatus is a pre-clinical stage, single-asset biopharmaceutical company. Liminatus is developing novel cancer
therapies that exploit the body&rsquo;s immune system. The Company&rsquo;s clinical candidate is a humanized anti CD47 monoclonal antibody.
The next generation CD47 checkpoint inhibitor&rsquo;s (code name: IBA101) initial indication is expected to be patients with advanced
solid cancers including non-small cell lung cancer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
is subject to the uncertainty of whether the Company&rsquo;s intellectual property will develop into successful commercial products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Going Concern, Liquidity
and Capital Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future
and may never become profitable. The Company has an accumulated deficit of $28.7 million as of December&nbsp;31, 2024 and a loss from
operations of $3.3 million and a net loss of $3.5 million for the year ended December&nbsp;31, 2024. To date, the Company has been funded
by issuing Class&nbsp;A and Class&nbsp;B member units and debt financing. As of December&nbsp;31, 2024, the Company has approximately
$56,000 of cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to
continue as a going concern over the next twelve months after the financial statements are issued. The Company&rsquo;s cash requirements
include, but are not limited to, research and development costs, license fees and working capital requirements. Due to these cash requirements,
the Company does not believe that it will have sufficient cash to fund operations for one year after the date that the accompanying financial
statements are issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
intends to raise additional cash through equity financings, debt financings or other arrangements to fund operations; however, there can
be no assurance that the Company will be able to raise adequate capital under acceptable terms, if at all. The sale of additional equity
may dilute existing members and newly issued member units may contain senior rights and preferences compared to currently outstanding
ordinary shares. Issued debt securities may contain covenants and limit the Company&rsquo;s ability to pay dividends or make other distributions
to members. If the Company is unable to obtain such additional financing, future operations would need to be reevaluated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the
accompanying financial statements are issued. These financial statements do not include any adjustments relating to the recovery of the
recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Proposed Business Combination</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November&nbsp;30,
2022, the Company entered into a business combination agreement (the &ldquo;Business Combination Agreement&rdquo;) with Iris Acquisition
Corp. (&ldquo;Iris&rdquo;), a Cayman Islands publicly traded special purpose acquisition company, whereby all of the Company&rsquo;s member
units would be exchanged by Iris for 25,000,000 ordinary shares of Iris with an aggregate equity value of $250 million (the &ldquo;Iris
Business Combination&rdquo;). On June&nbsp;1, 2023, the Company entered into an amendment to extend the outside date (date at which both
parties are able to terminate without penalty) to September&nbsp;30, 2023. On August&nbsp;14, 2023, the Company entered into a second
amendment to extend the outside date to March&nbsp;9, 2024. On March&nbsp;9, 2024, the Company entered into a third amendment to the Business
Combination Agreement extending the outside date to July&nbsp;31, 2024. On July&nbsp;19, 2024, the Company entered into a fourth amendment
to the Business Combination Agreement extending the outside date to September&nbsp;3, 2024. On August&nbsp;16, 2024, the Company entered
into a fifth amendment to the Business Combination Agreement extending the outside date to December&nbsp;31, 2024. On October&nbsp;23,
2024, the Company entered into a sixth amendment to the Business Combination Agreement to, among other things, reduce the enterprise value
associated with the Company to $175 million. The Iris Business Combination would result in gross proceeds to the Company of at least $15
million from equity subscriptions unrelated to the Iris Business Combination if the Iris Business Combination is completed in accordance
with the current terms of the agreement. On December&nbsp;26, 2024, the Company entered into a seventh amendment to the Business Combination
Agreement extending the outside date to June&nbsp;30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #231f20">Pursuant
to the Business Combination Agreement, on </FONT>April&nbsp;30, 2025<FONT STYLE="color: #231f20">, in sequential order: (a)&nbsp;Liminatus
Pharma Merger Sub, Inc., a Delaware corporation (&ldquo;Liminatus Merger Sub&rdquo;) merged with and into Liminatus, with Liminatus continuing
as the surviving company and a wholly owned subsidiary of Iris Parent Holding Corp., a Delaware corporation (&ldquo;ParentCo&rdquo;) (referred
to herein as the &ldquo;Liminatus Merger&rdquo;) and (b)&nbsp;simultaneously with the Liminatus Merger, SPAC Merger Sub, Inc., a Delaware
corporation (&ldquo;SPAC Merger Sub&rdquo;) merged with and into Iris (referred to herein as the &ldquo;SPAC Merger,&rdquo; together with
the Liminatus Merger (the &ldquo;Mergers&rdquo;)), with Iris surviving the SPAC Merger as a direct wholly-owned subsidiary of ParentCo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 2. Significant Accounting
Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&rsquo;s
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&ldquo;U.S.
GAAP&rdquo;) as determined by the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting Standards Codification (&ldquo;ASC&rdquo;)
and pursuant to the rules&nbsp;and regulations of the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Use of Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation
of the financial statements in conformity with U.S. GAAP requires the Company&rsquo;s management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting periods. Actual results may differ materially and adversely from
these estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Risks and Uncertainties</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
is subject to risks common to early-stage companies in the biotechnology industry, including, but not limited to, development by the Company
or its competitors of technological innovations, risks of failure of clinical studies, dependence on key personnel, protection of proprietary
technology, compliance with government regulations, and ability to transition from preclinical manufacturing to commercial production
of products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&rsquo;s
future product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies
prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary
approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate,
it could have a material adverse impact on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Segments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&rsquo;s
chief operating decision maker (&ldquo;CODM&rdquo;), the Chief Executive Officer, manages the Company&rsquo;s business activities as a
single operating and reportable segment. Accordingly, the Company&rsquo;s CODM uses net income/loss to measure the Company&rsquo;s single
segment&rsquo;s performance and allocate resources. Further, the CODM reviews and utilizes functional expenses (general and administrative
and research and development) to manage the Company&rsquo;s operations. The Company&rsquo;s general and administrative expenses for each
of the years ended December&nbsp;31, 2024 and 2023 included approximately $0.2 million of compensation expense related to the compensation
agreement the Company has executed with its Chief Executive Officer. The remaining general and administrative expenses related to legal
and accounting-related expenses for contractors. The Company&rsquo;s research and development expenses did not include any compensation-related
expenses. Other segment items included in net loss are interest expense, related parties and interest income which are reflected in the
Company&rsquo;s statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cash</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially
subject the Company to concentration of credit risk consist of cash accounts in a financial institution which can exceed government insured
limits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.
The Company does not have any cash equivalents as of December&nbsp;31, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Deferred Transaction Costs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Costs incurred
in connection with preparation for the proposed business combination are deferred on the balance sheets as of December&nbsp;31, 2024 and
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Loan Receivable</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
accounts for its loan receivable at amortized cost, net of expected credit losses. The Company provides reserves against its loan receivable
balance for estimated credit losses, if any, that may result from a counterparties inability to pay based on the composition of the loan
receivable, current economic conditions and, historical credit loss activity and future expected conditions and market trends (such as
general economic conditions, other macroeconomic and microeconomic events,&nbsp;etc.). Changes in circumstances relating to these factors
may result in the need to increase or decrease the allowance for credit losses in the future. Amounts deemed uncollectible are charged
or written-off against the reserve. As of December&nbsp;31, 2024 and 2023, no expected credit losses were recorded related to the loan
receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Fair Value of Financial
Instruments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&rsquo;s
financial assets and liabilities are accounted for in accordance with FASB ASC 820, <I>Fair Value Measurements and Disclosures, </I>which
defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal
or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The fair
value hierarchy requires an entity to maximize the use of observable inputs when measuring fair value and classifies those inputs into
three levels:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 1 &mdash;
Observable inputs, such as quoted prices in active markets for identical assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 2 &mdash;
Inputs other than Level 1 inputs that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities;
quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for
substantially the full term of the instrument&rsquo;s anticipated life.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 3 &mdash;
Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To the extent
the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires
more judgement. Accordingly, the degree of judgement exercised by management in determining fair value is greatest for instruments categorized
as Level 3. A financial instrument&rsquo;s level within the fair value hierarchy is based on the lowest level of any input that is significant
to the fair value measurement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The carrying
values reported in the Company&rsquo;s balance sheets for loan receivable, amounts due to research and development partner, due from related
party, accounts payable and accrued expenses, short-term debt, accrued interest, related parties and due to related parties are reasonable
estimates of their fair values due to the short-term nature of these items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Research and Development
Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Research
and development expenses consist of costs incurred by Targeted Diagnostics&nbsp;&amp; Therapeutics,&nbsp;Inc. (&ldquo;TDT&rdquo;) who
was performing the research and development activities for the Company in accordance with the license agreements with TDT and the annual
fee paid to TDT and are recorded as research and development expenses as incurred (see Note 3).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company is taxed as a
partnership for United States income tax purposes for the years ended December&nbsp;31, 2024 and 2023, thus the income or loss of the
Company flows to the members. As a partnership for income tax purposes, the Company is not subject to tax and any tax liability is the
responsibility of the members of the Company. Accordingly, no provision for federal and state income taxes is included in the financial
statements for the years ended December&nbsp;31, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comprehensive Loss</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Comprehensive
loss is equal to net loss as presented in the statements of operations for the year ended December&nbsp;31, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Net Loss per Member Unit</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
calculates basic and diluted net loss per member unit in accordance with the two-class method required for participating securities. The
Company has two classes of member units, which are referred to as Class&nbsp;A member units and Class&nbsp;B member units. Class&nbsp;B
member units are allocated 51% of earnings and losses, and Class&nbsp;A member units are allocated 49% of earnings and losses. The two-class
method requires net loss for the period to be allocated between the member units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Basic net
loss per member unit is computed by dividing net loss by the weighted-average number of member units outstanding during the period. Diluted
net loss per member unit excludes the potential impact of the Company&rsquo;s warrants and options because their effect would be anti-dilutive
due to the Company&rsquo;s net loss for the periods presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following
table presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per member unit for each class
of member units (in thousands, except member unit and per member unit information):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended December&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><B>Class&nbsp;A</B></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Class&nbsp;B</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><B>Class&nbsp;A</B></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Class&nbsp;B</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted net loss per member unit:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Numerator:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; width: 48%; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,738</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,808</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(2,442</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(2,542</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Denominator:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Basic and diluted weighted average units outstanding</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">95,555,554</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">85,825,570</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16,666,666</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Basic and diluted net loss per member unit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.15</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recently Adopted Accounting
Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In September&nbsp;2016,
the FASB issued Accounting Standards Update (&ldquo;ASU&rdquo;) No.&nbsp;2016-13, <I>Financial Instruments &mdash; Credit Losses</I>,
which was subsequently amended by ASU No.&nbsp;2018-19, ASU No.&nbsp;2019-04, ASU No.&nbsp;2019-05, ASU 2019-10, ASU No.&nbsp;2019-11,
ASU No.&nbsp;2020-03, and ASU No.&nbsp;2022-02. These ASUs have provided for various minor technical corrections and improvements to the
codification as well as other transition matters. The standard requires the measurement of expected credit losses for financial instruments
carried at amortized cost held at the reporting date based on historical experience, current conditions and reasonable forecasts. The
updated guidance also amends the current other-than-temporary impairment model for available-for-sale debt securities by requiring the
recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference
between a security&rsquo;s amortized cost basis and its fair value. The main objective of this ASU is to provide financial statement users
with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit
held by a reporting entity at each reporting date. The Company adopted this standard on January&nbsp;1, 2023, with no impact on its financial
statements and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In November&nbsp;2023,
the FASB issued Accounting Standards Update 2023-07, <I>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</I>,
which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant
segment expenses. The Company adopted this standard effective January&nbsp;1, 2024 using a retrospective method. For further information,
refer to the Segments section in Note 2 Significant Accounting Policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recently Issued Accounting
Pronouncements &ndash; Not Yet Adopted</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In December&nbsp;2023,
the FASB issued ASU 2023-09,&nbsp;<I>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</I>. The standard requires entities
to disclose additional categories about federal, state and foreign income taxes in the effective tax rate reconciliation as well as provide
annual income taxes paid disaggregated by federal, state and foreign taxes. The standard is effective for annual periods beginning after
December&nbsp;15, 2024. Early adoption is permitted. The Company is evaluating the impact of adopting this standard on its financial statements
and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management
does not believe that any additional recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on the Company&rsquo;s financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 3. License Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Metavagen License</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In December&nbsp;2022,
the Company entered into a Subscription Agreement In Kind with Metavagen LLC (&ldquo;Metavagen&rdquo;) (the &ldquo;Metavagen License&rdquo;),
owned by Chris Kim, the CEO of Liminatus, whereby the Company received the license rights initially granted from InnoBation Bio Co.,&nbsp;Ltd.,
a Korean company (&ldquo;InnoBation&rdquo;), to Metavagen to develop, market and sell YN1203,&nbsp;InnoBation Bio CAR NK biomarkers, including
devices, compounds and products used to detect analyte in body or tissue in exchange for 40,000,000 member units of Class&nbsp;A membership
interest in the Company. The Metavagen License transaction is consummated as the Company has the right to use the license, but the license
was not transferred. The Company and Metavagen are entities under common control, thus the license was recorded at Metavagen&rsquo;s cost
basis of zero. In March&nbsp;2023, the Company terminated the 40,000,000 of Class&nbsp;A membership units and the license rights with
Metavagen.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CAR-T Products License</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June&nbsp;2018,
the Company entered into a license and development agreement with TDT (the &ldquo;CAR-T License&rdquo;), whereby the Company received
an exclusive license to develop and commercialize chimeric antigen receptor (&ldquo;CAR-T&rdquo;) products and a non-exclusive license
to develop and commercialize companion diagnostics used to monitor treatment with a CAR-T product (the &ldquo;CAR-T Diagnostics&rdquo;).
Under the CAR-T License, the Company made an upfront payment recorded as research and development expenses in the year ended December&nbsp;31,
2018 and funded all of the development costs for the CAR-T products and the CAR-T Diagnostics which began with an upfront payment made
during the year ended December&nbsp;31, 2018 of $5.0 million, recorded as advances for research and development in the balance sheets.
The Company amortizes the advances to research and development expenses in the statements of operations as costs are incurred by TDT,
based on annual budgets approved jointly by Liminatus and TDT. As of December&nbsp;31, 2024 and 2023, all of the amounts funded have been
utilized. The Company was also obligated to pay a $0.5 million annual maintenance fee for the license which is included in research and
development expenses in the statements of operations. Unpaid annual maintenance fees become short-term debt that bears interest of 1.5%
per month on a compounded basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Prior to
the completion of the Phase I and Phase II clinical trials for the CAR-T product, the Company was obligated to advance the funding for
the Phase II and Phase III clinical trials, respectively, estimated at $20.0 million for each phase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition
to the funding for the CAR-T development, the Company was obligated to make four developmental and regulatory milestone payments for the
first CAR-T product that was developed aggregating up to $15.0 million. After the first four developmental and regulatory milestone payments
were made, the Company was obligated to pay four developmental and regulatory milestones aggregating up to $7.5 million for each additional
CAR-T product that was developed. For further information regarding the CAR-T product and the related termination, see below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In further
consideration of the license, the Company also agreed to pay a low double digit royalty rate (10% &ndash; 15%) based on annual net sales
of CAR-T products or CAR-T Diagnostics on a country-by-country basis for the period from the first commercial sale of the CAR-T product
or CAR-T Diagnostic until the CAR-T product or CAR-T Diagnostic&rsquo;s patent expires in an individual country. Once the CAR-T product
or CAR-T Diagnostic&rsquo;s patent expires in an individual country, the Company agreed to pay a mid-single digit royalty rate (5% &ndash;
9%) based on annual net sales of CAR-T products and CAR-T Diagnostics on a country- by-country basis. Royalties were payable on a country-by-country
basis for a period of ten years from the first commercial sale of the CAR-T product or CAR-T Diagnostic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company did not owe any developmental or regulatory milestone payments or royalty payments under the CAR-T License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August&nbsp;11,
2024, the Company received notice from TDT, exercising its right to terminate the license and development agreement. See <I>Termination of CAR-T Products and Vaccine Products Licenses from TDT</I> for
further detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Vaccine Products License</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April&nbsp;10,
2020, the Company was assigned a license and development agreement with TDT (the &ldquo;Vaccine License&rdquo;), whereby the Company received
an exclusive license to develop and commercialize vaccine products (the &ldquo;Vaccine Products&rdquo;) and a non-exclusive license to
develop and commercialize companion diagnostics used to monitor treatment with a Vaccine Product (the &ldquo;Vaccine Diagnostics&rdquo;).
Under the Vaccine License, the Company was responsible for all of the development costs for the Vaccine Products after the upfront payment
of $4.0 million, which was paid by Viral Gene, of which Chris Kim is also the CEO, to TDT. The Company was also obligated to pay a $0.4
million annual maintenance fee for the license which is included in research and development expenses in the statements of operations.
Unpaid annual maintenance fees will become short-term debt that bears interest of 1.5% per month on a compounded basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
amortizes the amounts due to research and development partner in the balance sheets to research and development expenses in the statements
of operations as costs are incurred by TDT, based on annual budgets approved jointly by Liminatus and TDT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition
to the funding for the Vaccine Products development, the Company was obligated to make four developmental and regulatory milestone payments
for the first Vaccine Product that was developed aggregating up to $12.0 million. After the first four developmental and regulatory milestone
payments are made, the Company was obligated to pay four developmental and regulatory milestones aggregating up to $6.0 million for each
additional Vaccine Product that is developed. As of December&nbsp;31, 2024 and 2023, all the amounts funded have been utilized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In further
consideration of the license, the Company also agreed pay a low double digit royalty rate (10% &ndash; 15%) based on annual net sales
of Vaccine Products or Vaccine Diagnostics on a country-by-country basis for the period from the first commercial sale of the Vaccine
Product or Vaccine Diagnostic until the Vaccine Product or Vaccine Diagnostic&rsquo;s patent expires in an individual country. Once the
Vaccine Product or Vaccine Diagnostic&rsquo;s patent expires in an individual country, the Company agreed to pay a mid-single digit royalty
rate (5% &ndash; 9%) based on annual net sales of Vaccine Products and Vaccine Diagnostics on a country- by-country basis. Royalties were
payable on a country-by-country basis for a period of ten years from the first commercial sale of the Vaccine Product or Vaccine Diagnostic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company did not owe any developmental or regulatory milestone payments or royalty payments under the Vaccine License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August&nbsp;11,
2024, the Company received notice from TDT, exercising its right to terminate the license and development agreement. See <I>Termination of CAR-T Products and Vaccine Products Licenses from TDT</I> for
further detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Termination of CAR-T Products
and Vaccine Products Licenses from TDT</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company owes $2.2 million and $0.2 million, respectively, to TDT for research and development for the aggregate CAR-T
Products and Vaccine Licenses, which is included in the due to research and development partner on the balance sheets, and accrued maintenance
fees on the balance sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August&nbsp;11,
2024, the Company received notice from TDT, exercising its right to terminate the license and development agreement, dated June&nbsp;10,
2018, by and between TDT and Liminatus. As of August&nbsp;2024, the CAR-T License and Vaccine License have been terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024, the Company and TDT are engaged in negotiations associated with the amounts due to TDT of $2.2 million on the Company&rsquo;s balance
sheet. Due to the termination of the license and development agreement between the Company and TDT, the Company is not certain as to the
amounts it will be required to pay to TDT, if any. As of December&nbsp;31, 2024, no agreement has been reached between the parties. As
such, the Company has not reversed the amounts due to TDT and will not do so until a final agreement has been executed between the two
parties in accordance with ASC 450-30, <I>Contingencies </I>- <I>Gain Contingencies.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CD47 License</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In October&nbsp;2022,
the Company was assigned a license and development agreement, as amended, with InnoBation (the &ldquo;CD47 License&rdquo;), whereby, effective
March&nbsp;31, 2023, the Company received an exclusive license to develop and commercialize products for the CD47 immune checkpoint inhibitor
to treat solid cancers, and companion diagnostics used to monitor treatment with CD47 products (collectively, &ldquo;CD47 Products&rdquo;),
from Curis Biotech Holdings LLC, the parent company of Valetudo, a related party of the Company, in exchange for 78,555,554 of the Company&rsquo;s
Class&nbsp;A member units. The license was recorded at Valetudo&rsquo;s cost basis of zero, and the Company recorded a $0.8 million Class&nbsp;A
membership interest with an offset to additional paid-in capital on the balance sheets. The Company is obligated to pay all development
costs for CD47 Products. The Company has not paid and does not owe any license fees, management fees, developmental or regulatory milestone
payments or royalty payments under the CD47 License through the years ended December&nbsp;31, 2023 and 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 4. Related Parties <I>Related Party Debt</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Feelux Bonds</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September&nbsp;15,
2018, the Company issued $10.0 million of bonds to Feelux Co.,&nbsp;Ltd., the parent company of Car-Tcellkor,&nbsp;Inc. (&ldquo;Car-Tcellkor&rdquo;),
the only holder of Class&nbsp;A member units (the &ldquo;Feelux Bonds&rdquo;). The bonds bear interest at 1% per annum, compounded annually,
and were due on October&nbsp;30, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection
with the issuance of the Feelux Bonds, the Company issued 6,666,666 equity-classified warrants to purchase member units at a price of
$1.50 per unit, which expired on June&nbsp;30, 2023. The fair value of the warrants to purchase member units of $6.4 million was estimated
using the option pricing framework on the issuance date. The Company&rsquo;s assumptions included (a)&nbsp;its expected stock volatility
of 82.0% based on the historical volatility of a publicly traded set of peer companies, (b)&nbsp;the contractual term of five years, (c)&nbsp;the
risk-free interest rate of 2.9% based on the U.S. Treasury yield curve in effect at the time of grant of the award for a five-year contractual
term and (d)&nbsp;no expected dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The $10.0
million of proceeds from the Feelux Bonds were allocated to the bonds and warrants using the relative fair value method resulting in a
debt discount for the relative fair value of the warrants of $4.5 million that was amortized to interest expense over the term of the
Feelux Bonds using the effective interest method using an effective interest rate of 21.0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of December&nbsp;31, 2024 and 2023, the Feelux Bonds have a carrying amount of $10.0 million and are included in short-term debt, related
parties in the balance sheets. As of December&nbsp;31, 2024 and 2023, the relate</FONT>d accrued interest of the Feelux Bonds was $0.6
million and $0.5 million, respectively, and is included in accrued interest, related parties in the balance sheets. For the years ended
December&nbsp;31, 2024 and 2023, the Company recorded approximately $0.1 million, respectively, of interest expense in the statements
of operations for the Feelux Bonds. The debt discount was fully amortized prior to the year ended December&nbsp;31, 2021 (see Note 5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Car-Tcellkor
Loan</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May&nbsp;18,
2019, the Company borrowed $0.8 million from its parent at the time of the loan, Car- Tcellkor (the &ldquo;Car-Tcellkor Loan&rdquo;).
The Car-Tcellkor Loan does not bear interest and was due on March&nbsp;18, 2020. In November&nbsp;2022, the maturity date was extended
to May&nbsp;18, 2023. As of December&nbsp;31, 2024 and December&nbsp;31, 2023, the Car-Tcellkor Loan of $0.8 million is recorded in short-term
debt, related parties in the balance sheets (see Note 5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Valetudo Loans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December&nbsp;1,
2022, the Company borrowed $0.7 million from Valetudo Therapeutics LLC (&ldquo;Valetudo&rdquo;), a related party of the Company due to
having common executives, in conjunction with the repayment of $0.7 million of membership interest from a member (see Note 6) (the &ldquo;Valetudo
Loan&rdquo;). The Valetudo Loan bears no interest and was due on June&nbsp;1, 2023. In June&nbsp;2023, the Company borrowed an additional
$0.3 million and $0.2 million (&ldquo;Valetudo June&nbsp;2023 Loans&rdquo;). The Valetudo June&nbsp;2023 Loans bear no interest and were
due in December&nbsp;2023. In July&nbsp;2023, the Company borrowed an additional $0.3 million (&ldquo;Valetudo July&nbsp;2023 Loan&rdquo;).
The Valetudo July&nbsp;2023 Loan bears interest at 6% per annum and was due on January&nbsp;9, 2024. In August&nbsp;2023, the Company
borrowed an additional $0.3 million and $0.2 million (&ldquo;Valetudo August&nbsp;2023 Loans&rdquo;). The Valetudo August&nbsp;2023 Loans
each bear interest at 6% interest per annum and were due on January&nbsp;31, 2024 and February&nbsp;2, 2024, respectively. In November&nbsp;2023,
the Company borrowed an additional $0.2 million (&ldquo;Valetudo November&nbsp;2023 Loan&rdquo;). The Valetudo November&nbsp;2023 Loan
bears interest at 6% per annum and was due on January&nbsp;26, 2024. In January&nbsp;2024, the Company borrowed an additional $0.6 million
and $0.2 million (Valetudo January&nbsp;2024 Loans&rdquo;). The Valetudo January&nbsp;2024 Loans each bear interest at 6% per annum and
were due on February&nbsp;28, 2024, which could be extended to the second anniversary upon mutual agreement of the parties, or upon failure
to close the Iris Business Combination. As of December&nbsp;31, 2024 and 2023, the loans from Valetudo of $2.8 million and $2.1 million
are recorded in short-term debt, related parties in the balance sheets, respectively (see Note 5). For the years ended December&nbsp;31,
2024 and 2023, interest expense related to the Valetudo loans was approximately $0.1 million and less than $0.1 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Ewon Loans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December&nbsp;12,
2022, the Company borrowed $5.0 million from Ewon Comfortech Co.,&nbsp;Ltd. (&ldquo;Ewon&rdquo;), a member and related party of the Company
(the &ldquo;Ewon Loan&rdquo;). The Ewon Loan bears interest at 2% per annum and was due on December&nbsp;12, 2023, which may be extended
one year upon mutual agreement of the parties, or upon failure to close the Iris Business Combination. The Ewon Loan has an option to
purchase $5.0 million of preferred membership interest in the Company for repayment at the closing of the Iris Business Combination. In
February&nbsp;2023, the Company repaid $1.0 million of the short-term loan. In March&nbsp;2023, the Company repaid an additional $2.0
million of the loan. On September&nbsp;10, 2023, the Company entered into a loan agreement to borrow $0.2 million from Ewon (&ldquo;Ewon
September&nbsp;2023 Loan&rdquo;). The Ewon September&nbsp;2023 Loan bears interest of 2% per annum and was due on September&nbsp;9, 2024,
which may be extended one year upon mutual agreement of the parties, or upon failure to close the Iris Business Combination. The Ewon
September&nbsp;2023 Loan has the option to purchase $0.2 million of preferred membership interest in the Company for repayment at the
closing of the Iris Business Combination. On December&nbsp;19, 2023, the Company and Ewon entered into an additional loan agreement and
the Company borrowed $1.0 million (the &ldquo;Ewon December&nbsp;2023 Loan&rdquo;). The Ewon December&nbsp;2023 Loan bears no interest.
As of December&nbsp;31, 2024 and 2023, the balance of $3.2 million of the Ewon loans is recorded in short-term debt, related parties in
the balance sheets (see Note 5). For both years ended December&nbsp;31, 2024 and 2023, interest expense related to the Ewon loans was
approximately $0.1 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Prophase Loans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September&nbsp;7,
2023, the Company entered into a short-term loan agreement with Prophase Sciences LLC (&ldquo;Prophase&rdquo;), a related party of the
Company (the &ldquo;Prophase Loan&rdquo;). The loan stipulates that $0.1 million would be loaned immediately, and an additional $0.2 million
would be loaned within a month from the date of the loan agreement. The Prophase Loan bears no interest and is payable by the first anniversary
of the month of the loan agreement. The Company repaid the $0.1 million on September&nbsp;12, 2023. On December&nbsp;11, 2023, the Company
borrowed an additional $0.2 million from Prophase. The loan bears no interest and was due on or before December&nbsp;21, 2024 or upon
failure to close the Iris Business Combination. The Company repaid the $0.2 million on December&nbsp;21, 2023. On February&nbsp;26, 2024,
the Company borrowed an additional $0.2 million from Prophase (the &ldquo;Prophase February&nbsp;2024 Loan&rdquo;). The loan bears 6%
interest per annum and was due on June&nbsp;1, 2024, which may be extended to the second anniversary upon mutual agreement of the parties.
On March&nbsp;6, 2024, the Company borrowed an additional $0.3 million from Prophase (the &ldquo;Prophase March&nbsp;2024 Loan&rdquo;).
The loan bears 6% interest per annum and was due on June&nbsp;1, 2024, which may be extended to the second anniversary upon mutual agreement
of the parties. On April&nbsp;1, 2024, the Company borrowed an additional $0.3 million from Prophase (the &ldquo;Prophase April&nbsp;2024
Loan&rdquo;). The loan bears 6% interest per annum and was due on June&nbsp;1, 2024, which may be extended to the second anniversary upon
mutual agreement of the parties. In May&nbsp;2024, the Company borrowed an additional $0.8 million from Prophase (the &ldquo;Prophase
May&nbsp;2024 Loans&rdquo;). The loans bear 6% interest per annum. Of the aggregate $0.8 million Prophase May&nbsp;2024 Loans, $0.3 million
was due on June&nbsp;1, 2024 and $0.5 million was due on July&nbsp;1, 2024, all of which may be extended to the second anniversary upon
mutual agreement of the parties. In July&nbsp;2024, the Company borrowed an additional $83,000 from Prophase (the &ldquo;Prophase July&nbsp;2024
Loans&rdquo;). The loans bear 6% interest per annum. Of the aggregate $83,000 Prophase July&nbsp;2024 Loans, $30,000 was due on September&nbsp;14,
2024, $3,000 was due on September&nbsp;24, 2024 and $50,000 was due on September&nbsp;29, 2024, all of which may be extended to the second
anniversary upon mutual agreement of the parties. In August&nbsp;2024, the Company borrowed an additional $50,000 from Prophase (the &ldquo;Prophase
August&nbsp;2024 Loans&rdquo;). The loans bear 6% interest per annum. Of the aggregate $50,000 Prophase August&nbsp;2024 Loans, $30,000
was due on October&nbsp;12, 2024 and $20,000 was due on October&nbsp;13, 2024, all of which may be extended to the second anniversary
upon mutual agreement of the parties. As of December&nbsp;31, 2024 and 2023, the balance of the Prophase loans is $1.6 million and $0.
For the years ended December&nbsp;31, 2024 and 2023, interest expense related to the Prophase Loans was less than $0.1 million and $0,
respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Hana Loans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August&nbsp;1,
2024, the Company borrowed $0.9 million from Hana Immunotherapeutics, LLC (&ldquo;Hana&rdquo;), a related party of the Company due to
having common executives (the &ldquo;Hana Loans&rdquo;). The Hana Loans bear interest at 6% per annum and were due on September&nbsp;30,
2024 and October&nbsp;26, 2024, which may be extended upon mutual agreement of the parties. As of December&nbsp;31, 2024 and 2023, the
balance of the Hana Loans is $0.9 million and $0, respectively. For the years ended December&nbsp;31, 2024 and 2023, interest expense
related to the Hana Loans was less than $0.1 million and $0, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Amantes Loans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
</FONT>November&nbsp;1, 2024, the Company borrowed $0.4 million from Amantes LLC (&ldquo;Amantes&rdquo;), a related party of the Company
due to having common executives, pursuant to a loan agreement between the Company and Amantes (the &ldquo;Amantes Loan&rdquo;). On November&nbsp;27,
2024, the Company borrowed an additional $0.3 million from Amantes (the &ldquo;Additional Amantes Loan&rdquo;) (together with the Amantes
Loan, the &ldquo;Amantes November&nbsp;2024 Loans&rdquo;). The Amantes November&nbsp;2024 Loans bear interest at 6% per annum and are
due on January&nbsp;1, 2025. As of December&nbsp;31, 2024 and 2023, the balance of the Amantes November&nbsp;2024 Loans is $0.7 million
and $0, respectively. For the years ended December&nbsp;31, 2024 and 2023, interest expense related to the Amantes November&nbsp;2024
Loans was less than $0.1 million and $0, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
5 for discussion related to notes which have passed their maturity dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Due to Related Party</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company has $0.2 million due to the CEO of the Company for compensation under his employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Viral Gene</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company has $0.1 million due from Viral Gene included in due from related party in the balance sheets for a loan to
Viral Gene and expense paid on behalf of Viral Gene. The Company&rsquo;s CEO is also the CEO of Viral Gene. The loan does not bear any
interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 5. Debt</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company
has the following debt outstanding as of December&nbsp;31, 2024 and 2023 (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 30%">Feelux Bonds</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">10,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">10,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Car-Tcellkor Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">800</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">800</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Ewon Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Valetudo Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Valetudo June 2023 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Valetudo July 2023 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">250</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">250</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Valetudo August 2023 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ewon September 2023 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Valetudo November 2023 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ewon December 2023 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Valetudo January 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase February 2024 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase March 2024 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">250</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase April 2024 Loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">250</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase May 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">790</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase July 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">83</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Prophase August 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Hana August 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">850</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Amantes November 2024 Loans</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Short-term debt, net, related parties</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Short-term debt, related parties</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">19,973</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">16,050</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December&nbsp;31,
2024 and 2023, the Company&rsquo;s outstanding debt agreements are all classified as current as all are past due with the exception of
the Amantes November&nbsp;2024 Loans, which are due within one year. All of the loans are with related parties (see Note 4).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As the Company&rsquo;s
loans are with related parties, the Company and its related parties have mutually agreed to defer repayment of the past due loans until
the completion of the Company&rsquo;s business combination with Iris.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 6. Members&rsquo; Deficit</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May&nbsp;20,
2018, the Company issued 10,000,000 Class&nbsp;A member units for $0.1 million to its Initial Member. On June&nbsp;11, 2018, in connection
with the Initial Member unit issuance, the Company granted equity-classified options to purchase 16,666,666 member units for $0.01 per
unit to the Initial Member, which were exercised in April&nbsp;2021 for $0.2 million in a non-cash transaction using the amounts in due
to related parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In May&nbsp;2022,
the Company issued 8,400,000 new Class&nbsp;A member units for $4.2 million, or $0.50 per unit. In December&nbsp;2022, in conjunction
with the Valetudo loans (see Note 4), the Company repurchased 1,400,000 of the Class&nbsp;A member units for $0.7 million, or $0.50 per
unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In December&nbsp;2022,
the Company received license rights from Metavagen in exchange for 40,000,000 Class&nbsp;A membership units in the Company. The Metavagen
License transaction was consummated as the Company has the right to use the license. In March&nbsp;2023, the Company terminated the 40,000,000
of Class&nbsp;A membership units and the license rights with Metavagen.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In March&nbsp;2023,
the Company exchanged 78,555,554 of the Company&rsquo;s Class&nbsp;A member units pursuant to a license and development agreement with
Valetudo, a related party under common control of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Member Units Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In May&nbsp;2021,
the Company revised its operating agreement to establish the rights of Class&nbsp;A and Class&nbsp;B member units. Prior to May&nbsp;2021,
the Company had one member, holding Class&nbsp;A member units, and no Class&nbsp;B member units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue and Expense Sharing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Class&nbsp;B
member units are allocated 51% of the annual revenue and expenses. The remaining 49% of the annual revenue and expenses will be allocated
on a pro rata basis to the remaining members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Voting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Class&nbsp;B
member units are allocated 51% of the votes which shall be cast as determined by the majority of the Class&nbsp;B member units. The remaining
49% of the votes will be allocated on a pro rata basis to the remaining member units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon sale,
merger or dissolution, the Class&nbsp;B member units are allocated 51% of the liquidation value of the Company. The remaining 49% of the
liquidation of the Company will be allocated on a pro rata basis to the remaining members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 7. Loan Receivable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October&nbsp;4,
2023, the Company entered into an unsecured promissory note to lend up to an aggregate principal amount up to $1.5 million to Iris (the
 &ldquo;Note&rdquo;). The Note is payable following the earlier of (i)&nbsp;closing of the Business Combination, as defined in the Business
Combination Agreement dated November&nbsp;30, 2022, or (ii)&nbsp;thirty (30) days following the termination of the Business Combination
Agreement; provided, however, in the event Iris commences liquidation proceedings, this Note shall be cancelled and all amounts due, including
all principal and accrued interest, shall be forgiven. Interest on the Note compounds annually and accrues on each unpaid advance made
under the Note at a rate of 5% per annum. On February&nbsp;28, 2024, the Company amended the Note (the &ldquo;Amended Note&rdquo;), increasing
the aggregate principal amount up to $2.5 million. On August&nbsp;2, 2024, the Amended Note was further amended to increase the aggregate
principal amount up to $3.5 million (the &ldquo;Second Amended Note&rdquo;). On November&nbsp;27, 2024, the Second Amended Note was further
amended to increase the aggregate principal amount up to $5.0 million (the &ldquo;Third Amended Note&rdquo;). As of December&nbsp;31,
2024 and 2023, the outstanding balance of the Third Amended Note was $3.7 million and $0.8 million, respectively. For the years ended
December&nbsp;31, 2024 and 2023, the Company recorded interest income of $0.1 million and less than $0.1 million, respectively, related
to the Note, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 8. Commitments and Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
Company is not a party to any material legal proceedings and is not aware of any material pending or threatened claims. From time to
time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business
activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See Note
7 for discussion on funding commitments on the Third Amended Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 9. Subsequent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">The
Company has completed an evaluation of all subsequent events through May 6,
2025, the date the financial statements were issued, to ensure that these financial statements include appropriate disclosure of events
both recognized in the financial statements and events which occurred but were not recognized in the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On January&nbsp;2,
2025 and January&nbsp;23, 2025, the Company borrowed a total of $0.3 million from Amantes, a related party of the Company due to having
common executives, pursuant to loan agreements between the Company and Amanates (the &ldquo;Amantes January&nbsp;2025 Loans&rdquo;). The
Amantes January&nbsp;2025 Loans bear interest at 6% per annum and are due on March&nbsp;1, 2025 and March&nbsp;22, 2025, respectively,
which may be extended upon mutual agreement of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On February&nbsp;12,
2025, the Company borrowed $0.2 million from Prophase, a related party of the Company due to having common executives, pursuant to a loan
agreement between the Company and Prophase (the &ldquo;Prophase February&nbsp;2025 Loan&rdquo;). The Prophase February&nbsp;2025 Loan
bears interest at 6% per annum and is due on April&nbsp;11, 2025, which may be extended upon mutual agreement of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March&nbsp;7,
2025, the Company borrowed $0.2 million from Prophase, a related party of the Company due to having common executives, pursuant to a loan
agreement between the Company and Prophase (the &ldquo;Prophase March&nbsp;2025 Loan&rdquo;). The Prophase March&nbsp;2025 Loan bears
interest at 6% per annum and is due on June&nbsp;6, 2025, which may be extended upon mutual agreement of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 3, 2025, April 14, 2025 and April 15, 2025,
the Company borrowed a total of $3.6 million from Prophase, a related party of the Company due to having common executives, pursuant to
loan agreements between the Company and Prophase (the &ldquo;Prophase April&nbsp;2025 Loans&rdquo;). The Prophase&nbsp;2025 Loans bear
interest at 6% per annum and are due on May 2, 2025, May 13, 2025, and May 14, 2025, respectively, which may be extended upon mutual agreement
of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On January&nbsp;7,
2025, February&nbsp;13, 2024, March&nbsp;7, 2025, April 3, 2025, and April 24, 2025, the Company funded additional advances under the
Amended Note, as discussed in Note 7 to these financial statements, of $4.3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #231f20"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #231F20">Pursuant
to the Business Combination Agreement, on </FONT>April&nbsp;30, 2025<FONT STYLE="color: #231F20">, the Mergers were completed with Iris
surviving the SPAC Merger as a direct wholly-owned subsidiary of ParentCo. In connection with the completion of the Mergers, the Amended
Note issued to Iris (see Note 7) were netted as Iris and Liminatus are now one consolidated entity.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="color: #231f20"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>12
<FILENAME>tm2513673d1_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNAUDITED PRO FORMA COMBINED
FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in"><I>Defined
terms included below have the same meaning as terms defined and included elsewhere in this report, unless defined below. As used in
this unaudited pro forma combined financial information, &ldquo;Liminatus&rdquo; refers to Liminatus Pharma, LLC, a Delaware limited
liability company, &ldquo;ParentCo&rdquo; refers to Iris Parent Holding Corp., a Delaware corporation, and &ldquo;Iris&rdquo; refers
to Iris Acquisition Corp (formerly Tribe Capital Growth Corp I) prior to the Business Combination.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
unaudited pro forma combined financial information has been prepared in accordance with Article&nbsp;11 of Regulation S-X and presents
the combination of the historical financial information of Iris and Liminatus, adjusted to give effect to the Business Combination and
the other events contemplated by the Business Combination Agreement. Unless otherwise indicated or the context otherwise requires, references
to the &ldquo;Combined Company&rdquo; refer to ParentCo and its consolidated
subsidiaries after giving effect to the Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The unaudited pro forma combined balance sheet as of
December&nbsp;31, 2024 combines the historical balance sheets of Iris, ParentCo, and Liminatus on a pro forma basis as if the Business
Combination and the other events contemplated by the Business Combination Agreement had been consummated on December&nbsp;31, 2024. The
unaudited pro forma combined statement of operations for the year ended December&nbsp;31, 2024, combines the historical statements of operations
of Iris, ParentCo and Liminatus on a pro forma basis as if the Business Combination and the other events contemplated by the Business
Combination Agreement had been consummated on January&nbsp;1, 2024, the beginning of the earliest period presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
unaudited pro forma combined balance sheet as of December&nbsp;31, 2024 and unaudited pro forma combined statement of operations for the
year ended December&nbsp;31, 2024 has been derived from and should be read in conjunction with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Iris as of and for the year ended December&nbsp;31, 2024
and the related notes, which are included in Iris&rsquo;s Annual Report on Form&nbsp;10-K filed with the SEC on April&nbsp;16, 2025 (the
 &ldquo;Iris 2024 10-K&rdquo;), which is incorporated by reference;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of ParentCo
as of and for the year ended December&nbsp;31, 2024 and the related notes, which are included elsewhere in this filing; and</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Liminatus as of and for the year ended December&nbsp;31,
2024 and the related notes, which are included elsewhere in this filing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The unaudited pro forma combined financial information should also
be read together with the sections of the Iris 2024 10-K, which has been incorporated by reference, the financial statements of ParentCo
as of and for the year ended December 31, 2024, and the financial statements of Liminatus as of and for the year ended December&nbsp;31,
2024, and the section of this filing entitled &ldquo;Liminatus&rsquo;s Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations,&rdquo; as well as other financial information included elsewhere in this filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 0.25in"><I>Business Combination
Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">On
November&nbsp;30, 2022,&nbsp;Iris entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified
from time to time), by and among Iris, ParentCo, Liminatus, Liminatus Pharma Merger Sub Inc. and SPAC Merger Sub,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Pursuant
to the Business Combination Agreement, on the Closing, in sequential order: (a)&nbsp;Liminatus Merger Sub will merge with and into Liminatus,
with Liminatus continuing as the surviving company and a wholly owned subsidiary of ParentCo (the &ldquo;Liminatus Merger&rdquo;) and
(b)&nbsp;simultaneously with the Liminatus Merger, SPAC Merger Sub will merge with and into Iris (the &ldquo;SPAC Merger&rdquo;, together
with the Liminatus Merger (the &ldquo;Mergers&rdquo;)), with Iris surviving the SPAC Merger as a direct wholly-owned subsidiary of ParentCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">In
connection with the Business Combination, the cash held in the Trust Account after giving effect to any redemption of shares by Iris&rsquo;
public stockholders will be used to pay certain fees and expenses in connection with the Business Combination, and for working capital
and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><I>Business Combination
Consideration</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Due to the
business combination being completed, each issued and outstanding Iris Class&nbsp;A Share converted automatically into the right to receive
one share of ParentCo Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The total
merger consideration received by securityholders of ParentCo at the Closing was the issue of ParentCo Common Stock with an aggregate
value equal to approximately $175 million. The number of shares comprising the equity consideration was determined originally based
on a deemed price of $10.00 per share of the ParentCo Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 0.25in"><B>Accounting for the
Business Combination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination
was accounted for as a reverse recapitalization in accordance with GAAP, whereby Iris was treated as the acquired company and Liminatus
was treated as the acquirer, which is now a wholly owned subsidiary of ParentCo. Accordingly, for accounting purposes, the financial statements
of the Combined Company represent a continuation of the financial statements of Liminatus, with the Business Combination treated as the
equivalent of Liminatus issuing stock for the net assets of Iris, accompanied by a recapitalization. The net assets of Iris are stated
at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Liminatus.
Liminatus has been determined to be the accounting acquirer based on an evaluation of the following facts and circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Liminatus&rsquo;s existing shareholders have a majority of the voting power;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 19px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the Combined Company&rsquo;s board consists of four directors, three of whom were designated by Liminatus and one of whom was designated by Iris;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">all of Liminatus&rsquo;s existing management will continue in their key positions in the management team
of the Combined Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Liminatus&rsquo;s operations prior to the Business Combination comprise the ongoing operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Basis of Pro Forma
Presentation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The
unaudited pro forma combined financial information has been prepared in accordance with Article&nbsp;11 of Regulation S-X. The adjustments
in the unaudited pro forma combined financial information have been identified and presented to provide relevant information necessary
for an illustrative understanding of the Combined Company upon consummation of the Business Combination and the other events contemplated
by the Business Combination Agreement in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">Assumptions
and estimates underlying the unaudited pro forma adjustments set forth in the unaudited pro forma combined financial information are described
in the accompanying notes. The unaudited pro forma combined financial information has been presented for illustrative purposes only and
is not necessarily indicative of the operating results and financial position that would have been achieved had the Business Combination
occurred on the dates indicated, and does not reflect adjustments for any anticipated synergies, operating efficiencies, tax savings or
cost savings. Any cash proceeds remaining after the consummation of the Business Combination and the other events contemplated by the
Business Combination Agreement are expected to be used for general corporate purposes. Further, the unaudited pro forma combined financial
information does not purport to project the future operating results or financial position of the Combined Company following the consummation
of the Business Combination. The unaudited pro forma adjustments represent management&rsquo;s estimates based on information available
as of the date of the unaudited pro forma combined financial information and are subject to change as additional information becomes available
and analyses are performed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The unaudited pro forma combined financial information
contained herein illustrates the consummation of the Business Combination, which closed on April 30, 2025. Pursuant to the Iris Certificate
of Incorporation, the Iris public stockholders could have elected to redeem their Iris common shares upon the closing of the Business Combination
for cash equal to their pro rata share of the aggregate amount on deposit (as of two business days prior to the Closing) in the Trust
Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The below unaudited pro forma combined balance sheet and statement
of operations do not include adjustments for the outstanding private warrants issued in connection with Iris&rsquo;s initial public offering,
as such these securities are not exercisable until 30 days after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The following summarizes the pro forma common shares
issued and outstanding immediately after the consummation of the Business Combination:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Pro Forma Combined</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">%</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left">Iris public stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">114,633</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.4</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Sponsor and independent directors</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,900,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">25.8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred underwriting commissions</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">700,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Equity PIPE Investor</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Liminatus Members</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">65.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Pro Forma Capitalization</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">26,714,633</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">100.0</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA COMBINED
BALANCE SHEET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS OF DECEMBER 31, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Dollars in Thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Transaction</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Accounting</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Liminatus</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Iris</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">ParentCo</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Adjustments</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Pro Forma</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt; font-style: italic"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Note
    2)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Combined</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">Assets</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; width: 40%"><FONT STYLE="font-size: 8pt">Cash</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">56</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">65</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,340</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font-size: 8pt; text-align: center">(b)</TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">11,962</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,314</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(c)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(500</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(e)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(4,322</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,995</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">15,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(g)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(300</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(n)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(500</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(p)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(196</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(q)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Loan receivable</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3,669</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,300</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(b)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(7,969</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(o)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Restricted cash - held in Trust Account</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">739</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">702</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(a)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,442</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(d)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Due from Sponsor</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Deferred transaction costs</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,401</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,401</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Prepaid and other current assets</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">156</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">7</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">196</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt">(q)</TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">359</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">Total current assets</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,282</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">812</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">6,227</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">12,322</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Cash and Investments held in Trust Account</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2,016</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(702</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(a)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,314</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(c)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Due from related party, non-current</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">126</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">126</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Property, plant and equipment, net</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Total assets</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,409</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">2,828</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">4,211</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">12,449</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">Liabilities</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Accounts payable and accrued expenses</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,484</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2,612</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(951</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,745</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,401</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Class A Common stock pending redemption</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">739</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">702</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(a)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,442</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(d)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Income taxes payable</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Excise tax payable</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">129</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; color: red"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; color: red; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; color: red; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; color: red; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; color: red"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; color: red; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">129</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Accrued interest, related parties</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">955</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">955</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Due to research and development partner</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,782</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,782</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Due to related parties</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">195</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">75</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">270</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Short-term debt</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">360</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">360</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Short-term debt, related parties</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">19,973</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,340</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(b)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">24,313</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Promissory note - related party, net of debt discount</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,454</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(300</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(n)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,154</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Promissory note - Liminatus</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3,669</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,300</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(b)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(7,969</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt">(o)</TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">Total current liabilities</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">24,749</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">8,681</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(2,720</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">30,711</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Deferred underwriting fee payable</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">9,660</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(9,160</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(e)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">500</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Warrant liability</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">357</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(69</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(l)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">239</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(49</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">(m)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Total liabilities</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">24,749</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">18,698</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(11,998</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">31,450</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">Redeemable equity</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Class A common stock subject to possible redemption</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,756</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(702</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(a)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,054</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(h)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">Stockholders' equity (deficit)/ Members'
    deficit</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Iris Preferred Stock</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Iris Common Stock</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left; padding-left: 18px"><FONT STYLE="font-size: 8pt">Class A common stock</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(i)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left; padding-left: 18px"><FONT STYLE="font-size: 8pt">Class B common stock</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Liminatus Member Units</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left; padding-left: 18px"><FONT STYLE="font-size: 8pt">Class A member units</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,547</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(4,547</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(j)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left; padding-left: 18px"><FONT STYLE="font-size: 8pt">Class B member units</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">167</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(167</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(j)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">ParentCo Common Stock</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(e)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(g)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(h)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(i)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(j)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Extension deposits due from Sponsor</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(161</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(161</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Additional paid-in capital</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,611</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">52</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">7,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(e)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">9,822</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,660</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(e)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(4,322</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">15,000</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(g)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">1,054</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(h)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">4,712</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(j)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(19,563</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(k)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">69</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(l)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">49</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(m)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(500</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: center">(p)</TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="background-color: rgb(204,238,255); font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Stock subscription receivable</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Accumulated deficit</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(28,665</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(17,518</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,044</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center">(f)</TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(28,665</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">19,563</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt">(k)</TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Total stockholders
    equity / Members' deficit</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(19,340</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(17,626</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">17,966</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(19,001</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Total liabilities
    and stockholders' equity/ Members' deficit</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,409</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">2,828</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">4,211</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">12,449</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA COMBINED
STATEMENT OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEAR ENDED DECEMBER 31, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Dollars In Thousands, Except
Share and Per Share Amounts)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Transaction</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Liminatus</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Iris</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">ParentCo</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Accounting</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Pro Forma</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Historical)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Adjustments</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Combined</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Operating expenses:</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left; width: 40%"><FONT STYLE="font-size: 8pt">General and administrative</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">645</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2,906</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 8%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">3,551</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Research and
    development</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2,685</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2,685</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Total operating
    expenses</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">3,330</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">2,906</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">6,236</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Loss from operations</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(3,330</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(2,906</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(6,236</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Other income (expense), net:</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Interest expense, related parties</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(339</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(1</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(340</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Interest expense</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(137</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(137</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Interest income</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">123</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">123</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Unrealized gain on fair value of
    warrant liabilities</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">19</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(4</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(bb)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(15</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(cc)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Unrealized gain on fair value of
    derivative liability</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">2</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(ee)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Interest income on marketable securities
    held in Trust Account</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">138</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(138</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">(aa)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Other expense</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,044</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">(dd)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,044</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Total other
    income (expense), net</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(216</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">21</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,203</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,398</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Income (loss) before provision for income taxes</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(3,546</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,885</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,203</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(8,634</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 8pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Provision
    of income taxes</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">19</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(19</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">(ff)</FONT></TD><TD STYLE="font-size: 8pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Net income (loss)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(3,546</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(2,904</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(2,184</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: center; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(8,634</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted weighted average units/ shares outstanding
    - Class A</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">95,555,554</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">7,191,610</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted net income (loss) per unit/ share -
    Class A</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(0.02</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(0.40</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted weighted average units/ shares outstanding
    - Class B</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">16,666,666</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted net income (loss) per unit/ share -
    Class B</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(0.11</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted weighted average shares outstanding
    - ParentCo</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">100</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted net income (loss) per share ParentCo</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(4.05</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">Basic and diluted weighted average shares outstanding</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">26,714,633</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">Basic and diluted net income (loss) per share</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 8pt">(0.32</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Notes to Unaudited Pro Forma
Combined Financial Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Basis of Presentation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination
was accounted for as a reverse recapitalization in accordance with GAAP, whereby Iris was treated as the &ldquo;acquired&rdquo; company.
Accordingly, for accounting purposes, the financial statements of the Combined Company represent a continuation of the financial statements
of Liminatus, and the Business Combination was treated as the equivalent of Liminatus issuing stock for the net assets of Iris, accompanied
by a recapitalization. The net assets of Iris are stated at historical cost, with no goodwill or other intangible assets recorded. Operations
prior to the Business Combination are those of Liminatus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The unaudited
pro forma combined balance sheet as of December&nbsp;31, 2024 gives pro forma effect to the Business Combination and other events contemplated
by the Business Combination Agreement as if they had been consummated on December&nbsp;31, 2024. The unaudited pro forma combined statement
of operations for the year ended December&nbsp;31, 2024 gives pro forma effect to the Business Combination and the other events contemplated
by the Business Combination Agreement as if they had been consummated on January&nbsp;1, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The unaudited pro forma combined balance sheet as of December 31, 2024 and unaudited pro forma combined statement of operation for the
year ended December 31, 2024 has been derived from and should be read in conjunction with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Iris as of and for the year ended December 31, 2024 and the related notes, which are included
in Iris&rsquo;s Annual Report on Form 10-K filed with the SEC on April 16, 2025 (the &ldquo;Iris 2024 10-K&rdquo;), which is incorporated by reference;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of ParentCo as of and for the year ended December 31, 2024 and the related notes, which are
included elsewhere in this filing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Liminatus as of and for the year ended December 31, 2024 and the related notes, which are
included elsewhere in this filing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The unaudited pro forma combined financial information should also
be read together with the sections of the Iris 2024 10-K, which has been incorporated by reference, the financial statements of ParentCo
as of and for the year ended December 31, 2024, and the financial statements of Liminatus as of and for the year ended December&nbsp;31,
2024, and the section of this filing entitled &ldquo;Liminatus&rsquo;s Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations,&rdquo; as well as other financial information included elsewhere in this filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management
has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma combined
financial information has been prepared based on estimates, the final amounts recorded may differ materially from the
information presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain transactions, specifically
the transaction expenses recognized by Iris and Liminatus in the pro forma transaction accounting adjustments for the year ended December&nbsp;31,
2024 are not expected to recur in the statement of operations of the combined entity subsequent to the consummation of the business combination.
Furthermore, while the Combined Company would be subject to tax at the corporate level subsequent to the consummation of the Business
Combination, the Company would be in a net loss position which would result in a deferred tax asset which has been determined to not be
more likely than not to be realized. Thus, the Combined Company would not have an income tax benefit. Accordingly, no adjustments for
the income tax impact of any transaction accounting adjustments have been reflected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The pro forma
adjustments reflecting the consummation of the Business Combination are based on information available as of the date of this filing
and certain assumptions and methodologies that management believes are reasonable under the circumstances. The unaudited pro forma adjustments,
which are described in these notes, may be revised as additional information becomes available and is evaluated. Therefore, the actual
adjustments may materially differ from the pro forma adjustments that appear in this filing. The unaudited pro forma
combined financial information does not reflect the income tax effects of the pro forma adjustments as based on the statutory rate in
effect for the historical periods presented, as management believes income tax adjustments to not be meaningful given the combined entity
incurred significant losses during the historical periods presented. Management considers this basis of presentation to be reasonable
under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Transaction Accounting Adjustments to Unaudited Pro Forma Combined Financial Information</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Transaction Accounting Adjustments
to Unaudited Pro Forma Combined Balance Sheet</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The transaction
accounting adjustments included in the unaudited pro forma combined balance sheet as of December&nbsp;31, 2024, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">(a)</FONT></TD><TD STYLE="text-align: justify">Reflects actual redemptions of 59,844 shares of common stock by public stockholders for an aggregate payment
of approximately $0.7 million in connection with the special meeting held by Iris on March&nbsp;4, 2025. Similar to those holders that
redeemed public shares of Iris on December&nbsp;26, 2024, see adjustment (d), such funds are indicated as restricted until the disbursement
occurs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">(b)</FONT></TD><TD STYLE="text-align: justify">To record additional advances under the Liminatus promissory note and additional related party loans received
by Liminatus of approximately $4.3 million that occurred after December&nbsp;31, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Reflects the liquidation and reclassification of cash and investments held in the Trust Account (as defined
in this filing) that became available for general corporate use following the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231f20">(d)</FONT></TD><TD STYLE="text-align: justify">Reflects the disbursement of cash restricted in the Trust Account for amounts owed to holders of
                                                                                                                                                                  64,453 public shares of Iris related to the pending redemption of such public shares on December&nbsp;26, 2024 and further those
                                                                                                                                                                  pending redemptions made by public holders on March&nbsp;4, 2025 as discussed in (a).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">Reflects the settlement of $9.2 million in deferred underwriting fees, of which $7.0 million was
                                                                 settled in Iris common shares (700,000 shares based on a deemed price of $10.00 per share; such price is subject to adjustment based
                                                                 on the five day volume-weighted average price prior to the filing of a resale registration statement covering such shares, with a
                                                                 minimum price of $4.00 per share), $0.5 million was settled in cash and $1.7 million was waived and no longer payable and was
                                                                 reflected as an increase to additional paid-in capital, as it would be eliminated upon execution of the Business combination due to
                                                                 the elimination of historical Iris equity. The remaining $0.5 million will be settled upon the earlier of the consummation of the
                                                                 Company&rsquo;s next share offering, or in six months from the date of the business combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">Represents the incremental transaction costs incurred
by Liminatus and Iris of $4.3 million and $2.9 million, respectively, for legal, financial advisory and other professional fees. The Iris
transaction costs exclude the deferred underwriting fees described in Note 2(e)&nbsp;above and the Benjamin Securities fees described
in Note 2(q) below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><I>For the Liminatus
transaction costs:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$1.4 million was capitalized in deferred transaction costs and accrued in accounts payable and accrued
expenses as of December&nbsp;31, 2024; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$4.3 million was reflected as a reduction of cash and capitalized and offset against the proceeds from
the Business Combination as a decrease to additional paid-in capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><I>For the Iris transaction
costs:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$0.9 million was accrued by Iris in accounts payable and accrued expenses and recognized in expense as
of December&nbsp;31, 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$1.7 million was recognized in expense and paid as of December&nbsp;31, 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$2.9 million was reflected as a reduction in cash; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">$2.0 million was reflected as an adjustment to accumulated deficit as of December&nbsp;31, 2024 which
represents Iris transaction costs recognized in expense by Iris as of December&nbsp;31, 2024. The
costs expensed through accumulated deficit are included in the unaudited pro forma combined statement of operations for the year ended
December&nbsp;31, 2024 as discussed in Note 2(dd) below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">Represents the PIPE Financing issuance of 1.5 million common shares at $10.00 per share with a par value
of $0.0001, generating gross proceeds of $15.0 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify">Reflects the transfer of Iris&rsquo;s Class&nbsp;A common shares subject to possible redemptions as of
December&nbsp;31, 2024 to permanent equity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">Represents the conversion of each issued and outstanding share of Iris common stock for ParentCo Common
Stock in the SPAC Merger.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify">Reflects the recapitalization of Liminatus Class&nbsp;A and Class&nbsp;B Member Units into 17,500,000
ParentCo common shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify">Reflects the elimination of Iris&rsquo;s historical accumulated deficit after recording the transaction
costs to be incurred by Iris as described in Note 2(d)&nbsp;above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(l)</TD><TD STYLE="text-align: justify">Reflects the reclassification of the public warrants&rsquo; derivative warrant liability of $0.1 million
to equity as Iris&rsquo;s public warrants are expected to be equity classified upon consummation of the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(m)</TD><TD STYLE="text-align: justify">Reflects the forfeiture of 4,177,778 private warrants held by the Sponsor immediately prior to the Business
Combination resulting in a net decrease to the derivative warrant liability of $0.1 million with an offset to additional paid-in capital.
The remaining outstanding private warrants issued in connection with Iris&rsquo;s initial public offering, are not exercisable until 30
days after the Closing, as such, the warrant liability has not been adjusted for these private warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(n)</TD><TD STYLE="text-align: justify">Represents the settlement of Iris&rsquo;s related party promissory note, including the associated derivative liability, upon the consummation
of the Business Combination, in cash.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(o)</TD><TD STYLE="text-align: justify">Reflects the settlement of the promissory note between Iris and Liminatus upon the closing of the Business
Combination</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(p)</TD><TD STYLE="text-align: justify">Represent fees to be paid to Benjamin Securities,&nbsp;Inc. pursuant to a Capital Markets Advisory Agreement
whereby Benjamin Securities,&nbsp;Inc. will assist ParentCo in meeting the initial listing standards of Nasdaq. This adjustment has been
shown as a reduction in additional paid-in capital, as it is a cost of issuing equity securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(q)</TD><TD STYLE="text-align: justify">Reflects the payment made by upon the consummation of the Business Combination  for D&amp;O
                                                                 insurance, which will be utilized by the post-combination Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Transaction Accounting Adjustments
to Unaudited Pro Forma Combined Statement of Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The transaction
accounting adjustments included in the unaudited pro forma combined statement of operations for the year ended December&nbsp;31, 2024
are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(aa)</TD><TD STYLE="text-align: justify">Reflects an adjustment to eliminate interest income related to the Trust Account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(bb)</TD><TD STYLE="text-align: justify">Reflects the elimination of the change in fair value of the public warrants, which are expected to be
reclassified to permanent equity upon the closing of the Business Combination, as discussed in Note 2(l)&nbsp;above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(cc)</TD><TD STYLE="text-align: justify">Reflects the elimination of the change in fair value of the 4,177,778 forfeited private warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(dd)</TD><TD STYLE="text-align: justify">Reflects preliminary estimated Iris transaction costs that were expensed upon the closing of the Business
Combination, as discussed in Note 2(d)&nbsp;above. These costs are reflected as if incurred on January&nbsp;1, 2024, the date the Business
Combination is deemed to have occurred for the purposes of the unaudited pro forma combined statements of operations. This is a non-recurring
item.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(ee)</TD><TD STYLE="text-align: justify">Reflects the elimination of change in fair value of the warrant liability. Such warrants were
                                                                  forfeited upon the closing of the Business Combination, as discussed in Note
                                                                  2(m)&nbsp;above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(ff)</TD><TD STYLE="text-align: justify">Reflects an adjustment to eliminate income taxes due to interest income related to the Trust Account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Loss per Share</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following
represents the net loss per share calculated using the historical weighted average shares of Liminatus exchanged common shares outstanding,
and the issuance of additional shares in connection with the Business Combination and other related events, assuming the shares were outstanding
since January&nbsp;1, 2024. As the Business Combination and other related events are being reflected as if they had occurred at the beginning
of the period presented, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that
the shares issuable in connection with the Business Combination have been outstanding for the entire period presented. No unexercised
stock options and warrants, which are discussed elsewhere in this filing, were included in the earnings per share
calculation as they would be anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Year Ended December <BR>
31, 2024</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Pro Forma Combined</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; font-size: 10pt; text-align: left">Pro forma net loss</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">(8,634</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Pro forma weighted average shares outstanding, basic and diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">26,714,633</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Pro forma net loss per share, basic and diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.32</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Pro forma weighted average shares calculation, basic and diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Iris public stockholders</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">114,633</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Sponsor and independent directors</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,900,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred underwriting commissions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">700,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Equity PIPE Investor</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Liminatus Members</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">17,500,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Pro forma weighted average Class A shares calculation, basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">26,714,633</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>limn-20250430.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKHObOdzZR+2YkxtmB1bYma/yYjLKyQDSgQzN6mESoH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:LIMN="http://tribecapitalgrowthcorp.com/20250430" elementFormDefault="qualified" targetNamespace="http://tribecapitalgrowthcorp.com/20250430">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://tribecapitalgrowthcorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="limn-20250430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="limn-20250430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="limn-20250430_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>limn-20250430_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tribecapitalgrowthcorp.com/role/Cover" xlink:href="limn-20250430.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://tribecapitalgrowthcorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:label="loc_deiFormerAddressMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiFormerAddressMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName_50" xlink:type="arc" order="58" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>limn-20250430_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:label="dei_FormerAddressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_FormerAddressMember" xlink:to="dei_FormerAddressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_FormerAddressMember_lbl" xml:lang="en-US">Former Address [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>limn-20250430_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tribecapitalgrowthcorp.com/role/Cover" xlink:href="limn-20250430.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://tribecapitalgrowthcorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:label="loc_deiFormerAddressMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiFormerAddressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIMINATUS PHARMA, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001971387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">93-2710748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6 Centerpointe Drive #625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Palma<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">273-5453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Iris Acquisition Corp<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LIMN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LIMNW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3rd Floor Zephyr House<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">122 Mary Street, George Town<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">PO Box 10085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Grand Cayman<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">KY1-1001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (Z*IEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( (Z*IEH;&!H [@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MZ5;AN>-SH8UB$+$12PHCA.O<#&^'H_[TXX2,W_?O;OM'9#@:'". )SO DRJ
M ^A,!1TY3"/^1*[YN@@15_(@;B<=/^AV$"S?<\73JP(V94]D& &=F(F0Y6YS
MN%]+)$^".NWX7J?9Q0CWRKM?A7"8AE(MI<KACLC$0 H0J<A 9A!3"*V,"CN\
M1/WB$H-TQ=]'R_6+ZG_T?$!R#_B0%I/ADNU\M'!X9@%?Y$*!]Y,W;;2N^,X
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( (Z*IEJ7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ CHJF6JK$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    ( (Z*IEHD'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " ".BJ9:99!YDAD!  #/ P
M$P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=
M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'
M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-
MF<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*
M1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP
MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,
M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (
M (Z*IEI&QTU(E0   ,T    0              "  0    !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ CHJF6AL8&@#N    *P(  !$
M ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ CHJF6IE<G",0
M!@  G"<  !,              ( !X $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " ".BJ9:)H&WT^D%   2'   &               @($A"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ CHJF6I^@&_"Q
M @  X@P   T              ( !0 X  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    " ".BJ9:EXJ[',     3 @  "P              @ $<$0  7W)E;',O
M+G)E;'-02P$"% ,4    " ".BJ9:JL0B%C,!   B @  #P
M@ $%$@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ CHJF6B0>FZ*M
M^ $  !H              ( !91,  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ CHJF6F60>9(9 0  SP,  !,              ( !
M2A0  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  E!4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>28</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2513673d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tribecapitalgrowthcorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>limn-20250430.xsd</File>
    <File>limn-20250430_def.xml</File>
    <File>limn-20250430_lab.xml</File>
    <File>limn-20250430_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2513673d1_8k.htm">tm2513673d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>25
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2513673d1_8k.htm": {
   "nsprefix": "LIMN",
   "nsuri": "http://tribecapitalgrowthcorp.com/20250430",
   "dts": {
    "schema": {
     "local": [
      "limn-20250430.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "limn-20250430_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "limn-20250430_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "limn-20250430_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2513673d1_8k.htm"
     ]
    }
   },
   "keyStandard": 28,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 69,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 34
   },
   "report": {
    "R1": {
     "role": "http://tribecapitalgrowthcorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513673d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513673d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r14",
      "r15"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r16"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tribecapitalgrowthcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>26
<FILENAME>0001104659-25-045127-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-045127-xbrl.zip
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M.6B%TU7'%YOGXPJ2'9*5/I30W3#!3AMRP%:DUW!@=U:*[YN%*<GH@ 5( ![
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M@-8L4)00:5Y.XNEVOF'.,2U[*3$T/@%QVFNST1%$@X7+E4E$I?DQ*+QXBKO
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M_DZ>P7I9.K], #:[4!BBB*AP.P.PJ,1(J9&0!P'CAF=KS)_G63(P5-A"OVA
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MLM%KN<N(4QH1*WW^ &;J$*1CZI2Z8>#9[A**ZRR+<$T=4L_8@&8-9BQ=3,!
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M;F^Z%)_$YGJ3^&N)"R*V_!=02P,$%     @ CHJF6O?*QG.9"   B&D  !4
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MK_M'*$VK#^;;\AO[P_[=''/E;U!+ P04    " ".BJ9: C3?_@N,  #UN ,
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M]?O??N)0_'L$=N*:E='4'V&5]W4Y"\O&]^V=9"M\7HID ?*%?[Z8#=/X(<;
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MU^<K[?I4<\%T%(<&KUX=XX\524B5 :[^!1N&A!1\KYS-2&C@P<3$073!R@G
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M;,=A[X7S2;*_="%V=$VG)YG65F17BGX'$_A[@B+$#5K/@T@'J.W0N-H=,F\
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MZ(^F8O2!U%I@#+*Q@*W8)QC 1T:(JV_@T FKY2UPNSX9X3 <=!R/)*$-YEC
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MWDBU:UB\CF:A]#=LUWS-UEPEP!#0-6SCCHS8H&>=>0&=).2>+UDQQWR:!;6
M'*=@%VY7=,U6=(H=K"TS2YWNG8J\)Z"A8F' Z,VFK]S:D<=&Q*#D(T80#V?P
M7@/S?==@15M^N+54#XV+%=G !=BWBPJM5(E\D1=BEBM ?UY;._M _XAR/B\)
M)=6S7,NN!QK?$@=)(BPDQJJJ(H\7:C2Y9:+U8B+R<-I2)183Y"79YU<+"0/+
MBQY!R@4QD!B8UB([IHXVO;:7<CJ:<K7N17['V\1_DU[83N,>>9H'Y#2F0)7J
MU!V8-*F1#5^EPE1.7GHCTM61NM7*B*!<"XSQV]W4CT'E['B!B2@R,V$?K"Q
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M4"T]LCW-.$+,N*.P-OX#@SD70<R\](?P.5>/N?\BQ>)@"=?&"0F%SJOW=-5
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M=-!P&J'@-RC10<%GJL2H=E[7D%WI(6T0%5>6#UJEI^EXG,/%(2:4U+I<U<#
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M[W4.=G>O4RX=]J%Z4%N'5,U:&OLE->L9H*U2HZU)=$$YWK+@18H%$6JO,2A
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MG(\B<A+=EEG62:+481(VAF.:TV#7C&-^%D'(/A?NL,[#^Z]@!I]^81JM;[C
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MW]/@4Q,MTIE=Q?R[FFV6['R>I6@HV^9-M@4NH']EK)L5<RXH[:T/<GJ(J/;
M/[-AJ%,!6:Q*=9/-T0EE1!CE)()XX+7(GVFGET'^ !%P0O,7/6=3ABI/M':,
M[)B+4EHUYSZ:^CYJ%<IX.7PJHC2BC'A^;H&'I/B(B<?/4U9L5PP*?C"]8MB)
M3+1  I$D$&LS.[[+8#CC@$X\\CD&OTC9>.IP$I8NA-<FIN5(*Y;B<@6.=^Q1
M"OO2RCVB#VFEV^[T2K>9"Z0-V%9(O4-!O/^HQ=5$GM25 +/TG]LM+%?QQ'%
M:6"'(K0\NKT>_*2X?.QS<B<^-8#\IJ-8H,'7BYX#8/,%TJENVPM18R?0"VFQ
M9,JX\\D0'RECT!%:L.5J":*,J5RJYEZGO=5"#L6\V9#E\X22&H":PSIYC]26
M(H/8%+0&\@.+%0+['="T]E=BA:Y;I. 'VGQ%7]NTF)\J!LP$SCON^FKNTTQ)
MO]+K2OH5?R7]GET*E9-2*!6/O8,R=Y]P4CN$Z<#FC4-D-RV8 G7]@,I!BG[U
M^LT03G.9I7Y&CX-06K+G5&T*<#"GJN^>.N(/,GM$1RH6AU"><!NA80U=!:N#
M.M,T,ZMSPR'H8\,[Y1]EMM!7(D/R[TH^CUT >HO5(0$(R!:4P>$,IA!^@J#'
M$CEBJ_><P+R-!SPH0,U !U@8Z))\Z$I4L+=J><@XN='PBPRL#2"+9(#;RUL'
MDBT R7*14MY:424QG9TK><5"N.J"S<JM7K"GXPWAQD:(([; ODZ6?FN<*$O.
M>2EZRZ7SN4+<&X9&DPB0I,=&YLX'&@O*!YK)?. LN!D4@HG6F8K@SASY0SYU
M?FJN<%YSS-#,L<J*<IIDJBHL4JG&/-A3@)PV@YMX2YXI-)4ANATQWP[\XX5A
MC#IJ"!6 4&X)# 7C/HG4;U/=PL#B4TF\Z\ <&SK0+U4])L2ZH3]'A N :&E1
M8D)NU^OYTHI2TT\X02A2&,,80(NJ-A];/ZV"I&6<S+@(NV S0&BGY7(T6B:1
M<$.YN(%J'PS^A-0#O:)"C D=WD<K(+F,1CM"2U#B;"ESF'H,1A.:^GBK,82?
MZ#USF2]&HTY3_3G>E92T=)2V9HF!A>!AK)1)!13+L7JV'I 9F[W 6[9U1(\>
M^4KL4)V*,I4]'8)J0O+1(1#Z<K Q!?K.6&Z,O3ROW68#,A$M344NNYTL>Z4
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MO\TQ'F+--[(2?(RK=#>TAEQ57#A7+4U[U8I6K5I2B<4J6':]:@.Q6&1O*FB
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MCD^/$<NPF^FLYT^?2X+=^N]1.L\*#O ];?]UC'8]&SLS_"#9GZ329,C';PY
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MFFN%_\V4A))*7"RR%C2?OFS!LKS]]O@0DS;C@N D[QYMO.%PG[^PQXMHG<"
M&0'DCX3Q@HLD(]C2KQK%BU?A59.B!1[%:X13W61$[' M:4YWH^6,9XM%.LO@
M^?D=OA3?N/?9PB[1JW52&7_SMY\/SH-E)^D_5G ;0$M4E+).9W7T;\]?/'WV
M#"?%]2I<,C_[^ZI&984I2RH#C>IEGC6P ORO688C+V;P"U!?U15<OG\F J$'
M7<-45NI7NCPCSSZE^XS@+.ZB%\^& X3<X"H>)7=<'"&PN)?/GEA_4DL.7]R[
MZYVY"CFKTGE,A><9>)\SP:TLI%A:ALC3H>PY.53^=#3V)@1EX7WC3#OE@7&W
MPHJ9WZ-(.D!JJ2-9,6"FC-0(Z(QD55=E+"[>-*FO8Z=D1 T23A0L5;/KF63W
MUO597!VK9!=U4;G%#3,ND.DDJ"R_!"L$?[%2RGL&*D#5/WKUJ<9#!W>Q\"N.
M^'[1?A(T;(Z\(@2%D'(39_NII%:&N<&,8@0],B9V*EB1V:K2XL65(2!R)ZLF
M,NB0ODK,S2L(D0.+I9,@-87F019S.%"CV(5"I<VRS"\?L\R[F&7^D'S.%JM%
M=+I""QKOD8FCW3?R& QZ?+_5)SO I/%%V><=L*3]R68%;?PX^93.D&ES? V"
M%57P?8/N.Y>!V43'?LAJ71_0IV'A_[A&(5I7HH 0:8$4=5<JN$48D50@HNW4
M 6 F8_7<*CS ,,:Z<H>>YWDE&7L;UC$@[>/Z0H8M/A/>]G>QO'XM4)1-K@!8
M2 L$X,_86YW#KK9T0KMZRN,#Y>+P<@$'3L'].\L"P#5<ZG>BI:3QJ(@ [?@2
M0?,U?5;Z>9FY)<RNO4=9(%W7P[F@V&(%=(.9[-"N!6YJB*7%NQ9[57>:,)4]
M$:LT*FG!,FFZLEK&YE2%7L3:2H]J]+9PV1+5@&WQH?//5W9U=3=!2^^!\0\O
M=BG3<K^4]U<3PP0=$UTD37)/ >OO]G#P-1@;1N%VPY59M2SM<DOT6<4ZZ*S1
M9((,F\]1BJ]('F&AL'FB^9AD0#0YI/6EX8"^5=;-$XM^$#]FOFC% G#TRL*!
M7PL[)C^Q2E%X@1&!4R"A9P:SXSL:4%8^K-51G9J0D2RU#M8W)AP#580_T:-7
M2XFO<HREMBI 6I"ZV% FXC=,U8&E8C9[6?H92SZX+M9^%+QA*F\@3;=JT$:D
M<\"QTU#,U2V/23GT(N&C.SNL](4K8P_6Z%_O/?M>7!)Y07(^]5H1NWG)0%G]
MWLR:_.8CY<IM+^&IPV_:L@EF#."EZ1<='#^Z%PAY^716?%#VYO8.A];26\K0
MV]M9CCN^_]W'!+;B%HO#YLBVZP;9(S<(3V\B/IM"+ *F]\2@MPY<(I64Y"S\
M>+P5!,>D<BZQ<8Y/VL%OX6Q0:0JA!+XN;],;8>I,6/S*#(F:9KK"*'E(/,2R
M!,:T9?DP3=%497^PPP:^O4Y!..T=J*UQ= &R3=K5KGY21]7JAM].FIA)_"VZ
M66,P6Z- L!63]G0]""DET+Z%&Q5KZ[7"FO-95F/].-6*6M%A5FY34!LS=#9Y
M_(XWX&J[U]'>6T4+VS<=3'OKFF%W) 7H ,0H9'.PSS%#,B^KUI0XJIM0N7."
MG$*I$ 91(1^6RZTJNAO&A7%?'\W2'!:2:O>%ZM@FZR(#!R.KC45' 0^?K/3I
M#4X/QR4A!)=?JVO#8,$.K04#G11<,3J#*BAAR77X^E''>@O.#O=:5T@[0[)%
MT,5*,9H\?_4*K8#%*K_B8K3.H[8GFH,(X&M$?U3Z*=83+-<H,BLM@9A]T(DK
MN19%&=V4^6J1FGR179I)@193XEWO4V7GWJAC^F:G:04DZ]%<5^7J"NFBHTE5
M?D(A,TOA_E5.S7M:<80FN/65G%SU5^N=NU)&ODDZX=5C.F$GT@GW,88[W7L5
M2W4%A"9RF!#-RE+$+8C'.>%5_<_7=@Q3Y:-GY72EZ-HHZYT91<*0!I*6Y+MH
M;@)7TL0Z"&-%;5#6U,H20ME_!8J=T_DMX4,7.S:ZL6/4I&7)M]>*=HNO\7TW
M/AI]7J9%W1]!Q$4&1?&DG#]9@D&78F:6O\5!=?N!:SDX\&$:6[)[-%;:G+/_
MBROE'!]S'8:#.4(7+8^)_NV;?/SAVL\T$'60OA7O--_4<3%;P<LHO( GO(0?
M#YAW 4Q6TP5C7P4X'1-"V7$M%(KMG.#O"M@Y1-3L'I.K-CCM_\X5B-0^OD;\
M# =LR#H0E0E2R->?[J(\N76V$71.718,E%#/!9M@ O:3!&OHX<SSI;BW/AIC
MH@ZY0_@VV"IX'6*>V-AE!HJN\/PVLY+#-AP&M@$)U!J2#_#-.BW(JVO2/%U>
MEP4W+A0[_$[OU';/\B@PR_N>#X<;>(NGVW7A1E^R!J3;"2X(CUNF]$R1I$3S
M+=8T^IJKHDF*QF<:1FVS0A<Q0E%*%P8Y3P)7J^6?4MW [JWSNPW76=T<6F*\
M5WO/Y9M$MJN/7DV$,Z:WSR+Y.VD1Y-7)B&V]UBEFORH491A(H:1ANR]0-RMZ
MS&PI<]$1*QF;7@GASWQ#SG[&UV1N77:@%UH9VPYKE(LUD$:H%JQX./WJ!1(I
M&E8K3>*'2)UH[G!P'LYF]!C)L9UJL'1D9SYB7\QND]E [(7_ HM@,M:9D91[
M'$O\;G;?7$9X EM\Q%JG"7SQNK'NX(,4P>T0'LQU S=F$AH.3-GIR]C.HNU6
ML:F[%E@"^ ")>J>YZTXEZ@.-I==EJY64V[7D?$^;LJ^TE*R_Z>)74TWESSK8
M*?RK ;GYLS5)E?M(LWM@G5_LSF)8Y4-!\D[L=)C<2>6$BMWP=_0U=^(XFLTQ
M*J>@";?Y%FQB2ZOU^4!<P#W\IKK/L*JD6] W:CN-6??'OSCTA5^ AZNR,EEL
MIX .UIUMLA*F@K\]_>5R!.;& B8Y323DB;^3GY)ZEOPC.I1:+IZ*\Z?W>3GI
M_<LE^6SN!Q2')X]?<6W$P\'9^/ _W^(T\(?_:B?H=";<]&9.KTJ8Y#8WJ]PL
M7?7=8[IJ)])5[5N^MEOQ5Z/\-Q1[A%=8AT/4[2,8/8+PJ#J[*J3\(9:P"[K:
M*78EP?X*E:J#L-LX\Y^O[Y:8TYY*XF9)#9WBB'N'*=S64D5YEAIM;3._*PB)
M($B<MY@_*;*'_(YA0NI?7),(7OH$A/&U2B*"DU\1^H:23TLL%/S'*KN!*2,P
MHZPSCAT0,$ 7T;8R+DBLF]H/FE)TH?TD5>%KVQM<D&5<IN??*^GID!SA-X<#
M\]+8KL*\LQM(P NK.VD>CA^Y398&\$! OBLK *39GEETTZ>HN07V/TX%:H7
MIM@2[,-!"AM>+K(I0:A$2%) "/LE5_5UME3;:H:HZ/TU&,PN)<YJ51&3-DW.
M(1<=NF_#86B(6 ?LGA':9:NUA0KZ%D6Y*J:F>(>BO0T6,/")X\"2P=S+H"00
MS$&K:9X@>;6^&/RF;=9LF\@#*XW4G[FW<EF":,$:6'55:P>A[(40D]KJ=$-@
M9I.]PO8/9ZJQ! ;A$.&$7X CI_>=7VA(7M@">R(M2'"S;NA-6[P77<N.\]^
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MTH<RA/4^HFK@M]Q*F?U1!:3!DDJ%>W(+(O%37]B.=9^S)4L"@Z>?E[ ?6-7
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M$KRB[I7M"]-R%81XZ^NH[$D4$[D)N_7ZQA-7A-<AAFM(0$[G:=-P UB2 [-
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MV1%8' L&@3NCIM2S[A]D)Y_WLD;B772DX("6(;83N/@3CA472:&176Z9G5<
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M7C:@V2#8#'Z^H<G !N2I@5M3N_I*#V<J6VZ._DAJ$(8# HHY^HMT%CXVOZ-
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MLZHJ4M1$W5@Q^&+\>@TAGC9N1"/ ?N*'H2=E^:E6)Q"T9<W+P:(!4WU2?47
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MZI"XF:5X.E]GICT6IWQ,CY)&#1[T%MN>%H=ML)<TB</2N@ XHP1E.RK"?#,
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M]9XN^3["7R\_US]GCK]Z_G]02P,$%     @ CHJF6N:3\+<V @  20<  !8
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M1J&1Y?K>3DBC.>\9:"01#O.OQ!9I>);/U#'Q YWYT8*%2K-NI]_#?-R6_QZ
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MKCENJT')P8,-]J*#U$\CX.JT5D/KDL/J8O9/V%M/%18XN@%A0'Q\56D "CL
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M)<HS:EW8,J$F@KYAOKSU%\:FB%MX2OT>SPGIG*4 /^QUR',Q"@1MPK>+&G&
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M%<U=RRLF]DVMG76,GBJ#@3$2\FDXYU0"O<2I>.[(MU( 1(:AXW>;*A#)[;H
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M&XF<Y@6_;\7G*]8#,[F)!;5:BU+6&!I2^K-L)B8'<Z<>%(:HP%N/0]U"E#G
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M=U:%/DDC1_12K'U+EEZF_1]02P,$%     @ CHJF6D\)2;"?)0  >F(! !8
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M!5>*@5UA@CMC7 UWC:\"=B-X1.O@!["##%PF?!=@L7#7:Q;P67C]( 8HMIW
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M1)(B"PS'DRA$GL(JQ@;B4[-F4 R'.M_QT4S.,;6+P]$D8Q8A IC"(%V-!::
M"O,'O?^&:/=97J$I9DE5!.D=1H$CW 0(H'-(!930T0JDX=]57KY97KPM(^Y4
ME3OTH)'7V2) 1K>UUW2U1T"!(<":K(>\RH&?8B>N.:P$:S50A#B01<7H&27
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M+PA5#ZB2A*K]4TE!*@4?GCO\K<2@$H/J N/J N/R"XS?51<85Q<8WW?[];C
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M_C%R*XGSF+R*%+HU$%Q3!2*"D"T3V@!0]HN?H30WV2E$GBX*"+6:@=C TX$
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MN_WQY>KRC)V>G=W\N+Z_O/Z=?;W\_FU-D/XS#B.G-UXS/O4L]SZ+!IQ]\<W
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M5N0\.)'#P]^*H%1VV)XZF?-9\Z4O2@-H@3?GF'+;-[;&%+A9J$U*XN/#PK*
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MSUY_#E5BQK(S.V3G[.S&-DRF2/%!-_?1<XB"Y%68%WL'QR>KM"Y>QXV /:S
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M@F$2#D[<9.BYN$275:IB>+V&)<,;VDF%WR>.+Q,,T#$  SBZ:R+7'<5=4*A
M $2!B4<@! .,K/ X0'R"-$MJD5O*N?6([ )L"/2&9!U?FLT+;HW^+F0=@L5V
MN0YWD[N-EH[*4KN#9H P!;*B!X>GQX27QDO48*46(*?FPC3K-+7%E/$"POOU
M6A%,%5P:#'#ZS]CCTEM'YLO!-&S"0@ 5-F$.?@<RP4OB^#P*4I!H@MGMT=_
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MEA.*+@79=M<M-632 0.>,9GG>_N6&<(N8=VA:8EF%R&R;>HR.P0='-8CNA[
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MDP ?V1?N![M05'8Q>U'9^BJ\/EQ_N_TWIFL__/G\]<O5_P=02P$"% ,4
M" ".BJ9:DR[3'% #   \#0  $0              @ $     ;&EM;BTR,#(U
M,#0S,"YX<V102P$"% ,4    " ".BJ9:VX6.KE()  "/<   %0
M    @ %_ P  ;&EM;BTR,#(U,#0S,%]D968N>&UL4$L! A0#%     @ CHJF
M6HT39$0J#   898  !4              ( !! T  &QI;6XM,C R-3 T,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( (Z*IEKWRL9SF0@  (AI   5
M  "  6$9  !L:6UN+3(P,C4P-#,P7W!R92YX;6Q02P$"% ,4    " ".BJ9:
M C3?_@N,  #UN , $@              @ $M(@  =&TR-3$S-C<S9#%?.&LN
M:'1M4$L! A0#%     @ CHJF6@TL(PS950  1_P! !8              ( !
M:*X  '1M,C4Q,S8W,V0Q7V5X,3 M,2YH=&U02P$"% ,4    " ".BJ9:X1%
M!R 9  ">G0  %@              @ %U! $ =&TR-3$S-C<S9#%?97@Q-"TQ
M+FAT;5!+ 0(4 Q0    ( (Z*IEJ/=Y_HC0(  #H+   6              "
M <D= 0!T;3(U,3,V-S-D,5]E>#$V+3$N:'1M4$L! A0#%     @ CHJF6D-3
MC$=W!P  !BX  !4              ( !BB ! '1M,C4Q,S8W,V0Q7V5X,BTR
M+FAT;5!+ 0(4 Q0    ( (Z*IEHGK++HD0T  /Q<   5              "
M 30H 0!T;3(U,3,V-S-D,5]E>#(M,RYH=&U02P$"% ,4    " ".BJ9:YI/P
MMS8"  !)!P  %@              @ 'X-0$ =&TR-3$S-C<S9#%?97@R,2TQ
M+FAT;5!+ 0(4 Q0    ( (Z*IEJJU?S?>R4   '%   5              "
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M+FAT;5!+ 0(4 Q0    ( (Z*IEJF.96D43X  -CV!  6              "
M 3OF 0!T;3(U,3,V-S-D,5]E>#DY+3,N:'1M4$L%!@     0 !  , 0  , D
$ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>tm2513673d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="limn-20250430.xsd" xlink:type="simple"/>
    <context id="AsOf2025-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001971387</identifier>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2025-04-302025-04-30_dei_FormerAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001971387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2025-04-302025-04-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001971387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2025-04-302025-04-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001971387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-04-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-04-30" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-04-30" id="Fact000005">0001971387</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-04-30" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-04-30" id="Fact000011">2025-04-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-04-30" id="Fact000012">LIMINATUS PHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-04-30" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-04-30" id="Fact000014">001-42626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-04-30" id="Fact000015">93-2710748</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-04-30" id="Fact000016">6 Centerpointe Drive #625</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-04-30" id="Fact000017">La Palma</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-04-30" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-04-30" id="Fact000019">90623</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-04-30" id="Fact000020">213</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-04-30" id="Fact000021">273-5453</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="AsOf2025-04-30" id="Fact000022">Iris Acquisition Corp</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:EntityAddressAddressLine1
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000023">3rd Floor Zephyr House</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000024">122 Mary Street, George Town</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000025">PO Box 10085</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000026">Grand Cayman</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000027">KY1-1001</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="From2025-04-302025-04-30_dei_FormerAddressMember"
      id="Fact000028">KY</dei:EntityAddressCountry>
    <dei:WrittenCommunications contextRef="AsOf2025-04-30" id="Fact000029">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-04-30" id="Fact000030">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-04-30" id="Fact000031">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-04-30" id="Fact000032">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember"
      id="Fact000033">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember"
      id="Fact000034">LIMN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-04-302025-04-30_us-gaap_CommonClassAMember"
      id="Fact000035">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember"
      id="Fact000036">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember"
      id="Fact000037">LIMNW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-04-302025-04-30_us-gaap_WarrantMember"
      id="Fact000038">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-04-30" id="Fact000039">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-04-30" id="Fact000040">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
